Name	Gene(s)	Condition(s)	Clinical significance (Last reviewed)	Review status	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	
NM_012179.3(FBXO7):c.[274G>C];[520T>A]			Uncertain significance(Last reviewed: Aug 7, 2017)	no assertion criteria provided					433544	
NM_000404.3(GLB1):c.[276G>A];[75+5G>C]			Likely pathogenic(Last reviewed: May 11, 2016)	no assertion criteria provided					427824	
NM_000157.3(GBA):c.[1448T>C];[167T>G]			Likely pathogenic(Last reviewed: Sep 25, 2015)	no assertion criteria provided					424819	
NM_000157.3(GBA):c.[1448T>C];[407C>T]			Likely pathogenic(Last reviewed: Sep 25, 2015)	no assertion criteria provided					424818	
NM_000404.3(GLB1):c.[245C>T];[367G>A]			Pathogenic(Last reviewed: Mar 12, 2013)	criteria provided, single submitter					424779	
NM_019112.3(ABCA7):c.3641G>A (p.Trp1214Ter)	ABCA7	not specified|Alzheimer disease, type 9	Uncertain significance(Last reviewed: Apr 25, 2016)	criteria provided, single submitter	19	1054255	19	1054256	225545	227448
NM_019112.3(ABCA7):c.2126_2131del (p.Glu709_Gln710del)	ABCA7	not provided|Alzheimer disease, type 9	Uncertain significance(Last reviewed: Apr 25, 2016)	criteria provided, single submitter	19	1047510 - 1047515	19	1047511 - 1047516	225544	227447
NM_020297.3(ABCC9):c.448A>G (p.Ile150Val)	ABCC9	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	12	22069996	12	21917062	487606	480711
NM_020297.3(ABCC9):c.2019+2T>C	ABCC9	Wolff-Parkinson-White pattern	Likely pathogenic(Last reviewed: Jul 14, 2017)	no assertion criteria provided	12	22035698	12	21882764	487597	480710
NM_005159.4(ACTC1):c.524_525insC (p.Ala176Cysfs)	ACTC1|LOC101928174	Wolff-Parkinson-White pattern	Likely pathogenic(Last reviewed: Jul 14, 2017)	no assertion criteria provided	15	35084700 - 35084701	15	34792499 - 34792500	487625	480715
NM_005159.4(ACTC1):c.944T>A (p.Met315Lys)	ACTC1|LOC101928174	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	15	35083361	15	34791160	487590	480714
NM_001103.3(ACTN2):c.2075T>A (p.Ile692Asn)	ACTN2	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	1	236918419	1	236755119	487588	480672
NM_000669.4(ADH1C):c.232G>T (p.Gly78Ter)	ADH1C	Parkinson disease, mitochondrial	risk factor(Last reviewed: Jan 1, 2005)	no assertion criteria provided	4	100268190	4	99347033	18181	33220
NM_000674.2(ADORA1):c.835G>A (p.Gly279Ser)	ADORA1	not provided	Uncertain significance(Last reviewed: Feb 22, 2017)	no assertion criteria provided	1	203134882	1	203165754	375733	362618
NM_147185.2(AKAP9):c.10567C>G (p.Gln3523Glu)	AKAP9	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	7	91727092	7	92097778	487601	480699
NM_147185.2(AKAP9):c.11273G>A (p.Arg3758Gln)	AKAP9	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	7	91732107	7	92102793	487596	480700
NM_020977.4(ANK2):c.1427A>G (p.Gln476Arg)	ANK2	Long QT syndrome|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	criteria provided, single submitter	4	114186093	4	113264937	487619	480686
NM_020977.4(ANK2):c.742G>A (p.Val248Met)	ANK2	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	4	114161689	4	113240533	487591	480685
NM_020977.4(ANK2):c.5437A>G (p.Lys1813Glu)	ANK2	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	4	114294327	4	113373171	487587	480687
NM_022089.2:c.1777_1778delTC	ATP13A2	Parkinson disease 9	Uncertain significance(Last reviewed: Jan 31, 2018)	criteria provided, single submitter	1	17319047 - 17319049	1	16992554 - 16992555	632090	619966
NM_022089.2:c.2983delG	ATP13A2	Parkinson disease 9	Uncertain significance(Last reviewed: Jul 12, 2017)	criteria provided, single submitter	1	17313640 - 17313641	1	16987150	632089	619965
NM_022089.2(ATP13A2):c.2640C>T (p.Ala880=)	ATP13A2	Spastic paraplegia 78, autosomal recessive|Parkinson disease 9	Uncertain significance(Last reviewed: Oct 22, 2018)	criteria provided, single submitter	1	17314939	1	16988444	626064	614198
NM_022089.2(ATP13A2):c.2746G>A (p.Val916Met)	ATP13A2	Spastic paraplegia 78, autosomal recessive|Parkinson disease 9	Uncertain significance(Last reviewed: Oct 22, 2018)	criteria provided, single submitter	1	17314833	1	16988338	626063	614197
NM_022089.2(ATP13A2):c.3405+9C>T	ATP13A2	Spastic paraplegia 78, autosomal recessive|Parkinson disease 9	Uncertain significance(Last reviewed: Feb 5, 2018)	criteria provided, single submitter	1	17312949	1	16986454	626062	614196
NM_022089.2(ATP13A2):c.1039+6C>T	ATP13A2	Spastic paraplegia 78, autosomal recessive|Parkinson disease 9	Uncertain significance(Last reviewed: Oct 25, 2018)	criteria provided, single submitter	1	17326500	1	17000005	625890	614200
NM_022089.2(ATP13A2):c.1542+3G>A	ATP13A2	Spastic paraplegia 78, autosomal recessive|Parkinson disease 9	Uncertain significance(Last reviewed: Dec 6, 2017)	criteria provided, single submitter	1	17322468	1	16995973	625889	614199
NM_022089.3(ATP13A2):c.746C>T (p.Ala249Val)	ATP13A2	Parkinson disease 9|not provided	Uncertain significance(Last reviewed: Sep 30, 2018)	criteria provided, single submitter	1	17326989	1	17000494	585085	576078
NM_022089.3(ATP13A2):c.3329A>G (p.Asn1110Ser)	ATP13A2	Spastic paraplegia 78, autosomal recessive|Parkinson disease 9	Uncertain significance(Last reviewed: May 11, 2018)	criteria provided, single submitter	1	17313034	1	16986539	583336	558224
NM_022089.3(ATP13A2):c.2T>G (p.Met1Arg)	ATP13A2	Spastic paraplegia 78, autosomal recessive|Parkinson disease 9	Uncertain significance(Last reviewed: Mar 30, 2018)	criteria provided, single submitter	1	17338232	1	17011737	583076	558234
NM_022089.3(ATP13A2):c.656A>G (p.Asn219Ser)	ATP13A2	Spastic paraplegia 78, autosomal recessive|Parkinson disease 9	Uncertain significance(Last reviewed: Apr 3, 2018)	criteria provided, single submitter	1	17328578	1	17002083	582385	557038
NM_022089.3(ATP13A2):c.649G>A (p.Gly217Ser)	ATP13A2	Spastic paraplegia 78, autosomal recessive|Parkinson disease 9	Uncertain significance(Last reviewed: Apr 9, 2018)	criteria provided, single submitter	1	17328585	1	17002090	582023	556688
NM_022089.3(ATP13A2):c.574C>T (p.Arg192Cys)	ATP13A2	Spastic paraplegia 78, autosomal recessive|Parkinson disease 9	Uncertain significance(Last reviewed: May 3, 2018)	criteria provided, single submitter	1	17328852	1	17002357	579676	558230
NM_022089.3(ATP13A2):c.385C>T (p.Arg129Trp)	ATP13A2	Spastic paraplegia 78, autosomal recessive|Parkinson disease 9	Uncertain significance(Last reviewed: Jan 19, 2018)	criteria provided, single submitter	1	17331279	1	17004784	579095	558232
NM_022089.3(ATP13A2):c.1630C>T (p.Arg544Cys)	ATP13A2	Spastic paraplegia 78, autosomal recessive|Parkinson disease 9	Uncertain significance(Last reviewed: Jun 29, 2018)	criteria provided, single submitter	1	17320243	1	16993748	578934	556739
NM_022089.3(ATP13A2):c.811A>G (p.Ile271Val)	ATP13A2	Parkinson disease 9|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: May 2, 2018)	criteria provided, single submitter	1	17326924	1	17000429	577023	557034
NM_022089.3(ATP13A2):c.2557C>G (p.Arg853Gly)	ATP13A2	Parkinson disease 9|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Jun 19, 2018)	criteria provided, single submitter	1	17316238	1	16989743	576357	558226
NM_022089.3(ATP13A2):c.769T>C (p.Tyr257His)	ATP13A2	Spastic paraplegia 78, autosomal recessive|Parkinson disease 9	Uncertain significance(Last reviewed: May 22, 2018)	criteria provided, single submitter	1	17326966	1	17000471	572420	557036
NM_022089.3(ATP13A2):c.813C>G (p.Ile271Met)	ATP13A2	Spastic paraplegia 78, autosomal recessive|Parkinson disease 9	Uncertain significance(Last reviewed: Feb 9, 2018)	criteria provided, single submitter	1	17326922	1	17000427	570178	556686
NM_022089.3(ATP13A2):c.472G>A (p.Gly158Arg)	ATP13A2	Spastic paraplegia 78, autosomal recessive|Parkinson disease 9	Uncertain significance(Last reviewed: Mar 13, 2018)	criteria provided, single submitter	1	17331192	1	17004697	569020	556741
NM_022089.3(ATP13A2):c.3314C>T (p.Pro1105Leu)	ATP13A2	Parkinson disease 9|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Mar 7, 2018)	criteria provided, multiple submitters, no conflicts	1	17313049	1	16986554	568939	556737
NM_022089.3(ATP13A2):c.3409G>A (p.Val1137Met)	ATP13A2	Spastic paraplegia 78, autosomal recessive|Parkinson disease 9	Uncertain significance(Last reviewed: Feb 17, 2018)	criteria provided, single submitter	1	17312850	1	16986355	567500	558222
NM_022089.3(ATP13A2):c.878T>C (p.Met293Thr)	ATP13A2	Spastic paraplegia 78, autosomal recessive|Parkinson disease 9	Uncertain significance(Last reviewed: Feb 9, 2018)	criteria provided, single submitter	1	17326770	1	17000275	567424	558228
NM_022089.3(ATP13A2):c.2972G>A (p.Arg991Gln)	ATP13A2	Spastic paraplegia 78, autosomal recessive|Parkinson disease 9	Uncertain significance(Last reviewed: May 14, 2018)	criteria provided, multiple submitters, no conflicts	1	17313652	1	16987157	566669	556682
NM_022089.3(ATP13A2):c.2260C>G (p.Leu754Val)	ATP13A2	Spastic paraplegia 78, autosomal recessive|Parkinson disease 9	Uncertain significance(Last reviewed: Apr 5, 2018)	criteria provided, single submitter	1	17316774	1	16990279	566479	556684
NM_022089.3(ATP13A2):c.477+2T>G	ATP13A2	Spastic paraplegia 78, autosomal recessive|Parkinson disease 9|not provided|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Apr 4, 2018)	criteria provided, conflicting interpretations	1	17331185	1	17004690	546591	537080
NM_022089.3(ATP13A2):c.844A>T (p.Ser282Cys)	ATP13A2	Spastic paraplegia 78, autosomal recessive|Parkinson disease 9|not provided	Likely benign(Last reviewed: Oct 13, 2017)	criteria provided, single submitter	1	17326804	1	17000309	533811	515306
NM_022089.3(ATP13A2):c.2093T>C (p.Val698Ala)	ATP13A2	History of neurodevelopmental disorder|Spastic paraplegia 78, autosomal recessive|Parkinson disease 9|not provided	Benign(Last reviewed: Nov 28, 2017)	criteria provided, multiple submitters, no conflicts	1	17318537	1	16992042	533810	515265
NM_022089.3(ATP13A2):c.2610-9T>C	ATP13A2	Spastic paraplegia 78, autosomal recessive|Parkinson disease 9	Likely benign(Last reviewed: Nov 28, 2017)	criteria provided, single submitter	1	17314978	1	16988483	533809	515351
NM_022089.3(ATP13A2):c.745G>A (p.Ala249Thr)	ATP13A2	Spastic paraplegia 78, autosomal recessive|Parkinson disease 9	Uncertain significance(Last reviewed: Jun 21, 2018)	criteria provided, single submitter	1	17326990	1	17000495	533808	515315
NM_022089.3(ATP13A2):c.2899G>C (p.Asp967His)	ATP13A2	Spastic paraplegia 78, autosomal recessive|Parkinson disease 9	Uncertain significance(Last reviewed: Nov 9, 2017)	criteria provided, single submitter	1	17313725	1	16987230	533807	515264
NM_022089.3(ATP13A2):c.2158G>T (p.Gly720Trp)	ATP13A2	Spastic paraplegia 78, autosomal recessive|Parkinson disease 9	Uncertain significance(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	1	17318322	1	16991827	533806	515354
NM_022089.3(ATP13A2):c.3476T>C (p.Phe1159Ser)	ATP13A2	Spastic paraplegia 78, autosomal recessive|Parkinson disease 9	Uncertain significance(Last reviewed: Nov 27, 2017)	criteria provided, single submitter	1	17312783	1	16986288	533805	515274
NM_022089.3(ATP13A2):c.1895C>T (p.Ser632Leu)	ATP13A2	Spastic paraplegia 78, autosomal recessive|Parkinson disease 9	Uncertain significance(Last reviewed: Aug 17, 2017)	criteria provided, single submitter	1	17318848	1	16992353	533804	515276
NM_022089.3(ATP13A2):c.2942C>T (p.Thr981Met)	ATP13A2	History of neurodevelopmental disorder|Spastic paraplegia 78, autosomal recessive|Parkinson disease 9	Uncertain significance(Last reviewed: Sep 6, 2017)	criteria provided, multiple submitters, no conflicts	1	17313682	1	16987187	533803	515262
NM_022089.3(ATP13A2):c.2404G>A (p.Gly802Ser)	ATP13A2	Spastic paraplegia 78, autosomal recessive|Parkinson disease 9	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	1	17316630	1	16990135	533802	515352
NM_022089.3(ATP13A2):c.1171G>A (p.Val391Ile)	ATP13A2	History of neurodevelopmental disorder|Parkinson disease 9|Spastic paraplegia 78, autosomal recessive|not provided	Uncertain significance(Last reviewed: Mar 29, 2017)	criteria provided, multiple submitters, no conflicts	1	17323539	1	16997044	500604	492028
NM_001141974.2(ATP13A2):c.3361A>T (p.Thr1121Ser)	ATP13A2	not provided|Parkinson disease 9	Uncertain significance(Last reviewed: Sep 30, 2018)	criteria provided, single submitter	1	17312596	1	16986101	493023	485986
NM_022089.3(ATP13A2):c.777C>T (p.Tyr259=)	ATP13A2	History of neurodevelopmental disorder|Spastic paraplegia 78, autosomal recessive|Parkinson disease 9	Likely benign(Last reviewed: Nov 21, 2017)	criteria provided, multiple submitters, no conflicts	1	17326958	1	17000463	465265	447421
NM_022089.3(ATP13A2):c.508G>A (p.Gly170Ser)	ATP13A2	Spastic paraplegia 78, autosomal recessive|Parkinson disease 9	Uncertain significance(Last reviewed: Aug 8, 2017)	criteria provided, single submitter	1	17330876	1	17004381	465264	447430
NM_022089.3(ATP13A2):c.453C>T (p.Ser151=)	ATP13A2	History of neurodevelopmental disorder|Spastic paraplegia 78, autosomal recessive|Parkinson disease 9|not provided	Benign(Last reviewed: Nov 26, 2016)	criteria provided, multiple submitters, no conflicts	1	17331211	1	17004716	465263	447484
NM_022089.3(ATP13A2):c.3175C>T (p.Leu1059Phe)	ATP13A2	Spastic paraplegia 78, autosomal recessive|Parkinson disease 9	Uncertain significance(Last reviewed: Oct 6, 2017)	criteria provided, single submitter	1	17313360	1	16986865	465262	447270
NM_022089.3(ATP13A2):c.3084-10G>T	ATP13A2	Spastic paraplegia 78, autosomal recessive|Parkinson disease 9	Uncertain significance(Last reviewed: Jul 12, 2017)	criteria provided, single submitter	1	17313461	1	16986966	465261	447277
NM_022089.3(ATP13A2):c.2412G>A (p.Lys804=)	ATP13A2	Spastic paraplegia 78, autosomal recessive|Parkinson disease 9	Uncertain significance(Last reviewed: Jul 10, 2017)	criteria provided, single submitter	1	17316622	1	16990127	465260	447410
NM_022089.3(ATP13A2):c.2367C>T (p.Leu789=)	ATP13A2	History of neurodevelopmental disorder|not provided|Spastic paraplegia 78, autosomal recessive|Parkinson disease 9	Benign/Likely benign(Last reviewed: Jul 18, 2017)	criteria provided, multiple submitters, no conflicts	1	17316667	1	16990172	465259	447369
NM_022089.3(ATP13A2):c.2348G>A (p.Arg783Gln)	ATP13A2	History of neurodevelopmental disorder|not provided|Spastic paraplegia 78, autosomal recessive|Parkinson disease 9	Benign/Likely benign(Last reviewed: Nov 26, 2016)	criteria provided, multiple submitters, no conflicts	1	17316686	1	16990191	465258	447469
NM_022089.3(ATP13A2):c.2236G>A (p.Ala746Thr)	ATP13A2	Spastic paraplegia 78, autosomal recessive|Parkinson disease 9	Uncertain significance(Last reviewed: May 22, 2017)	criteria provided, single submitter	1	17318244	1	16991749	465257	447278
NM_022089.3(ATP13A2):c.1831C>A (p.Gln611Lys)	ATP13A2	Spastic paraplegia 78, autosomal recessive|Parkinson disease 9	Uncertain significance(Last reviewed: Aug 2, 2017)	criteria provided, single submitter	1	17318995	1	16992500	465256	447418
NM_022089.3(ATP13A2):c.1545G>A (p.Thr515=)	ATP13A2	Spastic paraplegia 78, autosomal recessive|Parkinson disease 9	Uncertain significance(Last reviewed: Oct 7, 2017)	criteria provided, single submitter	1	17320328	1	16993833	465255	447279
NM_022089.3(ATP13A2):c.1195+7G>A	ATP13A2	Spastic paraplegia 78, autosomal recessive|Parkinson disease 9	Likely benign(Last reviewed: Apr 11, 2017)	criteria provided, single submitter	1	17323508	1	16997013	465254	447476
NM_022089.3(ATP13A2):c.3057delC (p.Tyr1020Thrfs)	ATP13A2	Parkinson disease 9|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 27, 2017)	criteria provided, multiple submitters, no conflicts	1	17313567	1	16987072	465253	447466
NM_022089.3(ATP13A2):c.1903C>T (p.Gln635Ter)	ATP13A2	Parkinson disease 9|Spastic paraplegia 78, autosomal recessive|Parkinson disease 9	Pathogenic(Last reviewed: Dec 5, 2016)	criteria provided, multiple submitters, no conflicts	1	17318840	1	16992345	465252	447471
NM_001141974.2(ATP13A2):c.3265C>T (p.His1089Tyr)	ATP13A2	Parkinson disease 9|not provided	Uncertain significance(Last reviewed: Apr 30, 2017)	criteria provided, single submitter	1	17312692	1	16986197	441003	434562
NM_022089.3(ATP13A2):c.-170C>T	ATP13A2	Parkinson disease 9	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	17338403	1	17011908	293806	278400
NM_022089.3(ATP13A2):c.-151C>T	ATP13A2	Parkinson disease 9	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	17338384	1	17011889	293805	278429
NM_022089.3(ATP13A2):c.106-14C>T	ATP13A2	Parkinson disease 9	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	17332065	1	17005570	293804	278416
NM_022089.3(ATP13A2):c.396G>A (p.Ala132=)	ATP13A2	Parkinson disease 9	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	17331268	1	17004773	293803	278414
NM_022089.3(ATP13A2):c.951C>T (p.Cys317=)	ATP13A2	Parkinson disease 9	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	17326594	1	17000099	293802	277554
NM_022089.3(ATP13A2):c.1040-6C>T	ATP13A2	Parkinson disease 9	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	17323676	1	16997181	293801	277347
NM_022089.3(ATP13A2):c.1065G>A (p.Thr355=)	ATP13A2	Parkinson disease 9	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	17323645	1	16997150	293800	278396
NM_022089.3(ATP13A2):c.1128C>T (p.Cys376=)	ATP13A2	History of neurodevelopmental disorder|Spastic paraplegia 78, autosomal recessive|Parkinson disease 9|Parkinson disease 9	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	1	17323582	1	16997087	293799	278393
NM_022089.3(ATP13A2):c.1163G>A (p.Gly388Glu)	ATP13A2	Parkinson disease 9	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	17323547	1	16997052	293798	277552
NM_022089.3(ATP13A2):c.1195+9C>T	ATP13A2	not provided|Parkinson disease 9|Spastic paraplegia 78, autosomal recessive|Parkinson disease 9	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	17323506	1	16997011	293797	278392
NM_022089.3(ATP13A2):c.1203C>T (p.Cys401=)	ATP13A2	not specified|Parkinson disease 9|History of neurodevelopmental disorder|Parkinson disease 9|Spastic paraplegia 78, autosomal recessive	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	1	17322984	1	16996489	293796	277550
NM_022089.3(ATP13A2):c.1208C>A (p.Ala403Glu)	ATP13A2	Parkinson disease 9	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	17322979	1	16996484	293795	277332
NM_022089.3(ATP13A2):c.1244G>A (p.Arg415Gln)	ATP13A2	Parkinson disease 9	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	17322943	1	16996448	293794	278390
NM_022089.3(ATP13A2):c.1309C>G (p.Leu437Val)	ATP13A2	not provided|Parkinson disease 9|History of neurodevelopmental disorder|Parkinson disease 9|Spastic paraplegia 78, autosomal recessive	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	1	17322793	1	16996298	293793	277331
NM_022089.3(ATP13A2):c.1314C>A (p.Leu438=)	ATP13A2	Parkinson disease 9	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	17322788	1	16996293	293792	277547
NM_022089.3(ATP13A2):c.1420C>G (p.Pro474Ala)	ATP13A2	Parkinson disease 9	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	17322593	1	16996098	293791	278389
NM_022089.3(ATP13A2):c.1442C>T (p.Thr481Met)	ATP13A2	Parkinson disease 9	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	17322571	1	16996076	293790	277328
NM_022089.3(ATP13A2):c.1449C>T (p.Tyr483=)	ATP13A2	Parkinson disease 9	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	17322564	1	16996069	293789	277326
NM_022089.3(ATP13A2):c.1744G>A (p.Gly582Ser)	ATP13A2	Parkinson disease 9	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	17320129	1	16993634	293788	278388
NM_022089.3(ATP13A2):c.1926G>A (p.Ala642=)	ATP13A2	not provided|Parkinson disease 9|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	1	17318817	1	16992322	293787	278413
NM_022089.3(ATP13A2):c.1947C>G (p.Pro649=)	ATP13A2	Parkinson disease 9	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	17318796	1	16992301	293786	277544
NM_022089.3(ATP13A2):c.2252-11A>G	ATP13A2	Parkinson disease 9	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	17316793	1	16990298	293785	277539
NM_022089.3(ATP13A2):c.2263C>G (p.Gln755Glu)	ATP13A2	History of neurodevelopmental disorder|Parkinson disease 9	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	17316771	1	16990276	293784	278382
NM_022089.3(ATP13A2):c.2285G>A (p.Arg762Gln)	ATP13A2	Parkinson disease 9	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	17316749	1	16990254	293783	277323
NM_022089.3(ATP13A2):c.2331C>T (p.His777=)	ATP13A2	not provided|Parkinson disease 9	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	17316703	1	16990208	293782	278410
NM_022089.3(ATP13A2):c.2381T>C (p.Met794Thr)	ATP13A2	Parkinson disease 9	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	17316653	1	16990158	293781	277313
NM_022089.3(ATP13A2):c.2406C>T (p.Gly802=)	ATP13A2	Parkinson disease 9	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	17316628	1	16990133	293780	277312
NM_022089.3(ATP13A2):c.2407G>A (p.Val803Ile)	ATP13A2	Parkinson disease 9	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	17316627	1	16990132	293779	277311
NM_022089.3(ATP13A2):c.2529+9G>A	ATP13A2	Parkinson disease 9	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	17316373	1	16989878	293778	277309
NM_022089.3(ATP13A2):c.2563G>A (p.Ala855Thr)	ATP13A2	Parkinson disease 9	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	17316232	1	16989737	293777	277305
NM_022089.3(ATP13A2):c.2609+10C>T	ATP13A2	Parkinson disease 9	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	17316176	1	16989681	293776	277532
NM_022089.3(ATP13A2):c.2619G>C (p.Val873=)	ATP13A2	Parkinson disease 9|Spastic paraplegia 78, autosomal recessive|Parkinson disease 9	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	1	17314960	1	16988465	293775	278381
NM_022089.3(ATP13A2):c.2808C>T (p.Tyr936=)	ATP13A2	Parkinson disease 9	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	17314684	1	16988189	293774	277299
NM_022089.3(ATP13A2):c.2952G>A (p.Ala984=)	ATP13A2	Parkinson disease 9	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	17313672	1	16987177	293773	278380
NM_022089.3(ATP13A2):c.3111C>T (p.Ala1037=)	ATP13A2	Parkinson disease 9	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	17313424	1	16986929	293772	278402
NM_022089.3(ATP13A2):c.3193G>A (p.Val1065Met)	ATP13A2	Spastic paraplegia 78, autosomal recessive|Parkinson disease 9|Parkinson disease 9	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	17313342	1	16986847	293771	277530
NM_022089.3(ATP13A2):c.3258G>C (p.Ala1086=)	ATP13A2	Parkinson disease 9	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	17313105	1	16986610	293770	278375
NM_022089.3(ATP13A2):c.3297C>T (p.Pro1099=)	ATP13A2	Parkinson disease 9|History of neurodevelopmental disorder|Parkinson disease 9|Spastic paraplegia 78, autosomal recessive	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	1	17313066	1	16986571	293769	277520
NM_022089.3(ATP13A2):c.3301C>T (p.Leu1101Phe)	ATP13A2	Parkinson disease 9	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	17313062	1	16986567	293768	278394
NM_022089.3(ATP13A2):c.3378C>T (p.Leu1126=)	ATP13A2	Parkinson disease 9	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	17312985	1	16986490	293767	278370
NM_022089.3(ATP13A2):c.3406-14C>T	ATP13A2	Parkinson disease 9	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	17312867	1	16986372	293766	277296
NM_022089.3(ATP13A2):c.3429C>T (p.Pro1143=)	ATP13A2	Parkinson disease 9	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	17312830	1	16986335	293765	277512
NM_022089.3(ATP13A2):c.3539G>A (p.Arg1180Lys)	ATP13A2	Parkinson disease 9	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	17312720	1	16986225	293764	278367
NM_022089.3(ATP13A2):c.*124C>T	ATP13A2	Parkinson disease 9	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	17312592	1	16986097	293763	277295
NM_022089.3(ATP13A2):c.*130C>T	ATP13A2	not provided|Parkinson disease 9|Spastic paraplegia 78, autosomal recessive|Parkinson disease 9	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	17312586	1	16986091	293762	277511
NM_022089.3(ATP13A2):c.*155C>T	ATP13A2	Parkinson disease 9	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	17312561	1	16986066	293761	277510
NM_022089.3(ATP13A2):c.*158T>C	ATP13A2	Parkinson disease 9	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	17312558	1	16986063	293760	278387
NM_022089.3(ATP13A2):c.*243A>C	ATP13A2	Parkinson disease 9	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	17312473	1	16985978	293759	278366
NM_022089.3(ATP13A2):c.*251A>G	ATP13A2	Parkinson disease 9	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	17312465	1	16985970	293758	278365
NM_022089.3(ATP13A2):c.1614C>T (p.Pro538=)	ATP13A2	History of neurodevelopmental disorder|Parkinson disease 9|Spastic paraplegia 78, autosomal recessive|Parkinson disease 9|not specified	Benign/Likely benign(Last reviewed: Dec 26, 2017)	criteria provided, multiple submitters, no conflicts	1	17320259	1	16993764	261541	249528
NM_022089.3(ATP13A2):c.132A>G (p.Pro44=)	ATP13A2	History of neurodevelopmental disorder|Parkinson disease 9|Spastic paraplegia 78, autosomal recessive|not provided|Parkinson disease 9|not specified	Benign/Likely benign(Last reviewed: Oct 13, 2017)	criteria provided, multiple submitters, no conflicts	1	17332025	1	17005530	261540	249529
NM_022089.3(ATP13A2):c.2859G>A (p.Thr953=)	ATP13A2	History of neurodevelopmental disorder|Parkinson disease 9|not specified|not provided	Uncertain significance(Last reviewed: Jul 25, 2016)	criteria provided, multiple submitters, no conflicts	1	17314633	1	16988138	210381	206728
NM_022089.3(ATP13A2):c.106-8G>A	ATP13A2	not provided|Parkinson disease 9|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Aug 28, 2014)	criteria provided, conflicting interpretations	1	17332059	1	17005564	210379	206730
NM_022089.3(ATP13A2):c.943G>A (p.Gly315Arg)	ATP13A2	Parkinson disease 9	Likely pathogenic(Last reviewed: Jan 29, 2013)	criteria provided, single submitter	1	17326602	1	17000107	209136	205722
NM_022089.3(ATP13A2):c.348-9_351del	ATP13A2	not provided|Parkinson disease 9	Conflicting interpretations of pathogenicity(Last reviewed: Jan 29, 2013)	criteria provided, conflicting interpretations	1	17331313 - 17331325	1	17004818 - 17004830	209135	205723
NM_022089.3(ATP13A2):c.1195+10G>A	ATP13A2	Spastic paraplegia 78, autosomal recessive|Parkinson disease 9|not specified|not provided|Parkinson disease 9	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	17323505	1	16997010	194113	191276
NM_022089.3(ATP13A2):c.490C>T (p.Arg164Trp)	ATP13A2	Parkinson disease 9	Pathogenic	no assertion criteria provided	1	17330894	1	17004399	143196	152914
NM_022089.3(ATP13A2):c.881G>A (p.Arg294Gln)	ATP13A2	History of neurodevelopmental disorder|Spastic paraplegia 78, autosomal recessive|Parkinson disease 9|not specified|not provided	Benign(Last reviewed: Aug 16, 2013)	criteria provided, multiple submitters, no conflicts	1	17326767	1	17000272	128476	133925
NM_001141974.2(ATP13A2):c.3214G>A (p.Ala1072Thr)	ATP13A2	History of neurodevelopmental disorder|not provided|Parkinson disease 9|not specified	Benign(Last reviewed: Aug 15, 2013)	criteria provided, multiple submitters, no conflicts	1	17312743	1	16986248	128475	133924
NM_022089.3(ATP13A2):c.3192C>T (p.Ala1064=)	ATP13A2	not provided|Parkinson disease 9|History of neurodevelopmental disorder|not specified	Benign(Last reviewed: Aug 15, 2013)	criteria provided, multiple submitters, no conflicts	1	17313343	1	16986848	128473	133922
NM_022089.3(ATP13A2):c.3144C>G (p.Thr1048=)	ATP13A2	History of neurodevelopmental disorder|Spastic paraplegia 78, autosomal recessive|Parkinson disease 9|not specified|not provided|Parkinson disease 9	Benign/Likely benign(Last reviewed: Sep 26, 2017)	criteria provided, multiple submitters, no conflicts	1	17313391	1	16986896	128472	133921
NM_022089.3(ATP13A2):c.3084-3C>T	ATP13A2	not specified|not provided|Parkinson disease 9|History of neurodevelopmental disorder	Benign(Last reviewed: Aug 15, 2013)	criteria provided, multiple submitters, no conflicts	1	17313454	1	16986959	128471	133920
NM_022089.3(ATP13A2):c.2970G>A (p.Val990=)	ATP13A2	not provided|Parkinson disease 9|History of neurodevelopmental disorder|not specified	Benign(Last reviewed: Aug 15, 2013)	criteria provided, multiple submitters, no conflicts	1	17313654	1	16987159	128470	133919
NM_022089.3(ATP13A2):c.2836A>T (p.Ile946Phe)	ATP13A2	Parkinson disease 9|Spastic paraplegia 78, autosomal recessive|Spastic paraplegia 78, autosomal recessive|History of neurodevelopmental disorder|not provided	Uncertain significance(Last reviewed: Feb 7, 2014)	criteria provided, multiple submitters, no conflicts	1	17314656	1	16988161	128469	133918
NM_022089.3(ATP13A2):c.2790G>A (p.Ser930=)	ATP13A2	History of neurodevelopmental disorder|not specified|not provided|Parkinson disease 9	Benign(Last reviewed: Aug 15, 2013)	criteria provided, multiple submitters, no conflicts	1	17314702	1	16988207	128468	133917
NM_022089.3(ATP13A2):c.2724G>A (p.Ser908=)	ATP13A2	History of neurodevelopmental disorder|Spastic paraplegia 78, autosomal recessive|Parkinson disease 9|not specified	Benign/Likely benign(Last reviewed: Dec 2, 2013)	criteria provided, multiple submitters, no conflicts	1	17314855	1	16988360	128467	133916
NM_022089.3(ATP13A2):c.2637C>T (p.Gly879=)	ATP13A2	not provided|Parkinson disease 9|History of neurodevelopmental disorder|not specified	Benign(Last reviewed: Aug 15, 2013)	criteria provided, multiple submitters, no conflicts	1	17314942	1	16988447	128466	133915
NM_022089.3(ATP13A2):c.1815C>T (p.Pro605=)	ATP13A2	History of neurodevelopmental disorder|not specified|not provided|Parkinson disease 9	Benign(Last reviewed: Aug 15, 2013)	criteria provided, multiple submitters, no conflicts	1	17319011	1	16992516	128465	133914
NM_022089.3(ATP13A2):c.1617G>T (p.Leu539=)	ATP13A2	not specified|not provided|Parkinson disease 9|History of neurodevelopmental disorder|Spastic paraplegia 78, autosomal recessive|Parkinson disease 9	Benign/Likely benign(Last reviewed: Aug 15, 2013)	criteria provided, multiple submitters, no conflicts	1	17320256	1	16993761	128464	133913
NM_022089.3(ATP13A2):c.1005C>T (p.Ala335=)	ATP13A2	History of neurodevelopmental disorder|not provided|Parkinson disease 9|Spastic paraplegia 78, autosomal recessive|Parkinson disease 9|not specified	Benign/Likely benign(Last reviewed: Aug 15, 2013)	criteria provided, multiple submitters, no conflicts	1	17326540	1	17000045	128463	133912
NM_022089.3(ATP13A2):c.2629G>A (p.Gly877Arg)	ATP13A2	Parkinson disease 9	Pathogenic(Last reviewed: Feb 1, 2011)	no assertion criteria provided	1	17314950	1	16988455	66099	77001
NM_022089.3(ATP13A2):c.2561T>G (p.Met854Arg)	ATP13A2	Parkinson disease 9	Pathogenic(Last reviewed: Jun 15, 2012)	no assertion criteria provided	1	17316234	1	16989739	66098	77000
NM_022089.3(ATP13A2):c.2552_2553del (p.Phe851Cysfs)	ATP13A2	Parkinson disease 9	Pathogenic(Last reviewed: Feb 1, 2011)	no assertion criteria provided	1	17316242 - 17316243	1	16989747 - 16989748	30834	39791
NM_022089.2(ATP13A2):c.1101_1102dup (p.Thr368Argfs)	ATP13A2	Parkinson disease 9	Pathogenic(Last reviewed: Jun 15, 2010)	no assertion criteria provided	1	17323608 - 17323609	1	16997113 - 16997114	30833	39790
NM_022089.3(ATP13A2):c.1510G>C (p.Gly504Arg)	ATP13A2	Parkinson disease 9	Pathogenic(Last reviewed: May 8, 2007)	no assertion criteria provided	1	17322503	1	16996008	1221	16260
ATP13A2, 22-BP DUP	ATP13A2	Parkinson disease 9	Pathogenic(Last reviewed: Aug 26, 2011)	no assertion criteria provided					1220	16259
NM_022089.3(ATP13A2):c.1306+5G>A	ATP13A2	Parkinson disease 9	Pathogenic(Last reviewed: Aug 26, 2011)	no assertion criteria provided	1	17322876	1	16996381	1219	16258
ATP13A2, 1-BP DEL, 3057C	ATP13A2	Parkinson disease 9	Pathogenic(Last reviewed: Aug 26, 2011)	no assertion criteria provided					1218	16257
NM_002973.3:c.496_498CAG([33_?])	ATXN2	Parkinson disease, late-onset|Spinocerebellar ataxia 2	Pathogenic, risk factor(Last reviewed: Aug 1, 2013)	no assertion criteria provided					65668	76576
ATXN2, (CAG)n EXPANSION, INTERMEDIATE	ATXN2	Amyotrophic lateral sclerosis 13	risk factor(Last reviewed: Oct 1, 2011)	no assertion criteria provided					8114	23153
NM_004993.5(ATXN3):c.892_894CAG(8_36) (p.Gln298_Gln305=)	ATXN3|LOC108663987	Parkinson disease, late-onset|Azorean disease	Pathogenic, risk factor(Last reviewed: Nov 1, 1994)	no assertion criteria provided	14	92537355 - 92537357	14	92071011 - 92071013	3551	18590
NG_016173.1:g.37172CTG[(107_127)]	ATXN8OS|ATXN8	Parkinson disease, late-onset|Spinocerebellar ataxia 8	Pathogenic, risk factor(Last reviewed: Jul 1, 2006)	no assertion criteria provided					562101	553277
NM_013247.4(HTRA2):c.-136C>G	AUP1|HTRA2	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	74756998	2	74529871	337125	290668
NM_013247.4(HTRA2):c.-146G>A	AUP1|HTRA2	Parkinson Disease, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	74756988	2	74529861	337124	288016
NM_013247.4(HTRA2):c.-216G>A	AUP1|HTRA2	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	74756918	2	74529791	337123	290946
NM_013247.4(HTRA2):c.-236G>C	AUP1|HTRA2	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	74756898	2	74529771	337122	287298
NM_013247.4(HTRA2):c.-314G>A	AUP1|HTRA2	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	74756820	2	74529693	337121	288015
NM_013247.4(HTRA2):c.-359G>A	AUP1|HTRA2	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	74756775	2	74529648	337120	288014
NM_013247.4(HTRA2):c.-363G>A	AUP1|HTRA2	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	74756771	2	74529644	337119	290667
NM_013247.4(HTRA2):c.-402G>A	AUP1|HTRA2	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	74756732	2	74529605	337118	290944
NM_013247.4(HTRA2):c.-547G>C	AUP1|HTRA2	Parkinson Disease, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	74756587	2	74529460	337117	290941
NM_013247.4(HTRA2):c.-586G>C	AUP1|HTRA2	Parkinson Disease, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	74756548	2	74529421	337116	290936
NM_001200.4(BMP2):c.987C>A (p.Cys329Ter)	BMP2	SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES	Likely pathogenic(Last reviewed: Feb 16, 2018)	criteria provided, single submitter	20	6759532	20	6778885	492937	485876
NM_001031726.3(C19orf12):c.424A>G (p.Lys142Glu)	C19orf12	Spastic paraplegia 43, autosomal recessive|Neurodegeneration with brain iron accumulation 4|Spastic paraplegia 43, autosomal recessive|Neurodegeneration with brain iron accumulation 4|Spastic paraplegia 5A|Tremor|Dystonia|Mental deterioration|Peripheral visual field loss|Adult-onset night blindness	Conflicting interpretations of pathogenicity(Last reviewed: Feb 15, 2017)	criteria provided, conflicting interpretations	19	30193654	19	29702747	31158	40115
NM_001129842.1(CACNA1C):c.2579G>A (p.Arg860Gln)	CACNA1C	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	12	2702427	12	2593261	190654	188574
NM_000719.6(CACNA1C):c.1485C>A (p.His495Gln)	CACNA1C	not provided|Long QT syndrome|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	criteria provided, multiple submitters, no conflicts	12	2666120	12	2556954	190639	188550
NM_000721.3(CACNA1E):c.6520C>T (p.Gln2174Ter)	CACNA1E	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	1	181767677	1	181798541	487600	480669
NM_001232.3(CASQ2):c.2T>C (p.Met1Thr)	CASQ2	not provided|Wolff-Parkinson-White syndrome	Likely pathogenic(Last reviewed: Dec 1, 2016)	criteria provided, single submitter	1	116311161	1	115768540	452250	442590
NM_000077.4(CDKN2A):c.339_340delGCinsCT (p.Pro114Ser)	CDKN2A	Cutaneous malignant melanoma 2|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 1, 2007)	criteria provided, single submitter	9	21971018 - 21971019	9	21971019 - 21971020	9424	24463
NM_001320327.1(CHCHD2):c.300+5G>A	CHCHD2	Parkinson disease 22, autosomal dominant	Pathogenic(Last reviewed: Jul 1, 2015)	no assertion criteria provided	7	56171914	7	56104221	218884	215641
NM_001320327.1(CHCHD2):c.434G>A (p.Arg145Gln)	CHCHD2	Parkinson disease 22, autosomal dominant	Pathogenic(Last reviewed: Jul 1, 2015)	no assertion criteria provided	7	56170571	7	56102878	218883	215640
NM_001320327.1(CHCHD2):c.182C>T (p.Thr61Ile)	CHCHD2	Parkinson disease 22, autosomal dominant	Pathogenic(Last reviewed: Jul 1, 2015)	no assertion criteria provided	7	56172037	7	56104344	218882	215639
NM_014043.3(CHMP2B):c.85A>G (p.Ile29Val)	CHMP2B	not provided|Amyotrophic lateral sclerosis 17|Frontotemporal Dementia, Chromosome 3-Linked|Frontotemporal Dementia, Chromosome 3-Linked|Amyotrophic lateral sclerosis 17	Uncertain significance(Last reviewed: Oct 4, 2012)	criteria provided, multiple submitters, no conflicts	3	87289899	3	87240749	21507	34359
NM_014043.3(CHMP2B):c.618A>C (p.Gln206His)	CHMP2B	not provided|Amyotrophic lateral sclerosis 17|Frontotemporal Dementia, Chromosome 3-Linked	Pathogenic(Last reviewed: Oct 4, 2012)	no assertion criteria provided	3	87302948	3	87253798	1654	16693
NM_000093.4(COL5A1):c.1389G>A (p.Pro463=)	COL5A1	not provided|Arthralgia|Wolff-Parkinson-White syndrome|Arrhythmia|Joint dislocation|Joint laxity|Hyperextensible hand joints	Uncertain significance(Last reviewed: Jun 12, 2016)	criteria provided, single submitter	9	137623973	9	134732127	373924	360909
NM_000754.3(COMT):c.472G>A (p.Val158Met)	COMT	not specified|CATECHOL-O-METHYLTRANSFERASE POLYMORPHISM|nicotine response - Efficacy	drug response(Last reviewed: Jan 1, 2011)	reviewed by expert panel	22	19951271	22	19963748	17591	32630
NM_000787.3(DBH):c.-979T=	DBH	Parkinson disease, late-onset	Benign(Last reviewed: Nov 1, 2011)	no assertion criteria provided	9	136500515	9	133635393	1749	16788
NM_001190836.1(DCTN1):c.3620C>T (p.Thr1207Ile)	DCTN1	Distal hereditary motor neuronopathy type 7B|Amyotrophic lateral sclerosis type 1|Perry syndrome|not provided|Amyotrophic lateral sclerosis, susceptibility to|Perry syndrome	Conflicting interpretations of pathogenicity, risk factor(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	74588717	2	74361590	8402	23441
NM_005216.4(DDOST):c.366C>T (p.Gly122=)	DDOST|PINK1	Parkinson Disease, Recessive|not specified|Congenital disorder of glycosylation	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	20982631	1	20656138	295156	278588
NM_005216.4(DDOST):c.882C>T (p.Ala294=)	DDOST|PINK1	Parkinson Disease, Recessive|not specified|Congenital disorder of glycosylation	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	20980231	1	20653738	295114	279913
NM_005216.4(DDOST):c.*40A>G	DDOST|PINK1	Parkinson Disease, Recessive|Congenital disorder of glycosylation	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	20978832	1	20652339	295057	279865
NM_005216.4(DDOST):c.*375_*376dupAA	DDOST|PINK1|PINK1-AS	Parkinson Disease, Recessive|Congenital disorder of glycosylation	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	20978496 - 20978497	1	20652003 - 20652004	295050	279979
NM_005216.4(DDOST):c.*462A>G	DDOST|PINK1|PINK1-AS	Parkinson Disease, Recessive|Congenital disorder of glycosylation	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	20978410	1	20651917	295047	278569
NM_005216.4(DDOST):c.*566_*577delTAAATAAATAAA	DDOST|PINK1|PINK1-AS	Parkinson Disease, Recessive|Congenital disorder of glycosylation	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	20978295 - 20978306	1	20651802 - 20651813	295043	279973
NM_032409.2(PINK1):c.*725_*728dupGAGA	DDOST|PINK1|PINK1-AS	Parkinson Disease, Recessive|Congenital disorder of glycosylation	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	20977909 - 20977912	1	20651416 - 20651419	295031	278679
NM_032409.2(PINK1):c.*672T>C	DDOST|PINK1|PINK1-AS	Parkinson Disease, Recessive|Congenital disorder of glycosylation	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	20977856	1	20651363	295030	279967
NM_032409.2(PINK1):c.*673_*675dupCTT	DDOST|PINK1|PINK1-AS	Parkinson Disease, Recessive|Congenital disorder of glycosylation	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	20977857 - 20977859	1	20651364 - 20651366	295029	278557
NM_032409.2(PINK1):c.*573_*576dupGACT	DDOST|PINK1|PINK1-AS	Parkinson Disease, Recessive|Congenital disorder of glycosylation	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	20977757 - 20977760	1	20651264 - 20651267	295026	279815
NM_032409.2(PINK1):c.*564T>G	DDOST|PINK1|PINK1-AS	Parkinson Disease, Recessive|Congenital disorder of glycosylation	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	20977748	1	20651255	295024	279966
NM_032409.2(PINK1):c.*490A>C	DDOST|PINK1|PINK1-AS	Parkinson Disease, Recessive|Congenital disorder of glycosylation	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	20977674	1	20651181	295019	278672
NM_032409.2(PINK1):c.*415C>G	DDOST|PINK1|PINK1-AS	Parkinson Disease, Recessive|Congenital disorder of glycosylation	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	20977599	1	20651106	295018	278658
NM_032409.2(PINK1):c.*265G>T	DDOST|PINK1|PINK1-AS	Parkinson Disease, Recessive|Congenital disorder of glycosylation	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	20977449	1	20650956	295015	279965
NM_032409.2(PINK1):c.*196T>C	DDOST|PINK1|PINK1-AS	Parkinson Disease, Recessive|Congenital disorder of glycosylation	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	20977380	1	20650887	295014	278656
NM_032409.2(PINK1):c.*181C>G	DDOST|PINK1|PINK1-AS	Parkinson Disease, Recessive|Congenital disorder of glycosylation	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	20977365	1	20650872	295013	278645
NM_032409.2(PINK1):c.*37A>T	DDOST|PINK1|PINK1-AS	Parkinson Disease, Recessive|Congenital disorder of glycosylation	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	20977221	1	20650728	295011	278644
NM_032409.2(PINK1):c.1562A>C (p.Asn521Thr)	DDOST|PINK1|PINK1-AS	Parkinson Disease, Recessive|not specified|Congenital disorder of glycosylation	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	20977000	1	20650507	295006	279809
NM_001256714.1(DNAAF3):c.735C>T (p.Gly245=)	DNAAF3|TNNI3	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Dilated Cardiomyopathy, Recessive|Familial restrictive cardiomyopathy|Ciliary dyskinesia|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	19	55673143	19	55161775	330217	334413
NM_015268.3(DNAJC13):c.2564A>G (p.Asn855Ser)	DNAJC13	Parkinson disease, late-onset|Essential tremor|Parkinson disease 21	Conflicting interpretations of pathogenicity(Last reviewed: Apr 1, 2014)	no assertion criteria provided	3	132196839	3	132477995	56171	70810
NM_001256864.1(DNAJC6):c.2468G>C (p.Arg823Pro)	DNAJC6	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: May 29, 2018)	criteria provided, single submitter	1	65871793	1	65406110	569095	557423
NM_001256864.1(DNAJC6):c.996-9T>C	DNAJC6	Parkinson disease 19a, juvenile-onset	Benign(Last reviewed: Aug 29, 2017)	criteria provided, single submitter	1	65852486	1	65386803	541545	516230
NM_001256864.1(DNAJC6):c.745A>G (p.Ile249Val)	DNAJC6	Parkinson disease 19a, juvenile-onset	Benign(Last reviewed: Sep 21, 2017)	criteria provided, single submitter	1	65849954	1	65384271	541544	516227
NM_001256864.1(DNAJC6):c.833A>G (p.Asp278Gly)	DNAJC6	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Sep 15, 2017)	criteria provided, single submitter	1	65851427	1	65385744	541543	516077
NM_001256864.1(DNAJC6):c.678G>A (p.Ala226=)	DNAJC6	Parkinson disease 19a, juvenile-onset	Benign(Last reviewed: Jun 13, 2017)	criteria provided, single submitter	1	65849887	1	65384204	474681	448350
NM_001256864.1(DNAJC6):c.2838C>T (p.Tyr946=)	DNAJC6	Parkinson disease 19a, juvenile-onset	Likely benign(Last reviewed: Aug 7, 2017)	criteria provided, single submitter	1	65878633	1	65412950	474680	448222
NM_001256864.1(DNAJC6):c.2290C>T (p.Leu764Phe)	DNAJC6	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Jul 25, 2017)	criteria provided, single submitter	1	65871615	1	65405932	474679	448427
NM_001256864.1(DNAJC6):c.2086T>C (p.Trp696Arg)	DNAJC6	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: May 4, 2017)	criteria provided, single submitter	1	65864543	1	65398860	474678	448369
NM_001256864.1(DNAJC6):c.2025G>T (p.Ser675=)	DNAJC6	Parkinson disease 19a, juvenile-onset	Likely benign(Last reviewed: Nov 8, 2016)	criteria provided, single submitter	1	65860702	1	65395019	474677	448363
NM_001256864.1(DNAJC6):c.194-5G>T	DNAJC6	Parkinson disease 19a, juvenile-onset	Likely benign(Last reviewed: Aug 21, 2017)	criteria provided, single submitter	1	65830313	1	65364630	474676	448345
NM_001256864.1(DNAJC6):c.1456C>T (p.Leu486Phe)	DNAJC6	Parkinson disease 19a, juvenile-onset|not provided	Benign/Likely benign(Last reviewed: Feb 27, 2017)	criteria provided, multiple submitters, no conflicts	1	65855298	1	65389615	445731	439003
NM_001256865.1(DNAJC6):c.2326C>T (p.Gln776Ter)	DNAJC6	Parkinson disease 19a, juvenile-onset	Pathogenic(Last reviewed: Oct 13, 2016)	no assertion criteria provided	1	65874368	1	65408685	265964	260693
NM_001256865.1(DNAJC6):c.2013A>T (p.Thr671=)	DNAJC6	Parkinson disease 19b, early-onset	Pathogenic(Last reviewed: Aug 9, 2016)	no assertion criteria provided	1	65867559	1	65401876	253095	247506
NM_001256865.1(DNAJC6):c.2569A>G (p.Arg857Gly)	DNAJC6	Parkinson disease 19b, early-onset	Pathogenic(Last reviewed: Aug 9, 2016)	no assertion criteria provided	1	65877077	1	65411394	253094	247505
NM_001256865.1(DNAJC6):c.2200C>T (p.Gln734Ter)	DNAJC6	Parkinson disease 19a, juvenile-onset	Pathogenic(Last reviewed: Mar 1, 2013)	no assertion criteria provided	1	65871735	1	65406052	88855	94424
NM_001256864.1(DNAJC6):c.801-2A>G	DNAJC6	Parkinson disease 19a, juvenile-onset	Pathogenic(Last reviewed: Feb 1, 2014)	no assertion criteria provided	1	65851393	1	65385710	88854	94423
NM_001039350.2(DPP6):c.962T>C (p.Met321Thr)	DPP6	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	7	154585806	7	154794096	487614	480698
NM_001039350.2(DPP6):c.899C>G (p.Pro300Arg)	DPP6	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	7	154564607	7	154772897	487598	480697
DRD4, 120-BP INS	DRD4	Attention deficit-hyperactivity disorder, susceptibility to	risk factor(Last reviewed: Nov 1, 2006)	no assertion criteria provided					16769	31808
NM_004415.3(DSP):c.3754G>A (p.Glu1252Lys)	DSP	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	6	7580177	6	7579944	487613	480692
NM_004415.3(DSP):c.193C>T (p.His65Tyr)	DSP	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	6	7555973	6	7555740	487612	480691
NM_182917.4(EIF4G1):c.3956+9A>G	EIF4G1	Parkinson disease 18	Benign	no assertion criteria provided	3	184045799	3	184328011	518346	508787
NM_182917.4(EIF4G1):c.3328+16C>T	EIF4G1	Parkinson disease 18	Benign	no assertion criteria provided	3	184044433	3	184326645	518345	508786
NM_182917.4(EIF4G1):c.1294A>G (p.Met432Val)	EIF4G1	Parkinson disease 18	Benign	no assertion criteria provided	3	184039666	3	184321878	518344	508785
NM_198241.2(EIF4G1):c.1505C>T (p.Ala502Val)	EIF4G1	Parkinson disease 18	risk factor(Last reviewed: Jan 1, 2015)	no assertion criteria provided	3	184039877	3	184322089	30073	39028
NM_198241.2(EIF4G1):c.3614G>A (p.Arg1205His)	EIF4G1	Parkinson disease 18	risk factor(Last reviewed: Jan 1, 2015)	no assertion criteria provided	3	184045189	3	184327401	30072	39027
NM_012179.4(FBXO7):c.1263_1267CATTC[3] (p.Tyr425Hisfs)	FBXO7	Parkinson disease 15	Uncertain significance(Last reviewed: Nov 30, 2018)	criteria provided, single submitter	22	32894209	22	32498224 - 32498228	631891	620687
NM_012179.4(FBXO7):c.722_723CT[2] (p.Cys243Argfs)	FBXO7	Parkinson disease 15	Uncertain significance(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	22	32881130 - 32881132	22	32485144 - 32485145	631890	620686
NM_012179.3(FBXO7):c.601G>A (p.Val201Met)	FBXO7	Parkinson disease 15	Likely benign(Last reviewed: Nov 28, 2017)	criteria provided, single submitter	22	32880067	22	32484080	533897	534312
NM_001033024.1(FBXO7):c.35T>G (p.Leu12Arg)	FBXO7	Parkinson disease 15	Benign(Last reviewed: Mar 28, 2016)	no assertion criteria provided	22	32871383	22	32475396	518326	508941
NM_012179.3(FBXO7):c.151delA (p.Asn51Thrfs)	FBXO7	Parkinson disease 15	Pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	22	32874996	22	32479009	488517	481385
NM_012179.3(FBXO7):c.1546G>C (p.Asp516His)	FBXO7	not provided|Parkinson disease 15	Uncertain significance(Last reviewed: Jul 7, 2017)	criteria provided, multiple submitters, no conflicts	22	32894494	22	32498507	444586	438226
NM_012179.3(FBXO7):c.*301A>G	FBXO7	Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	22	32894818	22	32498831	341324	352435
NM_012179.3(FBXO7):c.*282A>T	FBXO7	Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	22	32894799	22	32498812	341323	352434
NM_012179.3(FBXO7):c.*263A>G	FBXO7	Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	22	32894780	22	32498793	341322	351428
NM_012179.3(FBXO7):c.*170C>G	FBXO7	Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	22	32894687	22	32498700	341321	352433
NM_012179.3(FBXO7):c.*47A>T	FBXO7	Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	22	32894564	22	32498577	341320	337913
NM_012179.3(FBXO7):c.1527C>A (p.Pro509=)	FBXO7	Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	22	32894475	22	32498488	341319	352426
NM_012179.3(FBXO7):c.1505A>G (p.Asn502Ser)	FBXO7	Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	22	32894453	22	32498466	341318	337910
NM_012179.3(FBXO7):c.1144+9C>T	FBXO7	Parkinson Disease, Recessive|Parkinson disease 15	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	22	32889277	22	32493290	341317	337907
NM_012179.3(FBXO7):c.1125A>G (p.Leu375=)	FBXO7	Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	22	32889249	22	32493262	341316	351426
NM_012179.3(FBXO7):c.1054G>A (p.Val352Ile)	FBXO7	Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	22	32889178	22	32493191	341315	352421
NM_012179.3(FBXO7):c.949C>T (p.Leu317=)	FBXO7	Parkinson Disease, Recessive|Parkinson disease 15	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	22	32887150	22	32491163	341314	347523
NM_012179.3(FBXO7):c.745A>G (p.Thr249Ala)	FBXO7	Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	22	32881154	22	32485167	341313	337906
NM_012179.3(FBXO7):c.693C>T (p.Ser231=)	FBXO7	Parkinson Disease, Recessive|not specified|Parkinson disease 15	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	22	32881102	22	32485115	341312	352420
NM_012179.3(FBXO7):c.540A>G (p.Pro180=)	FBXO7	Parkinson Disease, Recessive|Parkinson disease 15	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	22	32880006	22	32484019	341311	351423
NM_012179.3(FBXO7):c.425C>G (p.Pro142Arg)	FBXO7	Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	22	32879891	22	32483904	341310	351422
NM_012179.3(FBXO7):c.358C>T (p.Pro120Ser)	FBXO7	Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	22	32875203	22	32479216	341309	351420
NM_012179.3(FBXO7):c.274G>C (p.Asp92His)	FBXO7	Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	22	32875119	22	32479132	341308	347522
NM_012179.3(FBXO7):c.122+9G>A	FBXO7	Parkinson disease 15|Parkinson Disease, Recessive|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	22	32871120	22	32475133	341307	347519
NM_012179.3(FBXO7):c.49C>G (p.Pro17Ala)	FBXO7	Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	22	32871038	22	32475051	341306	347518
NM_012179.3(FBXO7):c.-93G>A	FBXO7	Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	22	32870897	22	32474910	341305	337905
NM_012179.3(FBXO7):c.-118T>G	FBXO7	Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	22	32870872	22	32474885	341304	352419
NM_012179.3(FBXO7):c.-168A>G	FBXO7	Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	22	32870822	22	32474835	341303	351419
NM_012179.3(FBXO7):c.-184C>T	FBXO7	Parkinson Disease, Recessive	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	22	32870806	22	32474819	341302	347516
NM_012179.3(FBXO7):c.-197C>T	FBXO7	Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	22	32870793	22	32474806	341301	347512
NM_012179.3(FBXO7):c.-200G>A	FBXO7	Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	22	32870790	22	32474803	341300	351415
NM_012179.3(FBXO7):c.-221C>T	FBXO7	Parkinson Disease, Recessive	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	22	32870769	22	32474782	341299	352418
NM_012179.3(FBXO7):c.-232G>C	FBXO7	Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	22	32870758	22	32474771	341298	337898
NM_012179.3(FBXO7):c.-268C>G	FBXO7	Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	22	32870722	22	32474735	341297	347509
NM_012179.3(FBXO7):c.260T>C (p.Ile87Thr)	FBXO7	Parkinson disease 15	Uncertain significance(Last reviewed: Mar 18, 2016)	criteria provided, single submitter	22	32875105	22	32479118	225358	227415
NM_012179.3(FBXO7):c.345G>A (p.Met115Ile)	FBXO7	Parkinson Disease, Recessive|not specified|Parkinson disease 15	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	22	32875190	22	32479203	195275	192436
NM_012179.3(FBXO7):c.65C>T (p.Thr22Met)	FBXO7	Parkinson disease 15	Pathogenic(Last reviewed: Jan 20, 2009)	no assertion criteria provided	22	32871054	22	32475067	4811	19850
NM_012179.3(FBXO7):c.1144+1G>T	FBXO7	Parkinson disease 15	Pathogenic(Last reviewed: Jan 20, 2009)	criteria provided, single submitter	22	32889269	22	32493282	4810	19849
NM_012179.3(FBXO7):c.1492C>T (p.Arg498Ter)	FBXO7	Parkinson disease 15	Pathogenic(Last reviewed: Jan 20, 2009)	no assertion criteria provided	22	32894440	22	32498453	4809	19848
NM_012179.3(FBXO7):c.1132C>G (p.Arg378Gly)	FBXO7	Parkinson disease 15	Pathogenic(Last reviewed: Jun 1, 2008)	no assertion criteria provided	22	32889256	22	32493269	4808	19847
NM_019851.2(FGF20):c.*182C>T	FGF20	Parkinson disease, late-onset	Uncertain significance(Last reviewed: Feb 15, 2009)	no assertion criteria provided	8	16850399	8	16992890	4885	19924
NM_001456.3(FLNA):c.6244G>C (p.Val2082Leu)	FLNA	Periventricular nodular heterotopia 1|Frontometaphyseal dysplasia|Melnick-Needles syndrome|Oto-palato-digital syndrome, type II|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jan 12, 2017)	criteria provided, single submitter	X	153581251	X	154352883	465010	471375
NM_001458.4(FLNC):c.6748A>C (p.Met2250Leu)	FLNC|FLNC-AS1	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	7	128494487	7	128854433	487622	480694
NM_001458.4(FLNC):c.3014C>T (p.Ser1005Leu)	FLNC	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	7	128484142	7	128844088	487593	480693
NM_133372.2(FNIP1):c.2753_2756del (p.Lys918Argfs)	FNIP1	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	5	131007381 - 131007384	5	131671688 - 131671691	487638	480688
NM_133372.2(FNIP1):c.455+1G>A	FNIP1	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	5	131055009	5	131719316	487589	480689
GRCh38/hg38 9q21.11-21.12(chr9:68802194-69342807)x3	FXN|PRKACG|PIP5K1B|FAM189A2|TJP2|BANCR|LOC101927069|LOC108510657	See cases	Uncertain significance(Last reviewed: Jan 25, 2013)	no assertion criteria provided	9	71417110 - 71957723	9	68802194 - 69342807	155100	164854
NM_001005741.2(GBA):c.1294T>A (p.Trp432Arg)	GBA|LOC106627981	Parkinson disease, late-onset	Pathogenic	no assertion criteria provided	1	155205566	1	155235775	599275	590519
NM_001005741.2(GBA):c.1224G>A (p.Thr408=)	GBA|LOC106627981	not provided	Uncertain significance(Last reviewed: Feb 23, 2018)	criteria provided, single submitter	1	155206036	1	155236245	503740	495063
NM_001005741.2(GBA):c.1102C>T (p.Arg368Cys)	GBA|LOC106627981	not provided	Uncertain significance(Last reviewed: Mar 7, 2017)	criteria provided, single submitter	1	155206158	1	155236367	420153	404945
NM_000157.3(GBA):c.1220T>C (p.Ile407Thr)	GBA|LOC106627981	Parkinson disease, late-onset	Uncertain significance(Last reviewed: Oct 5, 2015)	no assertion criteria provided	1	155206040	1	155236249	212789	209422
NM_000157.3(GBA):c.1277C>T (p.Pro426Leu)	GBA|LOC106627981	Parkinson disease, late-onset	Uncertain significance(Last reviewed: Sep 8, 2015)	no assertion criteria provided	1	155205583	1	155235792	209104	205700
NM_000157.3(GBA):c.1440G>C (p.Lys480Asn)	GBA|LOC106627981	Parkinson disease, late-onset	Uncertain significance(Last reviewed: Sep 8, 2015)	no assertion criteria provided	1	155205051	1	155235260	209103	205699
NM_000157.3(GBA):c.221G>C (p.Gly74Ala)	GBA|LOC106627981	Parkinson disease, late-onset	Uncertain significance(Last reviewed: Sep 8, 2015)	no assertion criteria provided	1	155209763	1	155239972	209102	205701
NM_000157.3(GBA):c.1223C>T (p.Thr408Met)	GBA|LOC106627981	not specified|not provided|Parkinson disease, late-onset	Conflicting interpretations of pathogenicity(Last reviewed: May 9, 2016)	criteria provided, conflicting interpretations	1	155206037	1	155236246	93447	99354
NM_001005741.2(GBA):c.115+1G>A	GBA	Gaucher disease|Acute neuronopathic Gaucher's disease|Gaucher's disease, type 1|Parkinson disease, late-onset|Gaucher disease, perinatal lethal|Subacute neuronopathic Gaucher's disease|Acute neuronopathic Gaucher's disease|Lewy body dementia|Gaucher disease type 3C|Gaucher's disease, type 1	Pathogenic(Last reviewed: Feb 1, 2011)	criteria provided, multiple submitters, no conflicts	1	155210420	1	155240629	93445	99352
NM_001005741.2(GBA):c.1444G>A (p.Asp482Asn)	GBA|LOC106627981	Parkinson disease, late-onset	risk factor(Last reviewed: Jul 1, 2009)	no assertion criteria provided	1	155205047	1	155235256	4335	19374
NM_001005741.2(GBA):c.[880T>G;1342G>C]	GBA|LOC106627981		Pathogenic(Last reviewed: Apr 1, 2005)	no assertion criteria provided	1|1	155205518	1|1	155235727	4334	19332|19373
NM_001005741.2(GBA):c.887G>A (p.Arg296Gln)	GBA|LOC106627981	Gaucher disease type 3C|Lewy body dementia|Acute neuronopathic Gaucher's disease|Gaucher's disease, type 1|Subacute neuronopathic Gaucher's disease|Gaucher disease, perinatal lethal|Parkinson disease, late-onset|not provided|Gaucher disease|Gaucher disease, perinatal lethal|Gaucher's disease, type 1	Pathogenic(Last reviewed: Feb 1, 2011)	criteria provided, multiple submitters, no conflicts	1	155207244	1	155237453	4328	19367
NM_000157.3(GBA):c.1604G>A (p.Arg535His)	GBA|LOC106627981	Gaucher disease|Gaucher's disease, type 1|Gaucher disease type 3C|Lewy body dementia|Acute neuronopathic Gaucher's disease|Gaucher's disease, type 1|Subacute neuronopathic Gaucher's disease|Gaucher disease, perinatal lethal|Parkinson disease, late-onset	Pathogenic(Last reviewed: Feb 1, 2011)	criteria provided, multiple submitters, no conflicts	1	155204793	1	155235002	4311	19350
NM_001005741.2(GBA):c.[1448T>C;1483G>C;1497G>C]	GBA|LOC106627981		Pathogenic(Last reviewed: Mar 1, 2000)	no assertion criteria provided	1|1|1	155205043	1|1|1	155235252	4297	19327|38384|38385
NM_001005741.2(GBA):c.1504C>T (p.Arg502Cys)	GBA|LOC106627981	Gaucher disease|Parkinson disease, late-onset|Gaucher's disease, type 1|Gaucher disease type 3C|Lewy body dementia|Acute neuronopathic Gaucher's disease|Gaucher's disease, type 1|Subacute neuronopathic Gaucher's disease|Gaucher disease, perinatal lethal|Parkinson disease, late-onset|not provided|Acute neuronopathic Gaucher's disease|Subacute neuronopathic Gaucher's disease	Pathogenic(Last reviewed: Feb 1, 2011)	criteria provided, multiple submitters, no conflicts	1	155204987	1	155235196	4295	19334
NM_000157.3(GBA):c.1342G>C (p.Asp448His)	GBA|LOC106627981	Gaucher disease type 3C|Lewy body dementia|Acute neuronopathic Gaucher's disease|Gaucher's disease, type 1|Subacute neuronopathic Gaucher's disease|Gaucher disease, perinatal lethal|Parkinson disease, late-onset|not provided|Gaucher disease|Gaucher disease, perinatal lethal|Gaucher disease type 3C|Gaucher's disease, type 1|Acute neuronopathic Gaucher's disease|Subacute neuronopathic Gaucher's disease	Pathogenic/Likely pathogenic(Last reviewed: Sep 19, 2013)	criteria provided, multiple submitters, no conflicts	1	155205518	1	155235727	4293	19332
NM_001005741.2(GBA):c.1297G>T (p.Val433Leu)	GBA|LOC106627981	Gaucher disease type 3C|Lewy body dementia|Acute neuronopathic Gaucher's disease|Gaucher's disease, type 1|Subacute neuronopathic Gaucher's disease|Gaucher disease, perinatal lethal|Parkinson disease, late-onset|Gaucher disease|Subacute neuronopathic Gaucher's disease|Gaucher's disease, type 1	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2011)	criteria provided, multiple submitters, no conflicts	1	155205563	1	155235772	4292	19331
NM_001005741.2(GBA):c.1226A>G (p.Asn409Ser)	GBA|LOC106627981	Susceptibility to Parkinson's Disease|Gaucher disease type 3C|Lewy body dementia|Acute neuronopathic Gaucher's disease|Gaucher's disease, type 1|Subacute neuronopathic Gaucher's disease|Gaucher disease, perinatal lethal|Parkinson disease, late-onset|not provided|Gaucher disease|Parkinson disease, late-onset|Gaucher's disease, type 1|Dementia, Lewy body, susceptibility to|Rigidity|Akinesia	Conflicting interpretations of pathogenicity, risk factor(Last reviewed: Feb 12, 2015)	criteria provided, conflicting interpretations	1	155205634	1	155235843	4290	19329
NM_000157.3(GBA):c.1448T>C	GBA|LOC106627981	Abnormality of movement|Parkinsonism|Hypomimic face|Resting tremor|Thoracolumbar scoliosis|not provided|Gaucher disease|Parkinson disease, late-onset|Acute neuronopathic Gaucher's disease|Subacute neuronopathic Gaucher's disease|Gaucher's disease, type 1|Dementia, Lewy body, susceptibility to	Pathogenic/Likely pathogenic, risk factor(Last reviewed: Feb 1, 2011)	criteria provided, multiple submitters, no conflicts	1	155205043	1	155235252	4288	19327
NM_000161.2(GCH1):c.610G>A (p.Val204Ile)	GCH1	Dystonia, dopa-responsive|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2014)	criteria provided, conflicting interpretations	14	55312502	14	54845784	161248	171166
NM_015575.3(GIGYF2):c.1554G>A (p.Glu518=)	GIGYF2	Parkinson disease 11	Benign(Last reviewed: Sep 21, 2015)	criteria provided, single submitter	2	233660846	2	232796136	522283	512894
NM_015575.3(GIGYF2):c.3684+15G>A	GIGYF2	Parkinson disease 11	Benign(Last reviewed: Sep 21, 2015)	criteria provided, single submitter	2	233712296	2	232847586	518340	508781
NM_015575.3(GIGYF2):c.3651G>A (p.Pro1217=)	GIGYF2	Parkinson disease 11	Benign(Last reviewed: Sep 21, 2015)	criteria provided, single submitter	2	233712248	2	232847538	518339	508780
NM_015575.3(GIGYF2):c.3630_3632delACA (p.Gln1216del)	GIGYF2	Parkinson disease 11	Likely benign(Last reviewed: Sep 21, 2015)	criteria provided, single submitter	2	233712227 - 233712229	2	232847517 - 232847519	518338	508779
NM_015575.3(GIGYF2):c.3461-9G>A	GIGYF2	Parkinson disease 11	Benign(Last reviewed: May 31, 2017)	criteria provided, single submitter	2	233712049	2	232847339	518337	508778
NM_015575.3(GIGYF2):c.2940A>G (p.Gln980=)	GIGYF2	Parkinson disease 11	Benign(Last reviewed: Sep 21, 2015)	criteria provided, single submitter	2	233708806	2	232844096	518336	508777
NM_015575.3(GIGYF2):c.3629_3630insGC (p.Gln1211Hisfs)	GIGYF2	not specified|Parkinson disease 11	Benign/Likely benign(Last reviewed: Mar 28, 2016)	criteria provided, multiple submitters, no conflicts	2	233712226 - 233712227	2	232847516 - 232847517	402899	389487
NM_001103146.1(GIGYF2):c.2378C>T (p.Ala793Val)	GIGYF2	Parkinson disease 11	Likely pathogenic(Last reviewed: Apr 16, 2013)	criteria provided, single submitter	2	233684544	2	232819834	216934	213536
NM_015575.3(GIGYF2):c.1262A>G (p.Lys421Arg)	GIGYF2	Parkinson disease 11	risk factor(Last reviewed: Sep 1, 2009)	no assertion criteria provided	2	233656136	2	232791426	757	15796
NM_015575.3(GIGYF2):c.832A>G (p.Ile278Val)	GIGYF2	Parkinson disease 11	risk factor(Last reviewed: Apr 1, 2008)	no assertion criteria provided	2	233655527	2	232790817	756	15795
NM_015575.3(GIGYF2):c.1818C>G (p.Asp606Glu)	GIGYF2	Parkinson disease 11	risk factor(Last reviewed: Apr 1, 2008)	no assertion criteria provided	2	233674441	2	232809731	755	15794
NM_015575.3(GIGYF2):c.1370A>C (p.Asn457Thr)	GIGYF2	Parkinson disease 11	risk factor(Last reviewed: Aug 1, 2009)	no assertion criteria provided	2	233659545	2	232794835	754	15793
NM_015575.3(GIGYF2):c.167A>G (p.Asn56Ser)	GIGYF2	Parkinson disease 11	risk factor(Last reviewed: Aug 1, 2009)	no assertion criteria provided	2	233612450	2	232747740	753	15792
NM_181703.3(GJA5):c.895G>A (p.Glu299Lys)	GJA5	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	1	147230452	1	147758344	487608	480667
NM_000404.3(GLB1):c.817_818delTGinsCT (p.Trp273Leu)	GLB1	GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B	Pathogenic(Last reviewed: May 29, 2018)	criteria provided, single submitter	3	33093471 - 33093472	3	33051979 - 33051980	568792	559427
NM_000404.3(GLB1):c.623G>A (p.Arg208His)	GLB1	Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2	Uncertain significance(Last reviewed: Apr 20, 2018)	criteria provided, single submitter	3	33099691	3	33058199	562201	553376
NM_000404.3(GLB1):c.425_426del (p.Lys142Argfs)	GLB1	Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B	Likely pathogenic(Last reviewed: Jun 6, 2018)	criteria provided, single submitter	3	33109752 - 33109754	3	33068261 - 33068262	558711	542958
NM_000404.3(GLB1):c.2032T>C (p.Ter678Arg)	GLB1	Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B	Uncertain significance(Last reviewed: Jun 6, 2018)	criteria provided, single submitter	3	33038539	3	32997047	558705	542920
NM_000404.3(GLB1):c.188T>A (p.Phe63Tyr)	GLB1	Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B	Uncertain significance(Last reviewed: May 30, 2018)	criteria provided, single submitter	3	33114093	3	33072601	558551	542967
NM_000404.3(GLB1):c.1471G>A (p.Asp491Asn)	GLB1	Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B	Uncertain significance(Last reviewed: May 8, 2018)	criteria provided, single submitter	3	33058209	3	33016717	558272	543206
NM_000404.3(GLB1):c.1038G>T (p.Lys346Asn)	GLB1	Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B	Likely pathogenic(Last reviewed: May 11, 2018)	criteria provided, single submitter	3	33087642	3	33046150	558213	543186
NM_000404.3(GLB1):c.733+2_733+4del	GLB1	Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B	Likely pathogenic(Last reviewed: Apr 13, 2018)	criteria provided, single submitter	3	33099576 - 33099579	3	33058085 - 33058087	557859	543114
NM_000404.3(GLB1):c.1746G>A (p.Trp582Ter)	GLB1	Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B	Likely pathogenic(Last reviewed: Apr 10, 2018)	criteria provided, single submitter	3	33038825	3	32997333	557709	543198
NM_000404.3(GLB1):c.1479+1G>A	GLB1	Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 5, 2018)	criteria provided, multiple submitters, no conflicts	3	33058200	3	33016708	557669	543181
NM_000404.3(GLB1):c.626del (p.His209Profs)	GLB1	Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B	Likely pathogenic(Last reviewed: Apr 5, 2018)	criteria provided, single submitter	3	33099687 - 33099688	3	33058196	557667	543220
NM_000404.3(GLB1):c.302del (p.Asp101Alafs)	GLB1	Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis type 2	Likely pathogenic(Last reviewed: Mar 29, 2018)	criteria provided, single submitter	3	33110405 - 33110406	3	33068914	557540	542962
NM_000404.3(GLB1):c.2034A>C (p.Ter678Cys)	GLB1	Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis type 2	Uncertain significance(Last reviewed: Mar 28, 2018)	criteria provided, single submitter	3	33038537	3	32997045	557535	543091
NM_000404.3(GLB1):c.1144-2A>G	GLB1	Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis type 2	Likely pathogenic(Last reviewed: Mar 13, 2018)	criteria provided, single submitter	3	33063149	3	33021657	557226	542937
NM_000404.3(GLB1):c.2011del (p.Asp671Ilefs)	GLB1	Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis type 2	Uncertain significance(Last reviewed: Mar 12, 2018)	criteria provided, single submitter	3	33038559 - 33038560	3	32997068	557185	543156
NM_000404.3(GLB1):c.846del (p.Thr283Glnfs)	GLB1	Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis type 2	Pathogenic(Last reviewed: Mar 7, 2018)	criteria provided, single submitter	3	33093442 - 33093443	3	33051951	557052	543188
NM_000404.3(GLB1):c.395T>C (p.Met132Thr)	GLB1	Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis type 2	Uncertain significance(Last reviewed: Feb 21, 2018)	criteria provided, single submitter	3	33110313	3	33068821	556862	543242
NM_000404.3(GLB1):c.971A>G (p.Tyr324Cys)	GLB1	Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis type 2	Uncertain significance(Last reviewed: Feb 13, 2018)	criteria provided, single submitter	3	33087709	3	33046217	556658	543219
NM_000404.3(GLB1):c.769_792+13del	GLB1	Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis type 2	Likely pathogenic(Last reviewed: Feb 13, 2018)	criteria provided, single submitter	3	33094969 - 33095006	3	33053478 - 33053514	556646	543190
NM_000404.3(GLB1):c.501C>T (p.Pro167=)	GLB1	Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis type 2	Uncertain significance(Last reviewed: Feb 2, 2018)	criteria provided, single submitter	3	33107006	3	33065514	556506	543195
NM_000404.3(GLB1):c.1233+1G>A	GLB1	Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis type 2	Likely pathogenic(Last reviewed: Jan 24, 2018)	criteria provided, single submitter	3	33063057	3	33021565	556286	543185
NM_000404.3(GLB1):c.1714C>T (p.Gln572Ter)	GLB1	Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis type 2	Likely pathogenic(Last reviewed: Jan 24, 2018)	criteria provided, single submitter	3	33055568	3	33014076	556285	542931
NM_000404.3(GLB1):c.401G>T (p.Gly134Val)	GLB1	Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis type 2	Uncertain significance(Last reviewed: Jan 16, 2018)	criteria provided, single submitter	3	33109778	3	33068286	556153	542960
NM_000404.3(GLB1):c.1978A>T (p.Arg660Ter)	GLB1	Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis type 2	Uncertain significance(Last reviewed: Dec 28, 2017)	criteria provided, single submitter	3	33038593	3	32997101	555675	543095
NM_000404.3(GLB1):c.1454A>G (p.Tyr485Cys)	GLB1	Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B	Uncertain significance(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	3	33058226	3	33016734	555363	542932
NM_000404.3(GLB1):c.65_75+1del	GLB1|TMPPE	GM1 gangliosidosis type 2|Gangliosidosis GM1 type 3|Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis	Likely pathogenic(Last reviewed: Nov 29, 2017)	criteria provided, single submitter	3	33138501 - 33138513	3	33097010 - 33097021	555329	543224
NM_000404.3(GLB1):c.248A>G (p.Tyr83Cys)	GLB1	Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B	Uncertain significance(Last reviewed: Nov 30, 2017)	criteria provided, single submitter	3	33110460	3	33068968	555286	542965
NM_000404.3(GLB1):c.1510_1511insGA (p.Asn504Argfs)	GLB1	Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B	Likely pathogenic(Last reviewed: Nov 25, 2017)	criteria provided, single submitter	3	33055771	3	33014279 - 33014280	555117	543202
NM_000404.3(GLB1):c.335A>C (p.His112Pro)	GLB1	Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B	Uncertain significance(Last reviewed: Nov 12, 2017)	criteria provided, single submitter	3	33110373	3	33068881	555030	543243
NM_000404.3(GLB1):c.797A>G (p.Asn266Ser)	GLB1	Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B	Uncertain significance(Last reviewed: Dec 5, 2017)	criteria provided, single submitter	3	33093492	3	33052000	555028	542939
NM_000404.3(GLB1):c.765G>C (p.Gln255His)	GLB1	Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B	Likely pathogenic(Last reviewed: Nov 17, 2017)	criteria provided, single submitter	3	33095010	3	33053518	554850	543192
NM_000404.3(GLB1):c.245+1G>C	GLB1	Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B	Likely pathogenic(Last reviewed: Nov 2, 2017)	criteria provided, single submitter	3	33114035	3	33072543	554728	543122
NM_000404.3(GLB1):c.152T>A (p.Ile51Asn)	GLB1	Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B	Uncertain significance(Last reviewed: Oct 25, 2017)	criteria provided, single submitter	3	33114129	3	33072637	554550	542970
NM_000404.3(GLB1):c.645_648del (p.Val216Cysfs)	GLB1	Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B	Likely pathogenic(Last reviewed: Oct 13, 2017)	criteria provided, single submitter	3	33099665 - 33099669	3	33058174 - 33058177	554283	543194
NM_000404.3(GLB1):c.1310A>G (p.Asn437Ser)	GLB1	Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B	Likely benign(Last reviewed: Sep 29, 2017)	criteria provided, single submitter	3	33059977	3	33018485	554101	543215
NM_000404.3(GLB1):c.552+2T>C	GLB1	Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B	Likely pathogenic(Last reviewed: Sep 12, 2017)	criteria provided, single submitter	3	33106953	3	33065461	553673	542948
NM_000404.3(GLB1):c.1438A>G (p.Met480Val)	GLB1	Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	3	33058242	3	33016750	553636	543214
NM_000404.3(GLB1):c.1452C>G (p.Asn484Lys)	GLB1	Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B	Uncertain significance(Last reviewed: Dec 14, 2017)	criteria provided, single submitter	3	33058228	3	33016736	553506	543184
NM_000404.3(GLB1):c.446C>T (p.Ser149Phe)	GLB1	GM1 gangliosidosis type 2|Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B	Conflicting interpretations of pathogenicity(Last reviewed: Aug 7, 2017)	criteria provided, conflicting interpretations	3	33109733	3	33068241	553205	543223
NM_000404.3(GLB1):c.733+1G>A	GLB1	Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B	Likely pathogenic(Last reviewed: Jul 28, 2017)	criteria provided, single submitter	3	33099580	3	33058088	553125	542941
NM_000404.3(GLB1):c.1500_1503del (p.Leu501Valfs)	GLB1	Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B	Likely pathogenic(Last reviewed: Jul 14, 2017)	criteria provided, single submitter	3	33055778 - 33055782	3	33014287 - 33014290	552879	543173
NM_000404.3(GLB1):c.694dup (p.Ala232Glyfs)	GLB1	Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B	Likely pathogenic(Last reviewed: Jun 14, 2017)	criteria provided, single submitter	3	33099619	3	33058128	552535	543117
NM_000404.3(GLB1):c.1609G>T (p.Glu537Ter)	GLB1	Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B	Likely pathogenic(Last reviewed: Jun 16, 2017)	criteria provided, single submitter	3	33055673	3	33014181	552455	543200
NM_000404.2(GLB1):c.442C>A (p.Arg148Ser)	GLB1	Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B|Gangliosidosis GM1 type 3|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 15, 2017)	criteria provided, multiple submitters, no conflicts	3	33109737	3	33068245	551757	543207
NM_000404.3(GLB1):c.1321G>A (p.Asp441Asn)	GLB1	Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B	Likely pathogenic(Last reviewed: Apr 13, 2017)	criteria provided, single submitter	3	33059966	3	33018474	551496	542934
NM_000404.3(GLB1):c.1768C>A (p.Arg590Ser)	GLB1	Gangliosidosis GM1 type 3|Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B	Uncertain significance(Last reviewed: Apr 12, 2017)	criteria provided, single submitter	3	33038803	3	32997311	551476	543098
NM_000404.3(GLB1):c.93G>A (p.Met31Ile)	GLB1	Gangliosidosis GM1 type 3|Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B	Uncertain significance(Last reviewed: Mar 28, 2017)	criteria provided, single submitter	3	33114188	3	33072696	551262	543208
NM_000404.3(GLB1):c.523C>T (p.Gln175Ter)	GLB1	Gangliosidosis GM1 type 3|Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B	Likely pathogenic(Last reviewed: Apr 3, 2017)	criteria provided, single submitter	3	33106984	3	33065492	551241	543222
NM_000404.3(GLB1):c.2007_2010del (p.Asn669Lysfs)	GLB1	Gangliosidosis GM1 type 3|Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B	Uncertain significance(Last reviewed: Mar 20, 2017)	criteria provided, single submitter	3	33038560 - 33038564	3	32997069 - 32997072	551178	543093
NM_000404.3(GLB1):c.1991del (p.Pro664Hisfs)	GLB1	Gangliosidosis GM1 type 3|Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B	Uncertain significance(Last reviewed: Mar 14, 2017)	criteria provided, single submitter	3	33038579 - 33038580	3	32997088	551038	542929
NM_000404.3(GLB1):c.1038G>C (p.Lys346Asn)	GLB1	Gangliosidosis GM1 type 3|Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B	Likely pathogenic(Last reviewed: Mar 29, 2017)	criteria provided, single submitter	3	33087642	3	33046150	550856	543217
NM_000404.3(GLB1):c.2002A>T (p.Lys668Ter)	GLB1	Gangliosidosis GM1 type 3|Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B	Uncertain significance(Last reviewed: Feb 8, 2017)	criteria provided, single submitter	3	33038569	3	32997077	550693	543170
NM_000404.3(GLB1):c.433_437del (p.Ile145Serfs)	GLB1	Gangliosidosis GM1 type 3|Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B	Likely pathogenic(Last reviewed: Jan 26, 2017)	criteria provided, single submitter	3	33109741 - 33109746	3	33068250 - 33068254	550513	543226
NM_000404.3(GLB1):c.1634dup (p.Asn545Lysfs)	GLB1	Gangliosidosis GM1 type 3|Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B	Likely pathogenic(Last reviewed: Jan 19, 2017)	criteria provided, single submitter	3	33055647	3	33014156	550413	543109
NM_000404.3(GLB1):c.1783C>T (p.Arg595Trp)	GLB1	Gangliosidosis GM1 type 3|Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B	Uncertain significance(Last reviewed: Dec 27, 2016)	criteria provided, single submitter	3	33038788	3	32997296	550288	543193
NM_000404.3(GLB1):c.1481G>T (p.Gly494Val)	GLB1	Gangliosidosis GM1 type 3|Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B	Uncertain significance(Last reviewed: May 19, 2017)	criteria provided, single submitter	3	33055801	3	33014309	550166	543110
NM_000404.3(GLB1):c.572G>A (p.Ser191Asn)	GLB1	Gangliosidosis GM1 type 3|Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B	Uncertain significance(Last reviewed: May 15, 2018)	criteria provided, single submitter	3	33099742	3	33058250	549962	542944
NM_000404.3(GLB1):c.1325G>A (p.Arg442Gln)	GLB1	Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis type 2|Gangliosidosis GM1 type 3|Infantile GM1 gangliosidosis	Pathogenic/Likely pathogenic(Last reviewed: May 3, 2017)	criteria provided, multiple submitters, no conflicts	3	33059962	3	33018470	528328	519256
NM_000404.3(GLB1):c.443G>A (p.Arg148His)	GLB1	Mucopolysaccharidosis, MPS-IV-B|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis type 2|Gangliosidosis GM1 type 3|Infantile GM1 gangliosidosis	Pathogenic/Likely pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, multiple submitters, no conflicts	3	33109736	3	33068244	522884	513535
NM_000404.3(GLB1):c.439C>T (p.Leu147Phe)	GLB1	Infantile GM1 gangliosidosis	Likely pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, single submitter	3	33109740	3	33068248	522669	513262
NM_000404.3(GLB1):c.146G>A (p.Arg49His)	GLB1	Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B|Inborn genetic diseases	Uncertain significance(Last reviewed: Aug 24, 2017)	criteria provided, multiple submitters, no conflicts	3	33114135	3	33072643	521991	511481
NM_000404.3(GLB1):c.175C>T (p.Arg59Cys)	GLB1	Infantile GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2|Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2|Gangliosidosis GM1 type 3|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 3, 2017)	criteria provided, multiple submitters, no conflicts	3	33114106	3	33072614	496895	488319
NM_000404.2(GLB1):c.1588C>T (p.Arg530Cys)	GLB1	Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B|not provided	Uncertain significance(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	3	33055694	3	33014202	450616	443416
NM_000404.2(GLB1):c.1646C>T (p.Pro549Leu)	GLB1	Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 16, 2017)	criteria provided, multiple submitters, no conflicts	3	33055636	3	33014144	426185	414933
NM_000404.3(GLB1):c.245+1G>A	GLB1	Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2	Pathogenic(Last reviewed: Dec 12, 2016)	criteria provided, multiple submitters, no conflicts	3	33114035	3	33072543	417873	404764
NM_000404.2(GLB1):c.902C>T (p.Ala301Val)	GLB1	Infantile GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2017)	criteria provided, multiple submitters, no conflicts	3	33093387	3	33051895	381567	368399
NM_001317040.1(GLB1):c.985C>T (p.His329Tyr)	GLB1	GM1 gangliosidosis type 2|Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|Mucopolysaccharidosis, MPS-IV-B|Mucopolysaccharidosis, MPS-IV-B|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 23, 2017)	criteria provided, multiple submitters, no conflicts	3	33093448	3	33051956	372371	359418
NM_000404.2(GLB1):c.1343A>T (p.Asp448Val)	GLB1	Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B|Morquio syndrome|GM1 gangliosidosis	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	3	33059944	3	33018452	344790	294405
NM_000404.2(GLB1):c.808T>G (p.Tyr270Asp)	GLB1	Inborn genetic diseases|Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|not provided|Infantile GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B	Pathogenic/Likely pathogenic(Last reviewed: Oct 21, 2015)	criteria provided, multiple submitters, no conflicts	3	33093481	3	33051989	284172	268409
NM_000404.2(GLB1):c.464T>G (p.Leu155Arg)	GLB1	Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 2, 2017)	criteria provided, multiple submitters, no conflicts	3	33107043	3	33065551	265179	259759
NM_000404.3(GLB1):c.276G>A (p.Trp92Ter)	GLB1	Infantile GM1 gangliosidosis|Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B	Pathogenic(Last reviewed: Nov 2, 2017)	criteria provided, multiple submitters, no conflicts	3	33110432	3	33068940	264673	244010
NM_000404.3(GLB1):c.858C>T (p.Thr286=)	GLB1	Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B|Gangliosidosis GM1 type 3|not specified	Likely benign(Last reviewed: Oct 19, 2016)	criteria provided, multiple submitters, no conflicts	3	33093431	3	33051939	256027	251094
NM_000404.3(GLB1):c.1561C>T (p.Arg521Cys)	GLB1	Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis|not specified	Benign(Last reviewed: Jun 16, 2017)	criteria provided, multiple submitters, no conflicts	3	33055721	3	33014229	256024	251092
NM_000404.3(GLB1):c.1733A>G (p.Lys578Arg)	GLB1	Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis type 2|Gangliosidosis GM1 type 3|Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2016)	criteria provided, multiple submitters, no conflicts	3	33055549	3	33014057	252985	247388
NM_000404.3(GLB1):c.1285C>T (p.Pro429Ser)	GLB1	Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B|Gangliosidosis GM1 type 3|GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis	Conflicting interpretations of pathogenicity(Last reviewed: Jul 18, 2017)	criteria provided, conflicting interpretations	3	33060002	3	33018510	242561	205010
NM_000404.2(GLB1):c.[1285C>T;1097C>A]	GLB1		Uncertain significance(Last reviewed: May 13, 2016)	no assertion criteria provided	3|3	33065789	3|3	33024297	208495	205011|205010
NM_000404.4(GLB1):c.1577dup (p.Trp527Leufs)	GLB1	GLB1-Related Disorders|not provided|Infantile GM1 gangliosidosis	Pathogenic(Last reviewed: Nov 26, 2013)	criteria provided, multiple submitters, no conflicts	3	33055710	3	33014218	202191	198618
NM_000404.2(GLB1):c.602G>A (p.Arg201His)	GLB1	not provided|Gangliosidosis GM1 type 3|Infantile GM1 gangliosidosis|GM1 gangliosidosis|Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis type 2|GM1 gangliosidosis type 2	Pathogenic/Likely pathogenic(Last reviewed: Oct 27, 2014)	criteria provided, multiple submitters, no conflicts	3	33099712	3	33058220	198077	195238
NM_000404.3(GLB1):c.203G>A (p.Arg68Gln)	GLB1	GM1 gangliosidosis type 2|Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|Mucopolysaccharidosis, MPS-IV-B|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 10, 2018)	criteria provided, conflicting interpretations	3	33114078	3	33072586	195074	192236
NM_000404.3(GLB1):c.169delT (p.Tyr57Thrfs)	GLB1	not provided|GM1 gangliosidosis type 2|Gangliosidosis GM1 type 3	Pathogenic(Last reviewed: Jan 28, 2015)	criteria provided, single submitter	3	33114112	3	33072620	195073	192235
NM_000404.3(GLB1):c.1768C>T (p.Arg590Cys)	GLB1	Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis|Gangliosidosis GM1 type 3|Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|not provided	Pathogenic(Last reviewed: Jun 25, 2014)	criteria provided, multiple submitters, no conflicts	3	33038803	3	32997311	194596	191759
NM_000404.3(GLB1):c.1A>C (p.Met1Leu)	GLB1|TMPPE	not provided|GM1 gangliosidosis type 2	Likely pathogenic(Last reviewed: Apr 30, 2015)	criteria provided, single submitter	3	33138577	3	33097085	193093	190258
NM_000404.3(GLB1):c.901G>A (p.Ala301Thr)	GLB1	Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2|Gangliosidosis GM1 type 3	Likely pathogenic(Last reviewed: Mar 14, 2014)	criteria provided, single submitter	3	33093388	3	33051896	167148	177089
NM_000404.3(GLB1):c.1077delA (p.Val360Tyrfs)	GLB1	Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2|Gangliosidosis GM1 type 3	Pathogenic(Last reviewed: Dec 19, 2013)	criteria provided, single submitter	3	33065809	3	33024317	167146	177750
NM_000404.3(GLB1):c.922T>C (p.Phe308Leu)	GLB1	Infantile GM1 gangliosidosis	Pathogenic	no assertion criteria provided	3	33093283	3	33051791	100727	106592
NM_000404.2:c.672_673delAT	GLB1	Infantile GM1 gangliosidosis	Pathogenic	no assertion criteria provided					100726	106591
NM_000404.3(GLB1):c.1188dupG (p.Pro397Alafs)	GLB1	Infantile GM1 gangliosidosis	Pathogenic	no assertion criteria provided	3	33063103	3	33021611	100725	106590
NM_000404.2(GLB1):c.75+1G>C	GLB1|TMPPE	GM1 gangliosidosis|GM1 gangliosidosis type 2|Gangliosidosis GM1 type 3|Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis	Conflicting interpretations of pathogenicity(Last reviewed: Aug 24, 2012)	criteria provided, conflicting interpretations	3	33138502	3	33097010	92913	98820
NM_000404.3(GLB1):c.734-8A>G	GLB1	Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B|not provided	Uncertain significance(Last reviewed: Sep 12, 2017)	criteria provided, multiple submitters, no conflicts	3	33095049	3	33053557	92912	98819
NM_000404.3(GLB1):c.481T>G (p.Trp161Gly)	GLB1	Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 14, 2018)	criteria provided, conflicting interpretations	3	33107026	3	33065534	92910	98817
NM_000404.3(GLB1):c.457+2T>C	GLB1	Mucopolysaccharidosis, MPS-IV-B|Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2|Infantile GM1 gangliosidosis	Pathogenic(Last reviewed: Nov 1, 2012)	criteria provided, single submitter	3	33109720	3	33068228	92908	98815
NM_000404.2(GLB1):c.442C>T (p.Arg148Cys)	GLB1	GM1 gangliosidosis|Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis type 2|Gangliosidosis GM1 type 3|Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2	Pathogenic/Likely pathogenic(Last reviewed: Jul 8, 2013)	criteria provided, multiple submitters, no conflicts	3	33109737	3	33068245	92907	98814
NM_000404.3(GLB1):c.397-1G>A	GLB1	Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B|Mucopolysaccharidosis, MPS-IV-B|Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2|Infantile GM1 gangliosidosis	Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 2012)	criteria provided, multiple submitters, no conflicts	3	33109783	3	33068291	92906	98813
NM_000404.3(GLB1):c.1769G>A (p.Arg590His)	GLB1	Gangliosidosis GM1 type 3|Infantile GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis type 2|GM1 gangliosidosis type 2|Gangliosidosis GM1 type 3|Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis	Conflicting interpretations of pathogenicity(Last reviewed: Nov 6, 2013)	criteria provided, conflicting interpretations	3	33038802	3	32997310	92901	98808
NM_000404.3(GLB1):c.171C>G (p.Tyr57Ter)	GLB1	not provided|GM1 gangliosidosis type 2|Gangliosidosis GM1 type 3|Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|Infantile GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis type 2	Pathogenic/Likely pathogenic(Last reviewed: Aug 30, 2013)	criteria provided, multiple submitters, no conflicts	3	33114110	3	33072618	92900	98807
NM_000404.3(GLB1):c.1594A>G (p.Ser532Gly)	GLB1	GM1 gangliosidosis|GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|Morquio syndrome|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	33055688	3	33014196	92899	98806
NM_000404.3(GLB1):c.1456_1466dupGGTGCATATAT (p.Ile489Metfs)	GLB1	Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B|Mucopolysaccharidosis, MPS-IV-B|Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2|Infantile GM1 gangliosidosis	Pathogenic/Likely pathogenic(Last reviewed: Oct 18, 2012)	criteria provided, multiple submitters, no conflicts	3	33058214 - 33058224	3	33016722 - 33016732	92898	98805
NM_000404.3(GLB1):c.1310A>T (p.Asn437Ile)	GLB1	Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B|Mucopolysaccharidosis, MPS-IV-B|Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2|Infantile GM1 gangliosidosis	Conflicting interpretations of pathogenicity(Last reviewed: Dec 10, 2013)	criteria provided, conflicting interpretations	3	33059977	3	33018485	92896	98803
NM_001135602.2(GLB1):c.913C>T (p.Leu305Phe)	GLB1	not specified|Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis type 2	Benign/Likely benign(Last reviewed: Mar 2, 2015)	criteria provided, multiple submitters, no conflicts	3	33059981	3	33018489	92895	98802
NM_000404.3(GLB1):c.1174_1175delCT (p.Leu392Valfs)	GLB1	Infantile GM1 gangliosidosis|Gangliosidosis GM1 type 3|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis type 2|Gangliosidosis GM1 type 3|Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2	Pathogenic/Likely pathogenic(Last reviewed: Feb 18, 2013)	criteria provided, multiple submitters, no conflicts	3	33063116 - 33063117	3	33021624 - 33021625	92893	98800
NM_000404.3(GLB1):c.1004C>T (p.Ala335Val)	GLB1	Mucopolysaccharidosis, MPS-IV-B|Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2|Infantile GM1 gangliosidosis	Likely pathogenic(Last reviewed: Oct 22, 2012)	criteria provided, single submitter	3	33087676	3	33046184	92892	98799
NM_000404.3(GLB1):c.456A>T (p.Pro152=)	GLB1	GM1 gangliosidosis type 2	not provided	no assertion provided	3	33109723	3	33068231	68480	79372
NM_000404.3(GLB1):c.518T>C (p.Leu173Pro)	GLB1	GM1 gangliosidosis type 2|GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B	Likely pathogenic(Last reviewed: Aug 11, 2017)	criteria provided, single submitter	3	33106989	3	33065497	68479	79371
NM_000404.3(GLB1):c.319T>C (p.Phe107Leu)	GLB1	GM1 gangliosidosis type 2|Inborn genetic diseases	Likely pathogenic(Last reviewed: Sep 12, 2016)	criteria provided, single submitter	3	33110389	3	33068897	68478	79370
NM_000404.3(GLB1):c.1150A>T (p.Thr384Ser)	GLB1	GM1 gangliosidosis type 2	not provided	no assertion provided	3	33063141	3	33021649	66110	77008
NM_000404.3(GLB1):c.1061T>G (p.Ile354Ser)	GLB1	GM1 gangliosidosis type 2	not provided	no assertion provided	3	33087619	3	33046127	66109	77007
NM_000404.3(GLB1):c.1772A>G (p.Tyr591Cys)	GLB1	Infantile GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2|GM1-gangliosidosis, type I, with cardiac involvement	Uncertain significance(Last reviewed: Jan 1, 2000)	criteria provided, single submitter	3	33038799	3	32997307	948	15987
NM_000404.2(GLB1):c.176G>A (p.Arg59His)	GLB1	GM1 gangliosidosis|GM1-gangliosidosis, type I, with cardiac involvement|GM1 gangliosidosis type 2|Gangliosidosis GM1 type 3|Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|not provided	Pathogenic(Last reviewed: Oct 2, 2018)	criteria provided, multiple submitters, no conflicts	3	33114105	3	33072613	945	15984
NM_000404.2(GLB1):c.202C>T (p.Arg68Trp)	GLB1	Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2	Pathogenic(Last reviewed: Jul 1, 2003)	criteria provided, single submitter	3	33114079	3	33072587	944	15983
NM_000404.3(GLB1):c.1223A>C (p.Gln408Pro)	GLB1	Infantile GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B	Uncertain significance(Last reviewed: Aug 1, 2001)	criteria provided, single submitter	3	33063068	3	33021576	943	15982
NM_000404.3(GLB1):c.1498A>G (p.Thr500Ala)	GLB1	Infantile GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B	Likely pathogenic(Last reviewed: Aug 1, 2001)	criteria provided, single submitter	3	33055784	3	33014292	942	15981
NM_000404.3(GLB1):c.1051C>T (p.Arg351Ter)	GLB1	GM1-gangliosidosis, type I, with cardiac involvement|Infantile GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis	Pathogenic/Likely pathogenic(Last reviewed: Feb 14, 2017)	criteria provided, multiple submitters, no conflicts	3	33087629	3	33046137	941	15980
NM_000404.3(GLB1):c.1313G>A (p.Gly438Glu)	GLB1	Mucopolysaccharidosis, MPS-IV-B	Pathogenic(Last reviewed: May 14, 2019)	no assertion criteria provided	3	33059974	3	33018482	940	15979
NM_000404.3(GLB1):c.622C>T (p.Arg208Cys)	GLB1	GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2|Gangliosidosis GM1 type 3	Pathogenic(Last reviewed: Dec 6, 2013)	criteria provided, multiple submitters, no conflicts	3	33099692	3	33058200	939	15978
NM_000404.3(GLB1):c.1444C>T (p.Arg482Cys)	GLB1	Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B|Gangliosidosis GM1 type 3|Mucopolysaccharidosis, MPS-IV-B	Uncertain significance(Last reviewed: Aug 1, 1995)	criteria provided, single submitter	3	33058236	3	33016744	938	15977
NM_000404.3(GLB1):c.247T>C (p.Tyr83His)	GLB1	Mucopolysaccharidosis, MPS-IV-B	Pathogenic(Last reviewed: Aug 1, 1995)	no assertion criteria provided	3	33110461	3	33068969	937	15976
NM_000404.4(GLB1):c.75+2dup	GLB1|TMPPE	Infantile GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|not provided	Pathogenic(Last reviewed: Jun 1, 1994)	criteria provided, multiple submitters, no conflicts	3	33138501	3	33097009	936	15975
NM_000404.2(GLB1):c.245C>T	GLB1	Inborn genetic diseases|Infantile GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2|Gangliosidosis GM1 type 3	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 1994)	criteria provided, multiple submitters, no conflicts	3	33114036	3	33072544	935	15974
NM_000404.4(GLB1):c.256_278dup (p.Gln95Thrfs)	GLB1	Infantile GM1 gangliosidosis	Pathogenic(Last reviewed: May 1, 1992)	no assertion criteria provided	3	33110430 - 33110452	3	33068938 - 33068960	934	15973
NM_000404.3(GLB1):c.1527G>T (p.Trp509Cys)	GLB1	Mucopolysaccharidosis, MPS-IV-B	Pathogenic(Last reviewed: Nov 1, 1991)	no assertion criteria provided	3	33055755	3	33014263	933	15972
NM_000404.3(GLB1):c.1445G>A (p.Arg482His)	GLB1	GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2|Gangliosidosis GM1 type 3|Gangliosidosis GM1 type 3|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis type 2|Infantile GM1 gangliosidosis	Pathogenic(Last reviewed: May 1, 1993)	criteria provided, multiple submitters, no conflicts	3	33058235	3	33016743	932	15971
NM_000404.3(GLB1):c.818G>T (p.Trp273Leu)	GLB1	Mucopolysaccharidosis, MPS-IV-B	Pathogenic(Last reviewed: Aug 1, 2001)	no assertion criteria provided	3	33093471	3	33051979	931	15970
NM_000404.3(GLB1):c.1370G>A (p.Arg457Gln)	GLB1	Gangliosidosis GM1 type 3	Pathogenic(Last reviewed: Aug 1, 1991)	no assertion criteria provided	3	33058310	3	33016818	930	15969
NM_000404.3(GLB1):c.947A>G (p.Tyr316Cys)	GLB1	Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B|Gangliosidosis GM1 type 3|Infantile GM1 gangliosidosis	Likely pathogenic(Last reviewed: May 1, 1992)	criteria provided, single submitter	3	33093258	3	33051766	929	15968
NM_000404.2(GLB1):c.367G>A	GLB1	not provided|Infantile GM1 gangliosidosis	Likely pathogenic(Last reviewed: Aug 1, 1991)	criteria provided, single submitter	3	33110341	3	33068849	928	15967
NM_000404.2(GLB1):c.1069_1233dup	GLB1	Infantile GM1 gangliosidosis	Pathogenic(Last reviewed: Aug 1, 1991)	no assertion criteria provided			3	33018562 - 33046119	927	15966
NM_000404.3(GLB1):c.152T>C (p.Ile51Thr)	GLB1	Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B|Gangliosidosis GM1 type 3|Gangliosidosis GM1 type 3	Pathogenic(Last reviewed: Mar 1, 1992)	criteria provided, single submitter	3	33114129	3	33072637	926	15965
NM_001317040.1(GLB1):c.745C>T (p.Arg249Cys)	GLB1	GM1 gangliosidosis|Morquio syndrome|not provided|Gangliosidosis GM1 type 3|Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2	Conflicting interpretations of pathogenicity(Last reviewed: Jul 1, 2003)	criteria provided, conflicting interpretations	3	33099713	3	33058221	925	15964
NM_000404.3(GLB1):c.1369C>T (p.Arg457Ter)	GLB1	Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B|Gangliosidosis GM1 type 3|Infantile GM1 gangliosidosis	Pathogenic(Last reviewed: Sep 1, 1991)	criteria provided, single submitter	3	33058311	3	33016819	924	15963
NM_000404.3(GLB1):c.145C>T (p.Arg49Cys)	GLB1	Infantile GM1 gangliosidosis|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B|Gangliosidosis GM1 type 3|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis|Infantile GM1 gangliosidosis|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 1991)	criteria provided, conflicting interpretations	3	33114136	3	33072644	923	15962
NM_012084.3(GLUD2):c.1492T>G (p.Ser498Ala)	GLUD2	Parkinson disease, late-onset	Pathogenic(Last reviewed: Mar 1, 2010)	no assertion criteria provided	X	120183030	X	121049176	29936	38891
NM_015141.3(GPD1L):c.775G>A (p.Gly259Arg)	GPD1L	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	3	32200524	3	32159032	487599	480683
GRN, IVS0DS, G-C, +5	GRN	Frontotemporal dementia, ubiquitin-positive	Pathogenic(Last reviewed: Oct 1, 2007)	no assertion criteria provided					16006	31045
NM_032620.3(GTPBP3):c.32_33delAAinsGTG (p.Gln11Argfs)	GTPBP3	Combined oxidative phosphorylation deficiency 23	Pathogenic(Last reviewed: Dec 4, 2014)	no assertion criteria provided	19	17448452 - 17448453	19	17337643 - 17337644	180619	178785
NM_004134.6(HSPA9):c.1426G>A (p.Ala476Thr)	HSPA9	not provided	Uncertain significance(Last reviewed: Jul 12, 2017)	no assertion criteria provided	5	137894331	5	138558642	430651	424181
NM_013247.4(HTRA2):c.*531A>G	HTRA2|LOXL3	Parkinson Disease, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	74760643	2	74533516	337145	290732
NM_013247.4(HTRA2):c.*384C>A	HTRA2|LOXL3	Parkinson Disease, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	74760496	2	74533369	337142	290720
NM_013247.4(HTRA2):c.*291G>A	HTRA2|LOXL3	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	74760403	2	74533276	337141	287311
NM_013247.4(HTRA2):c.*249G>C	HTRA2|LOXL3	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	74760361	2	74533234	337140	290718
NM_013247.4(HTRA2):c.*94C>T	HTRA2|LOXL3	Parkinson Disease, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	74760206	2	74533079	337139	288038
NM_013247.4(HTRA2):c.1346C>T (p.Thr449Ile)	HTRA2|LOXL3	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	74760081	2	74532954	337138	290950
NM_013247.4(HTRA2):c.1155C>T (p.Pro385=)	HTRA2|LOXL3	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	74759785	2	74532658	337137	290715
NM_013247.4(HTRA2):c.1131A>G (p.Leu377=)	HTRA2|LOXL3	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	74759761	2	74532634	337136	290714
NM_013247.4(HTRA2):c.1046-13C>T	HTRA2	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	74758970	2	74531843	337135	287303
NM_013247.4(HTRA2):c.873T>C (p.Asn291=)	HTRA2	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	74758199	2	74531072	337134	287302
NM_013247.4(HTRA2):c.825T>C (p.Val275=)	HTRA2	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	74758151	2	74531024	337133	290711
NM_013247.4(HTRA2):c.627A>G (p.Arg209=)	HTRA2	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	74757864	2	74530737	337132	288035
NM_013247.4(HTRA2):c.507-9C>A	HTRA2	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	74757735	2	74530608	337131	290709
NM_013247.4(HTRA2):c.507-10T>A	HTRA2	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	74757734	2	74530607	337130	290701
NM_013247.4(HTRA2):c.480C>G (p.Ala160=)	HTRA2	Parkinson Disease, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	74757613	2	74530486	337129	290947
NM_013247.4(HTRA2):c.241G>A (p.Ala81Thr)	HTRA2	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	74757374	2	74530247	337128	287301
NM_013247.4(HTRA2):c.215T>C (p.Leu72Pro)	HTRA2	not provided|Parkinson Disease, Dominant	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	74757348	2	74530221	337127	288021
NM_013247.4(HTRA2):c.-86G>C	HTRA2	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	74757048	2	74529921	337126	290700
NM_013247.4(HTRA2):c.427C>G (p.Pro143Ala)	HTRA2	Parkinson disease 13	risk factor(Last reviewed: Dec 1, 2011)	no assertion criteria provided	2	74757560	2	74530433	30583	39540
NM_013247.4(HTRA2):c.421G>T (p.Ala141Ser)	HTRA2	Parkinson disease 13|Parkinson Disease, Dominant	Likely benign(Last reviewed: Jul 1, 2008)	criteria provided, single submitter	2	74757554	2	74530427	4342	19381
NM_013247.4(HTRA2):c.1195G>A (p.Gly399Ser)	HTRA2|LOXL3	Parkinson disease 13|Parkinson Disease, Dominant	Likely benign(Last reviewed: Jul 1, 2008)	criteria provided, single submitter	2	74759825	2	74532698	4341	19380
NM_000202.8(IDS):c.238C>T (p.Gln80Ter)	IDS	Mucopolysaccharidosis, MPS-II	Pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, single submitter	X	148585689	X	149504159	633269	621680
NM_021991.3(JUP):c.251G>A (p.Arg84Gln)	JUP	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	17	39925887	17	41769635	487584	480722
NM_021991.3(JUP):c.578T>C (p.Met193Thr)	JUP	Naxos disease|Arrhythmogenic right ventricular cardiomyopathy, type 12|Primary dilated cardiomyopathy|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Sep 15, 2015)	criteria provided, multiple submitters, no conflicts	17	39925350	17	41769098	222661	224519
NM_021991.3(JUP):c.773A>G (p.Glu258Gly)	JUP	Wolff-Parkinson-White pattern|not provided	Uncertain significance(Last reviewed: Jul 14, 2017)	criteria provided, single submitter	17	39923767	17	41767515	201830	198498
NM_172057.2(KCNH2):c.1026G>C (p.Glu342Asp)	KCNH2	not provided|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	criteria provided, single submitter	7	150648108	7	150951020	487626	480695
NM_000238.3(KCNH2):c.1225G>A (p.Val409Met)	KCNH2	Wolff-Parkinson-White pattern|Long QT syndrome	Uncertain significance(Last reviewed: Jul 14, 2017)	criteria provided, single submitter	7	150649845	7	150952757	456884	457546
NM_000891.2(KCNJ2):c.49G>A (p.Asp17Asn)	KCNJ2	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	17	68171229	17	70175088	487624	480723
NM_000218.2(KCNQ1):c.1621G>A (p.Val541Ile)	KCNQ1	not provided|Congenital long QT syndrome|Wolff-Parkinson-White pattern|Arrhythmia|not specified	Uncertain significance(Last reviewed: Jul 26, 2016)	criteria provided, multiple submitters, no conflicts	11	2797220	11	2775990	67043	77939
NM_000218.2(KCNQ1):c.724G>A (p.Asp242Asn)	KCNQ1	Congenital long QT syndrome|not provided|Long QT syndrome|Wolff-Parkinson-White pattern	Pathogenic/Likely pathogenic(Last reviewed: Jan 20, 2014)	criteria provided, multiple submitters, no conflicts	11	2593283	11	2572053	53090	67758
NM_000218.2(KCNQ1):c.1189C>T (p.Arg397Trp)	KCNQ1	Cardiovascular phenotype|Familial atrial fibrillation|Congenital long QT syndrome|short QT syndrome|not provided|Romano-Ward syndrome|Long QT syndrome|Jervell and Lange-Nielsen syndrome|Wolff-Parkinson-White pattern|Long QT syndrome 1|Arrhythmia	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2014)	criteria provided, conflicting interpretations	11	2608860	11	2587630	52970	67638
NM_001105207.2(LAMA4):c.1399G>T (p.Val467Phe)	LAMA4	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	6	112493944	6	112172742	487609	480690
NM_002290.4(LAMA4):c.2377C>T (p.Arg793Cys)	LAMA4	Dilated cardiomyopathy 1JJ|not provided|Wolff-Parkinson-White pattern	Conflicting interpretations of pathogenicity(Last reviewed: Jun 24, 2013)	criteria provided, conflicting interpretations	6	112466091	6	112144889	192119	189798
NM_002293.3(LAMC1):c.3304C>T (p.Arg1102Cys)	LAMC1	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	1	183099502	1	183130367	487617	480670
NM_002294.2(LAMP2):c.718C>T (p.Gln240Ter)	LAMP2	not provided	Pathogenic(Last reviewed: Sep 27, 2017)	criteria provided, single submitter	X	119581719	X	120447864	488987	482232
NM_002294.2(LAMP2):c.1075C>T (p.Gln359Ter)	LAMP2	not provided	Likely pathogenic(Last reviewed: Aug 19, 2016)	criteria provided, single submitter	X	119575603	X	120441748	372712	360562
NM_002294.2(LAMP2):c.293G>A (p.Trp98Ter)	LAMP2	not provided|Danon disease	Pathogenic(Last reviewed: Mar 18, 2015)	criteria provided, multiple submitters, no conflicts	X	119589316	X	120455461	44423	53590
NM_002294.2(LAMP2):c.520C>T (p.Gln174Ter)	LAMP2	Danon disease	Pathogenic(Last reviewed: Aug 1, 2004)	criteria provided, single submitter	X	119582861	X	120449006	9981	25020
NM_007078.2(LDB3):c.2017G>A (p.Asp673Asn)	LDB3	Myofibrillar myopathy, ZASP-related|not provided|Left ventricular noncompaction 3|Dilated cardiomyopathy 1C	Uncertain significance(Last reviewed: Nov 27, 2017)	criteria provided, multiple submitters, no conflicts	10	88485932	10	86726175	4735	19774
NM_001257374.2(LMNA):c.1420G>A (p.Val474Met)	LMNA	Charcot-Marie-Tooth disease, type 2|Dilated cardiomyopathy 1A|Emery-Dreifuss muscular dystrophy 3, autosomal recessive|Hutchinson-Gilford syndrome|Congenital muscular dystrophy, LMNA-related|Heart-hand syndrome, Slovenian type|Charcot-Marie-Tooth disease type 2B1|Familial partial lipodystrophy 2|Benign scapuloperoneal muscular dystrophy with cardiomyopathy|Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome|Mandibuloacral dysostosis|Lethal tight skin contracture syndrome|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	criteria provided, multiple submitters, no conflicts	1	156108336	1	156138545	487635	480668
NM_013247.4(HTRA2):c.*537G>A	LOXL3|HTRA2	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	74760649	2	74533522	337146	290952
NM_013247.4(HTRA2):c.*513T>A	LOXL3|HTRA2	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	74760625	2	74533498	337144	290951
NM_013247.4(HTRA2):c.*443T>A	LOXL3|HTRA2	Parkinson Disease, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	74760555	2	74533428	337143	290725
NM_198578.3:c.4037delG	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Oct 18, 2018)	criteria provided, single submitter	12	40702344 - 40702345	12	40308544	632191	620442
NM_198578.4(LRRK2):c.2752C>T (p.Arg918Ter)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Apr 5, 2019)	criteria provided, single submitter	12	40687409	12	40293607	631544	619925
NM_198578.3(LRRK2):c.6382-2A>G	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: May 21, 2018)	criteria provided, single submitter	12	40745339	12	40351537	583272	568030
NM_198578.3(LRRK2):c.1093C>A (p.His365Asn)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 20, 2018)	criteria provided, single submitter	12	40645168	12	40251366	580102	571834
NM_198578.3(LRRK2):c.1240G>A (p.Val414Ile)	LRRK2	Parkinson disease 8, autosomal dominant|not provided	Uncertain significance(Last reviewed: Apr 18, 2018)	criteria provided, multiple submitters, no conflicts	12	40646770	12	40252968	579293	568026
NM_198578.3(LRRK2):c.3033G>T (p.Glu1011Asp)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: May 21, 2018)	criteria provided, single submitter	12	40689383	12	40295581	578792	571841
NM_198578.3(LRRK2):c.2818T>G (p.Phe940Val)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: May 14, 2018)	criteria provided, single submitter	12	40688656	12	40294854	577777	566828
NM_198578.3(LRRK2):c.368C>G (p.Thr123Arg)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 19, 2018)	criteria provided, single submitter	12	40629448	12	40235646	573487	568025
NM_198578.3(LRRK2):c.5594C>G (p.Pro1865Arg)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 20, 2018)	criteria provided, single submitter	12	40717046	12	40323244	571682	565444
NM_198578.3(LRRK2):c.3721G>A (p.Ala1241Thr)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 27, 2018)	criteria provided, single submitter	12	40697880	12	40304078	566690	571842
NM_198578.3(LRRK2):c.4883G>A (p.Arg1628His)	LRRK2	Parkinson disease 8, autosomal dominant|not provided	Uncertain significance(Last reviewed: Jun 13, 2018)	criteria provided, multiple submitters, no conflicts	12	40713845	12	40320043	546702	537191
NM_198578.3(LRRK2):c.3960-5A>G	LRRK2	Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Dec 28, 2017)	criteria provided, single submitter	12	40702264	12	40308462	533779	527162
NM_198578.3(LRRK2):c.177T>A (p.Asn59Lys)	LRRK2	Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Nov 17, 2017)	criteria provided, single submitter	12	40619382	12	40225580	533778	527134
NM_198578.3(LRRK2):c.2915A>G (p.Asp972Gly)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Dec 22, 2017)	criteria provided, single submitter	12	40689265	12	40295463	533777	527161
NM_198578.3(LRRK2):c.7384C>T (p.Gln2462Ter)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Oct 25, 2017)	criteria provided, single submitter	12	40758846	12	40365044	533776	527165
NM_198578.3(LRRK2):c.4608G>A (p.Ser1536=)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 18, 2017)	criteria provided, single submitter	12	40707845	12	40314043	533775	527135
NM_198578.3(LRRK2):c.4417C>T (p.Leu1473Phe)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Oct 17, 2017)	criteria provided, single submitter	12	40704332	12	40310530	533774	527626
NM_198578.3(LRRK2):c.7296C>G (p.Gly2432=)	LRRK2	Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Sep 26, 2016)	criteria provided, single submitter	12	40758758	12	40364956	465217	463050
NM_198578.3(LRRK2):c.5870G>T (p.Arg1957Leu)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Feb 21, 2017)	criteria provided, single submitter	12	40728881	12	40335079	465216	462146
NM_198578.3(LRRK2):c.2701_2702delTCinsCT (p.Ser901Leu)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 27, 2017)	criteria provided, single submitter	12	40687358 - 40687359	12	40293556 - 40293557	465215	462432
NM_198578.3(LRRK2):c.1201G>A (p.Val401Met)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jul 14, 2017)	criteria provided, single submitter	12	40646731	12	40252929	465214	462143
NM_198578.3(LRRK2):c.3643G>A (p.Ala1215Thr)	LRRK2	not provided|Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jul 19, 2017)	criteria provided, multiple submitters, no conflicts	12	40697802	12	40304000	444287	437927
NM_198578.3(LRRK2):c.-124G>C	LRRK2	Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40618810	12	40225008	369016	353245
NM_198578.3(LRRK2):c.*1482A>G	LRRK2	Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40763049	12	40369247	308680	324765
NM_198578.3(LRRK2):c.*1464T>G	LRRK2	Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40763031	12	40369229	308679	324764
NM_198578.3(LRRK2):c.*1446T>A	LRRK2	Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40763013	12	40369211	308678	330898
NM_198578.3(LRRK2):c.*1388T>C	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40762955	12	40369153	308677	324760
NM_198578.3(LRRK2):c.*1279T>C	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40762846	12	40369044	308676	324759
NM_198578.3(LRRK2):c.*1186C>T	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40762753	12	40368951	308675	324757
NM_198578.3(LRRK2):c.*1182C>T	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40762749	12	40368947	308674	330897
NM_198578.3(LRRK2):c.*1181C>T	LRRK2	Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40762748	12	40368946	308673	332404
NM_198578.3(LRRK2):c.*1140A>T	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40762707	12	40368905	308672	317049
NM_198578.3(LRRK2):c.*1069A>G	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40762636	12	40368834	308671	332397
NM_198578.3(LRRK2):c.*1035T>C	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40762602	12	40368800	308670	332396
NM_198578.3(LRRK2):c.*1018G>T	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40762585	12	40368783	308669	317047
NM_198578.3(LRRK2):c.*979T>C	LRRK2	Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40762546	12	40368744	308668	330896
NM_198578.3(LRRK2):c.*971C>A	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40762538	12	40368736	308667	317043
NM_198578.3(LRRK2):c.*936delT	LRRK2	Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40762503	12	40368701	308666	324748
NM_198578.3(LRRK2):c.*934_*936dupTTT	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40762501 - 40762503	12	40368699 - 40368701	308665	330877
NM_198578.3(LRRK2):c.*935_*936dupTT	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40762502 - 40762503	12	40368700 - 40368701	308664	317038
NM_198578.3(LRRK2):c.*936dupT	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40762503	12	40368701	308663	332395
NM_198578.3(LRRK2):c.*736G>C	LRRK2	Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40762303	12	40368501	308662	317036
NM_198578.3(LRRK2):c.*721G>T	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40762288	12	40368486	308661	332390
NM_198578.3(LRRK2):c.*615T>A	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40762182	12	40368380	308660	332388
NM_198578.3(LRRK2):c.*470G>T	LRRK2	Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40762037	12	40368235	308659	324746
NM_198578.3(LRRK2):c.*405C>T	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40761972	12	40368170	308658	324745
NM_198578.3(LRRK2):c.*384C>T	LRRK2	Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40761951	12	40368149	308657	332384
NM_198578.3(LRRK2):c.*364A>C	LRRK2	Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40761931	12	40368129	308656	317030
NM_198578.3(LRRK2):c.*346A>G	LRRK2	Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40761913	12	40368111	308655	324744
NM_198578.3(LRRK2):c.*223C>T	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40761790	12	40367988	308654	317029
NM_198578.3(LRRK2):c.*148T>C	LRRK2	Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40761715	12	40367913	308653	324729
NM_198578.3(LRRK2):c.*131delT	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40761698	12	40367896	308652	317028
NM_198578.3(LRRK2):c.*123A>C	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40761690	12	40367888	308651	330873
NM_198578.3(LRRK2):c.*96T>C	LRRK2	Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40761663	12	40367861	308650	330872
NM_198578.3(LRRK2):c.*84G>A	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40761651	12	40367849	308649	332383
NM_198578.3(LRRK2):c.7483G>A (p.Val2495Ile)	LRRK2	Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40761466	12	40367664	308648	324728
NM_198578.3(LRRK2):c.7190T>C (p.Met2397Thr)	LRRK2	Parkinson disease 8, autosomal dominant|not provided	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	40758652	12	40364850	308647	324716
NM_198578.3(LRRK2):c.7062C>T (p.Ile2354=)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40757237	12	40363435	308646	324713
NM_198578.3(LRRK2):c.6844-14_6844-13insA	LRRK2	Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40753048 - 40753049	12	40359246 - 40359247	308645	332380
NM_198578.3(LRRK2):c.6801C>T (p.Thr2267=)	LRRK2	Parkinson disease 8, autosomal dominant	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	12	40749947	12	40356145	308644	324707
NM_198578.3(LRRK2):c.6688G>A (p.Glu2230Lys)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40748212	12	40354410	308643	324706
NM_198578.3(LRRK2):c.6582T>C (p.Val2194=)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40748106	12	40354304	308642	332370
NM_198578.3(LRRK2):c.6281-3dupT	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40742208	12	40348406	308641	332364
NM_198578.3(LRRK2):c.5713G>C (p.Val1905Leu)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40722218	12	40328416	308640	324704
NM_198578.3(LRRK2):c.5510-9A>G	LRRK2	Parkinson Disease, Dominant|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	40716953	12	40323151	308639	332363
NM_198578.3(LRRK2):c.5270A>G (p.Asn1757Ser)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40715936	12	40322134	308638	332354
NM_198578.3(LRRK2):c.4934A>G (p.Tyr1645Cys)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40713896	12	40320094	308637	317022
NM_198578.3(LRRK2):c.4930A>G (p.Asn1644Asp)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40713892	12	40320090	308636	332353
NM_198578.3(LRRK2):c.4828-9A>T	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40713781	12	40319979	308635	324698
NM_198578.3(LRRK2):c.4627A>G (p.Ile1543Val)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40707864	12	40314062	308634	324697
NM_198578.3(LRRK2):c.4317+12delT	LRRK2	Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40703047	12	40309245	308633	324696
NM_198578.3(LRRK2):c.3969A>G (p.Gln1323=)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40702278	12	40308476	308632	332351
NM_198578.3(LRRK2):c.3864G>A (p.Met1288Ile)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40699673	12	40305871	308631	324695
NM_198578.3(LRRK2):c.3778-9C>T	LRRK2	Parkinson disease 8, autosomal dominant	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	40699578	12	40305776	308630	332342
NM_198578.3(LRRK2):c.3777+7C>T	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40697943	12	40304141	308629	324694
NM_198578.3(LRRK2):c.3678A>C (p.Leu1226Phe)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40697837	12	40304035	308628	330868
NM_198578.3(LRRK2):c.3595C>A (p.Arg1199=)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40697754	12	40303952	308627	324690
NM_198578.3(LRRK2):c.3497-8delT	LRRK2	Parkinson disease 8, autosomal dominant|not provided	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	40696583	12	40302781	308626	332341
NM_198578.3(LRRK2):c.3435A>C (p.Ser1145=)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40692998	12	40299196	308625	332335
NM_198578.3(LRRK2):c.3429C>T (p.Ser1143=)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40692992	12	40299190	308624	330863
NM_198578.3(LRRK2):c.3026A>C (p.His1009Pro)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40689376	12	40295574	308623	324688
NM_198578.3(LRRK2):c.2987A>T (p.Asp996Val)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40689337	12	40295535	308622	332334
NM_198578.3(LRRK2):c.2900A>G (p.His967Arg)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40689250	12	40295448	308621	317020
NM_198578.3(LRRK2):c.2826T>C (p.His942=)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40688664	12	40294862	308620	330854
NM_198578.3(LRRK2):c.2689+20dupA	LRRK2	Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40681361	12	40287559	308619	332330
NM_198578.3(LRRK2):c.2588A>G (p.Asn863Ser)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40681240	12	40287438	308618	324686
NM_198578.3(LRRK2):c.2501-9dupT	LRRK2	Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40681144	12	40287342	308617	330850
NM_198578.3(LRRK2):c.2070+9T>A	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40671827	12	40278025	308616	332321
NM_198578.3(LRRK2):c.1446A>G (p.Ala482=)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40653309	12	40259507	308615	324685
NM_198578.3(LRRK2):c.1182-4A>G	LRRK2	Parkinson disease 8, autosomal dominant	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	40646708	12	40252906	308614	332320
NM_198578.3(LRRK2):c.1102-10C>A	LRRK2	Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40645257	12	40251455	308613	324683
NM_198578.3(LRRK2):c.867C>T (p.Asn289=)	LRRK2	Parkinson disease 8, autosomal dominant	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	40643656	12	40249854	308612	332319
NM_198578.3(LRRK2):c.712_714delAAT (p.Asn238del)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40637357 - 40637359	12	40243555 - 40243557	308611	332317
NM_198578.3(LRRK2):c.344A>C (p.His115Pro)	LRRK2	Parkinson disease 8, autosomal dominant	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	12	40626182	12	40232380	308610	317019
NM_198578.3(LRRK2):c.-44G>A	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	40618890	12	40225088	308609	324682
NM_198578.3(LRRK2):c.7267A>T (p.Thr2423Ser)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Dec 11, 2014)	no assertion criteria provided	12	40758729	12	40364927	236298	237853
NM_198578.3(LRRK2):c.7006A>G (p.Ile2336Val)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Dec 11, 2014)	no assertion criteria provided	12	40753224	12	40359422	236297	237851
NM_198578.3(LRRK2):c.6929C>T (p.Thr2310Met)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Dec 11, 2014)	no assertion criteria provided	12	40753147	12	40359345	236296	237850
NM_198578.3(LRRK2):c.5273A>C (p.His1758Pro)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Dec 11, 2014)	no assertion criteria provided	12	40715939	12	40322137	236295	237849
NM_198578.3(LRRK2):c.4441G>A (p.Ala1481Thr)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Dec 11, 2014)	no assertion criteria provided	12	40704356	12	40310554	236294	237848
NM_198578.3(LRRK2):c.4358A>G (p.His1453Arg)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Dec 11, 2014)	no assertion criteria provided	12	40704273	12	40310471	236293	237847
NM_198578.3(LRRK2):c.4314A>G (p.Ile1438Met)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Dec 11, 2014)	no assertion criteria provided	12	40703032	12	40309230	236292	237852
NM_198578.3(LRRK2):c.3187C>T (p.Leu1063Phe)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Dec 11, 2014)	no assertion criteria provided	12	40692135	12	40298333	236291	237846
NM_198578.3(LRRK2):c.2314C>T (p.Arg772Ter)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Dec 11, 2014)	no assertion criteria provided	12	40677749	12	40283947	236290	237845
NM_198578.3(LRRK2):c.1829T>C (p.Ile610Thr)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Dec 11, 2014)	no assertion criteria provided	12	40668683	12	40274881	236289	237844
NM_198578.3(LRRK2):c.1288G>A (p.Val430Ile)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Dec 11, 2014)	no assertion criteria provided	12	40646818	12	40253016	236288	237843
NM_198578.3(LRRK2):c.1132C>T (p.Leu378Phe)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Dec 11, 2014)	no assertion criteria provided	12	40645297	12	40251495	236287	237842
NM_198578.3(LRRK2):c.856C>G (p.Leu286Val)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Dec 11, 2014)	criteria provided, single submitter	12	40643645	12	40249843	236286	237841
NM_198578.3(LRRK2):c.691T>C (p.Ser231Pro)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Dec 11, 2014)	no assertion criteria provided	12	40634404	12	40240602	236285	237840
NM_198578.3(LRRK2):c.4321C>A (p.Arg1441Ser)	LRRK2	Parkinson disease, late-onset	Pathogenic(Last reviewed: Apr 14, 2016)	no assertion criteria provided	12	40704236	12	40310434	225276	227175
NM_198578.3(LRRK2):c.7300A>G (p.Ile2434Val)	LRRK2	Parkinson disease, late-onset|not provided	Uncertain significance(Last reviewed: Jul 21, 2018)	criteria provided, single submitter	12	40758762	12	40364960	96731	102617
NM_198578.3(LRRK2):c.2352C>A (p.Ser784Arg)	LRRK2	Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 22, 2014)	no assertion criteria provided	12	40677787	12	40283985	96730	102616
NM_198578.3(LRRK2):c.6523G>C (p.Asp2175His)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40745482	12	40351680	39278	47884
NM_198578.3(LRRK2):c.936G>T (p.Ala312=)	LRRK2	Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Sep 13, 2012)	criteria provided, single submitter	12	40643725	12	40249923	39246	47852
NM_198578.3(LRRK2):c.894T>C (p.Ala298=)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40643683	12	40249881	39245	47851
NM_198578.3(LRRK2):c.867C= (p.Asn289=)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40643656	12	40249854	39244	47850
NM_198578.3(LRRK2):c.825T= (p.His275=)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40637470	12	40243668	39243	47849
NM_198578.3(LRRK2):c.7468del (p.Gln2490Asnfs)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40761451	12	40367649	39242	47848
NM_198578.3(LRRK2):c.7435A>G (p.Asn2479Asp)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40760852	12	40367050	39241	47847
NM_198578.3(LRRK2):c.7397T>A (p.Leu2466His)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40760814	12	40367012	39240	47846
NM_198578.3(LRRK2):c.7224G>A (p.Met2408Ile)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40758686	12	40364884	39239	47845
NM_198578.3(LRRK2):c.7190T= (p.Met2397=)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40758652	12	40364850	39238	47844
NM_198578.3(LRRK2):c.7187_7188insGT (p.Met2397Terfs)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40758648 - 40758649	12	40364846 - 40364847	39237	47843
NM_198578.3(LRRK2):c.7183G>A (p.Glu2395Lys)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40758645	12	40364843	39236	47842
NM_198578.3(LRRK2):c.7168G>A (p.Val2390Met)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40757343	12	40363541	39235	47841
NM_198578.3(LRRK2):c.7155A>G (p.Gly2385=)	LRRK2	not provided|Parkinson disease 8, autosomal dominant	Conflicting interpretations of pathogenicity(Last reviewed: Aug 11, 2017)	criteria provided, conflicting interpretations	12	40757330	12	40363528	39234	47840
NM_198578.3(LRRK2):c.713A>T (p.Asn238Ile)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40637358	12	40243556	39233	47839
NM_198578.3(LRRK2):c.7067C>T (p.Thr2356Ile)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40757242	12	40363440	39232	47838
NM_198578.3(LRRK2):c.683G>C (p.Cys228Ser)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jul 10, 2017)	criteria provided, single submitter	12	40634396	12	40240594	39231	47837
NM_198578.3(LRRK2):c.6782A>T (p.Asn2261Ile)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40749928	12	40356126	39230	47836
NM_198578.3(LRRK2):c.6566A>G (p.Tyr2189Cys)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40745525	12	40351723	39229	47835
NM_198578.3(LRRK2):c.6510C>A (p.Gly2170=)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40745469	12	40351667	39228	47834
NM_198578.3(LRRK2):c.6428G>A (p.Arg2143His)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40745387	12	40351585	39227	47833
NM_198578.3(LRRK2):c.6422C>T (p.Thr2141Met)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40745381	12	40351579	39226	47832
NM_198578.3(LRRK2):c.6415T>A (p.Cys2139Ser)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40745374	12	40351572	39225	47831
NM_198578.3(LRRK2):c.6356C>T (p.Pro2119Leu)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40742286	12	40348484	39224	47830
NM_198578.3(LRRK2):c.632C>T (p.Ala211Val)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 31, 2018)	criteria provided, single submitter	12	40634345	12	40240543	39223	47829
NM_198578.3(LRRK2):c.6324G>A (p.Glu2108=)	LRRK2	Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Sep 13, 2012)	criteria provided, single submitter	12	40742254	12	40348452	39222	47828
NM_198578.3(LRRK2):c.6241A>G (p.Asn2081Asp)	LRRK2	not provided|Parkinson disease 8, autosomal dominant	Conflicting interpretations of pathogenicity(Last reviewed: Jul 27, 2017)	criteria provided, conflicting interpretations	12	40740686	12	40346884	39221	47827
NM_198578.3(LRRK2):c.6187_6191delCTCTA (p.Leu2063Terfs)	LRRK2	Parkinson disease 8, autosomal dominant|not provided	Uncertain significance(Last reviewed: May 21, 2018)	criteria provided, multiple submitters, no conflicts	12	40740632 - 40740636	12	40346830 - 40346834	39220	47826
NM_198578.3(LRRK2):c.6091A>T (p.Thr2031Ser)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40734238	12	40340436	39219	47825
NM_198578.3(LRRK2):c.6035T>C (p.Ile2012Thr)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40734182	12	40340380	39218	47824
NM_198578.3(LRRK2):c.6016T>C (p.Tyr2006His)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40734163	12	40340361	39217	47823
NM_198578.3(LRRK2):c.5822G>A (p.Arg1941His)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40728833	12	40335031	39216	47822
NM_198578.3(LRRK2):c.5620G>T (p.Glu1874Ter)	LRRK2	Parkinson disease 8, autosomal dominant	Pathogenic(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40717072	12	40323270	39215	47821
NM_198578.3(LRRK2):c.5610G>T (p.Leu1870Phe)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40717062	12	40323260	39214	47820
NM_198578.3(LRRK2):c.5606T>C (p.Met1869Thr)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40717058	12	40323256	39213	47819
NM_198578.3(LRRK2):c.5605A>G (p.Met1869Val)	LRRK2	Parkinson disease 8, autosomal dominant	Pathogenic(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40717057	12	40323255	39212	47818
NM_198578.3(LRRK2):c.546A>G (p.Lys182=)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40631880	12	40238078	39211	47817
NM_198578.3(LRRK2):c.5467C>A (p.Gln1823Lys)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40716270	12	40322468	39210	47816
NM_198578.3(LRRK2):c.5457T>C (p.Gly1819=)	LRRK2	Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Sep 13, 2012)	criteria provided, single submitter	12	40716260	12	40322458	39209	47815
NM_198578.3(LRRK2):c.5385G>T (p.Leu1795Phe)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40716188	12	40322386	39208	47814
NM_198578.3(LRRK2):c.5183G>T (p.Arg1728Leu)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40715849	12	40322047	39207	47813
NM_198578.3(LRRK2):c.5183G>A (p.Arg1728His)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40715849	12	40322047	39206	47812
NM_198578.3(LRRK2):c.5174G>A (p.Arg1725Gln)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40715840	12	40322038	39205	47811
NM_198578.3(LRRK2):c.5173C>T (p.Arg1725Ter)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40715839	12	40322037	39204	47810
NM_198578.3(LRRK2):c.5163A>G (p.Ser1721=)	LRRK2	Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Sep 13, 2012)	criteria provided, single submitter	12	40714983	12	40321181	39203	47809
NM_198578.3(LRRK2):c.4959A>G (p.Leu1653=)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40713921	12	40320119	39202	47808
NM_198578.3(LRRK2):c.4939T>A (p.Ser1647Thr)	LRRK2	Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Sep 13, 2012)	criteria provided, single submitter	12	40713901	12	40320099	39201	47807
NM_198578.3(LRRK2):c.4937T>C (p.Met1646Thr)	LRRK2	not provided|Parkinson disease 8, autosomal dominant	Conflicting interpretations of pathogenicity(Last reviewed: Sep 25, 2017)	criteria provided, conflicting interpretations	12	40713899	12	40320097	39200	47806
NM_198578.3(LRRK2):c.4911A>G (p.Lys1637=)	LRRK2	Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Sep 13, 2012)	criteria provided, single submitter	12	40713873	12	40320071	39199	47805
NM_198578.3(LRRK2):c.4883G>C (p.Arg1628Pro)	LRRK2	Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Sep 13, 2012)	criteria provided, single submitter	12	40713845	12	40320043	39198	47804
NM_198578.3(LRRK2):c.4872C>A (p.Gly1624=)	LRRK2	Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Sep 13, 2012)	criteria provided, single submitter	12	40713834	12	40320032	39197	47803
NM_198578.3(LRRK2):c.4838T>C (p.Val1613Ala)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40713800	12	40319998	39196	47802
NM_198578.3(LRRK2):c.4793T>A (p.Val1598Glu)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40709068	12	40315266	39195	47801
NM_198578.3(LRRK2):c.4666C>A (p.Leu1556Ile)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40707903	12	40314101	39194	47800
NM_198578.3(LRRK2):c.4624C>T (p.Pro1542Ser)	LRRK2	Parkinson disease 8, autosomal dominant|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 10, 2017)	criteria provided, conflicting interpretations	12	40707861	12	40314059	39193	47799
NM_198578.3(LRRK2):c.457T>C (p.Leu153=)	LRRK2	Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Sep 13, 2012)	criteria provided, single submitter	12	40631791	12	40237989	39192	47798
NM_198578.3(LRRK2):c.4541G>A (p.Arg1514Gln)	LRRK2	Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Oct 26, 2016)	criteria provided, single submitter	12	40707778	12	40313976	39191	47797
NM_198578.3(LRRK2):c.4448G>A (p.Arg1483Gln)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40704363	12	40310561	39190	47796
NM_198578.3(LRRK2):c.4402A>G (p.Lys1468Glu)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40704317	12	40310515	39189	47795
NM_198578.3(LRRK2):c.4364_4365delAT (p.Asp1455Glyfs)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40704279 - 40704280	12	40310477 - 40310478	39188	47794
NM_198578.3(LRRK2):c.4348G>A (p.Val1450Ile)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40704263	12	40310461	39187	47793
NM_198578.3(LRRK2):c.4337C>T (p.Pro1446Leu)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40704252	12	40310450	39186	47792
NM_198578.3(LRRK2):c.4324G>C (p.Ala1442Pro)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40704239	12	40310437	39185	47791
NM_198578.3(LRRK2):c.4323C>T (p.Arg1441=)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40704238	12	40310436	39184	47790
NM_198578.3(LRRK2):c.4309A>C (p.Asn1437His)	LRRK2	Parkinson disease 8, autosomal dominant	Pathogenic(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40703027	12	40309225	39183	47789
NM_198578.3(LRRK2):c.4290C>T (p.Ala1430=)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40703008	12	40309206	39182	47788
NM_198578.3(LRRK2):c.4269G>A (p.Lys1423=)	LRRK2	not provided|Parkinson disease 8, autosomal dominant	Conflicting interpretations of pathogenicity(Last reviewed: Sep 14, 2017)	criteria provided, conflicting interpretations	12	40702987	12	40309185	39181	47787
NM_198578.3(LRRK2):c.4258G>A (p.Asp1420Asn)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40702976	12	40309174	39180	47786
NM_198578.3(LRRK2):c.4229C>T (p.Thr1410Met)	LRRK2	Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Sep 13, 2012)	criteria provided, single submitter	12	40702947	12	40309145	39179	47785
NM_198578.3(LRRK2):c.4193G>A (p.Arg1398His)	LRRK2	Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Sep 13, 2012)	criteria provided, single submitter	12	40702911	12	40309109	39178	47784
NM_198578.3(LRRK2):c.4125C>A (p.Asp1375Glu)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40702434	12	40308632	39177	47783
NM_198578.3(LRRK2):c.4111A>G (p.Ile1371Val)	LRRK2	Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Sep 26, 2017)	criteria provided, multiple submitters, no conflicts	12	40702420	12	40308618	39176	47782
NM_198578.3(LRRK2):c.3974G>A (p.Arg1325Gln)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Feb 27, 2018)	criteria provided, single submitter	12	40702283	12	40308481	39175	47781
NM_198578.3(LRRK2):c.3960G>T (p.Arg1320Ser)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40702269	12	40308467	39174	47780
NM_198578.3(LRRK2):c.3784C>G (p.Pro1262Ala)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40699593	12	40305791	39173	47779
NM_198578.3(LRRK2):c.3683G>T (p.Ser1228Ile)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40697842	12	40304040	39172	47778
NM_198578.3(LRRK2):c.3683G>C (p.Ser1228Thr)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: May 1, 2018)	criteria provided, single submitter	12	40697842	12	40304040	39171	47777
NM_198578.3(LRRK2):c.364C= (p.Leu122=)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40629444	12	40235642	39170	47776
NM_198578.3(LRRK2):c.3647A>G (p.His1216Arg)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40697806	12	40304004	39169	47775
NM_198578.3(LRRK2):c.3574A>G (p.Ile1192Val)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40696668	12	40302866	39168	47774
NM_198578.3(LRRK2):c.356T>C (p.Leu119Pro)	LRRK2	not provided|Parkinson disease 8, autosomal dominant	Conflicting interpretations of pathogenicity(Last reviewed: Dec 19, 2016)	criteria provided, conflicting interpretations	12	40629436	12	40235634	39167	47773
NM_198578.3(LRRK2):c.3494T>C (p.Leu1165Pro)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40693057	12	40299255	39166	47772
NM_198578.3(LRRK2):c.3451G>A (p.Ala1151Thr)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 7, 2018)	criteria provided, single submitter	12	40693014	12	40299212	39165	47771
NM_198578.3(LRRK2):c.3342A>G (p.Leu1114=)	LRRK2	Parkinson disease 8, autosomal dominant	Pathogenic(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40692290	12	40298488	39164	47770
NM_198578.3(LRRK2):c.3333G>T (p.Gln1111His)	LRRK2	Parkinson disease 8, autosomal dominant	Conflicting interpretations of pathogenicity(Last reviewed: Nov 17, 2017)	criteria provided, conflicting interpretations	12	40692281	12	40298479	39163	47769
NM_198578.3(LRRK2):c.3287C>G (p.Ser1096Cys)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40692235	12	40298433	39162	47768
NM_198578.3(LRRK2):c.3200G>A (p.Arg1067Gln)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40692148	12	40298346	39161	47767
NM_198578.3(LRRK2):c.3021T= (p.Ser1007=)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40689371	12	40295569	39160	47766
NM_198578.3(LRRK2):c.3018A>G (p.Ile1006Met)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	12	40689368	12	40295566	39159	47765
NM_198578.3(LRRK2):c.2918G>A (p.Ser973Asn)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40689268	12	40295466	39158	47764
NM_198578.3(LRRK2):c.28G>A (p.Glu10Lys)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40618961	12	40225159	39157	47763
NM_198578.3(LRRK2):c.2857T>C (p.Leu953=)	LRRK2	not provided|Parkinson disease 8, autosomal dominant	Conflicting interpretations of pathogenicity(Last reviewed: Aug 14, 2017)	criteria provided, conflicting interpretations	12	40688695	12	40294893	39156	47762
NM_198578.3(LRRK2):c.2830G>T (p.Asp944Tyr)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40688668	12	40294866	39155	47761
NM_198578.3(LRRK2):c.2789A>G (p.Gln930Arg)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40687446	12	40293644	39154	47760
NM_198578.3(LRRK2):c.2769G>C (p.Gln923His)	LRRK2	not provided|Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	12	40687426	12	40293624	39153	47759
NM_198578.3(LRRK2):c.2611A>G (p.Lys871Glu)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40681263	12	40287461	39152	47758
NM_198578.3(LRRK2):c.2481T>C (p.Ser827=)	LRRK2	Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Aug 11, 2017)	criteria provided, single submitter	12	40677916	12	40284114	39151	47757
NM_198578.3(LRRK2):c.2428A>G (p.Ile810Val)	LRRK2	not provided|Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Mar 15, 2017)	criteria provided, single submitter	12	40677863	12	40284061	39150	47756
NM_198578.3(LRRK2):c.2378G>T (p.Arg793Met)	LRRK2	Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Sep 13, 2012)	criteria provided, single submitter	12	40677813	12	40284011	39149	47755
NM_198578.3(LRRK2):c.2264C>T (p.Pro755Leu)	LRRK2	Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Sep 13, 2012)	criteria provided, single submitter	12	40677699	12	40283897	39148	47754
NM_198578.3(LRRK2):c.225G>A (p.Ala75=)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40619430	12	40225628	39147	47753
NM_198578.3(LRRK2):c.2167A>G (p.Ile723Val)	LRRK2	Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Sep 13, 2012)	criteria provided, single submitter	12	40671989	12	40278187	39146	47752
NM_198578.3(LRRK2):c.2147C>T (p.Ala716Val)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40671969	12	40278167	39145	47751
NM_198578.3(LRRK2):c.2134A>G (p.Met712Val)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40671956	12	40278154	39144	47750
NM_198578.3(LRRK2):c.2022A>C (p.Val674=)	LRRK2	not specified|Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Jan 27, 2017)	criteria provided, single submitter	12	40671770	12	40277968	39143	47749
NM_198578.3(LRRK2):c.1987T>C (p.Ser663Pro)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40671735	12	40277933	39142	47748
NM_198578.3(LRRK2):c.1847A>G (p.Lys616Arg)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40668701	12	40274899	39141	47747
NM_198578.3(LRRK2):c.1674G= (p.Gly558=)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40668402	12	40274600	39140	47746
NM_198578.3(LRRK2):c.1653C>G (p.Asn551Lys)	LRRK2	Parkinson disease 8, autosomal dominant|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 29, 2017)	criteria provided, conflicting interpretations	12	40657700	12	40263898	39139	47745
NM_198578.3(LRRK2):c.1630A>G (p.Lys544Glu)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40657677	12	40263875	39138	47744
NM_198578.3(LRRK2):c.1561A>G (p.Arg521Gly)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40657608	12	40263806	39137	47743
NM_198578.3(LRRK2):c.155C>T (p.Ser52Phe)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40619360	12	40225558	39136	47742
NM_198578.3(LRRK2):c.1517G>A (p.Arg506Gln)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40653380	12	40259578	39135	47741
NM_198578.3(LRRK2):c.149A>G (p.His50Arg)	LRRK2	not specified|Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Jan 30, 2017)	criteria provided, multiple submitters, no conflicts	12	40619082	12	40225280	39134	47740
NM_198578.3(LRRK2):c.1464A>T (p.Leu488=)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40653327	12	40259525	39133	47739
NM_198578.3(LRRK2):c.1383T= (p.Ser461=)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40651144	12	40257342	39132	47738
NM_198578.3(LRRK2):c.1256C>T (p.Ala419Val)	LRRK2	Parkinson disease 8, autosomal dominant	Pathogenic(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40646786	12	40252984	39131	47737
NM_198578.3(LRRK2):c.1096G>A (p.Val366Met)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40645171	12	40251369	39130	47736
NM_198578.3(LRRK2):c.1088A>G (p.Asn363Ser)	LRRK2	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40645163	12	40251361	39129	47735
NM_198578.3(LRRK2):c.1000G>A (p.Glu334Lys)	LRRK2	not provided|Parkinson disease 8, autosomal dominant	Conflicting interpretations of pathogenicity(Last reviewed: Sep 13, 2012)	criteria provided, conflicting interpretations	12	40645075	12	40251273	39128	47734
NM_198578.3(LRRK2):c.7153G>A (p.Gly2385Arg)	LRRK2	Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Sep 13, 2012)	criteria provided, single submitter	12	40757328	12	40363526	1943	16982
NM_198578.3(LRRK2):c.4322G>A (p.Arg1441His)	LRRK2	Parkinson disease 8, autosomal dominant	Pathogenic(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40704237	12	40310435	1942	16981
NM_198578.3(LRRK2):c.6059T>C (p.Ile2020Thr)	LRRK2	Parkinson disease 8, autosomal dominant	Pathogenic(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40734206	12	40340404	1941	16980
NM_198578.3(LRRK2):c.6055G>A (p.Gly2019Ser)	LRRK2	not provided|Inborn genetic diseases|Parkinson disease 8, autosomal dominant	Pathogenic(Last reviewed: Sep 13, 2012)	criteria provided, multiple submitters, no conflicts	12	40734202	12	40340400	1940	16979
NM_198578.3(LRRK2):c.3364A>G (p.Ile1122Val)	LRRK2	Parkinson disease 8, autosomal dominant	Pathogenic(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40692927	12	40299125	1939	16978
NM_198578.3(LRRK2):c.4321C>T (p.Arg1441Cys)	LRRK2	Parkinson disease 8, autosomal dominant	Pathogenic(Last reviewed: Sep 13, 2012)	criteria provided, single submitter	12	40704236	12	40310434	1938	16977
NM_198578.3(LRRK2):c.5096A>G (p.Tyr1699Cys)	LRRK2	Parkinson disease 8, autosomal dominant	Pathogenic(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40714916	12	40321114	1937	16976
NM_198578.3(LRRK2):c.4321C>G (p.Arg1441Gly)	LRRK2	Parkinson disease 8, autosomal dominant	Pathogenic(Last reviewed: Sep 13, 2012)	no assertion criteria provided	12	40704236	12	40310434	1936	16975
NM_016841.4(MAPT):c.47G>T (p.Gly16Val)	MAPT	Frontotemporal dementia|Progressive supranuclear ophthalmoplegia|Pick's disease|Parkinson disease, late-onset	Uncertain significance(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	17	44039750	17	45962384	548576	539073
NM_005910.5(MAPT):c.374-3346C>T	MAPT	Pick's disease|Progressive supranuclear ophthalmoplegia|Parkinson disease, late-onset|Frontotemporal dementia|Parkinson-dementia syndrome|not provided	Uncertain significance(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	17	44061060	17	45983694	429936	422174
NM_016835.4(MAPT):c.1838_1840delATA (p.Asn613del)	MAPT	not provided|Parkinson disease, late-onset|Supranuclear palsy, progressive, 1, atypical	Pathogenic, risk factor(Last reviewed: Mar 1, 2004)	no assertion criteria provided	17	44087740 - 44087742	17	46010374 - 46010376	98243	104135
NM_005910.5(MAPT):c.837T>G (p.Asn279Lys)	MAPT	Frontotemporal dementia|Parkinson-dementia syndrome|Progressive supranuclear ophthalmoplegia|Parkinson disease, late-onset|Pick's disease|not provided|Frontotemporal dementia	Pathogenic(Last reviewed: Oct 1, 2004)	criteria provided, multiple submitters, no conflicts	17	44087690	17	46010324	14253	29292
NM_005910.5(MAPT):c.1216C>T (p.Arg406Trp)	MAPT	Frontotemporal dementia|Parkinson-dementia syndrome|Progressive supranuclear ophthalmoplegia|Parkinson disease, late-onset|Pick's disease|not provided|Frontotemporal dementia	Pathogenic(Last reviewed: Nov 1, 2003)	criteria provided, multiple submitters, no conflicts	17	44101427	17	46024061	14247	29286
NM_005910.5(MAPT):c.902C>T (p.Pro301Leu)	MAPT	Frontotemporal dementia|Parkinson-dementia syndrome|Progressive supranuclear ophthalmoplegia|Parkinson disease, late-onset|Pick's disease|not provided|Frontotemporal dementia|Progressive supranuclear ophthalmoplegia	Pathogenic(Last reviewed: Jul 14, 2009)	criteria provided, multiple submitters, no conflicts	17	44087755	17	46010389	14245	29284
NM_002386.3(MC1R):c.451C>T (p.Arg151Cys)	MC1R	Malignant Melanoma Susceptibility|Skin/hair/eye pigmentation 2, red hair/fair skin|Cutaneous malignant melanoma 5|Increased analgesia from kappa-opioid receptor agonist, female-specific|not specified|not provided|OCULOCUTANEOUS ALBINISM, TYPE II, MODIFIER OF	Conflicting interpretations of pathogenicity, Affects, association, risk factor(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	16	89986117	16	89919709	14312	29351
NM_002386.3(MC1R):c.478C>T (p.Arg160Trp)	MC1R	Malignant Melanoma Susceptibility|not specified|Skin/hair/eye pigmentation 2, red hair/fair skin|Increased analgesia from kappa-opioid receptor agonist, female-specific|not provided|OCULOCUTANEOUS ALBINISM, TYPE II, MODIFIER OF	Conflicting interpretations of pathogenicity, Affects, association, risk factor(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	16	89986144	16	89919736	14310	29349
NM_005460.3(SNCAIP):c.*574dupG	MGC32805|SNCAIP	Parkinson Disease, Dominant/Recessive	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	5	121799765	5	122464070	350511	300497
GRCh38/hg38 13q12.12(chr13:22943845-24355293)x3	MIPEP|SGCG|SACS|TNFRSF19|SPATA13|C1QTNF9|C1QTNF9B|PCOTH|MIR2276|SACS-AS1|LINC00327|LINC00566|SPATA13-AS1|LOC106783494|LOC112163649	See cases	conflicting data from submitters(Last reviewed: Jan 25, 2013)	no assertion criteria provided	13	23517984 - 24929431	13	22943845 - 24355293	149939	159690
NC_012920.1:m.8969G>A	MT-ATP6	Myopathy, lactic acidosis, and sideroblastic anemia 3	Pathogenic(Last reviewed: Nov 1, 2014)	no assertion criteria provided	MT	8969	MT	8969	191364	189167
NC_012920.1:m.3548T>C	MT-ND1	not specified	Uncertain significance(Last reviewed: Mar 18, 2014)	no assertion criteria provided	MT	3548	MT	3548	235006	236826
m.3796A>G	MT-ND1	Dystonia, adult-onset	Pathogenic(Last reviewed: Aug 1, 2003)	no assertion criteria provided	MT	3796	MT	3796	9730	24769
m.3397A>G	MT-ND1	Parkinson disease, late-onset|Alzheimer's disease	Pathogenic(Last reviewed: Jul 18, 1995)	no assertion criteria provided	MT	3397	MT	3397	9726	24765
m.10398A>G	MT-ND3	Parkinson disease, resistance to	protective(Last reviewed: Feb 1, 2007)	no assertion criteria provided	MT	10398	MT	10398	9713	24752
m.12397A>G	MT-ND5	Parkinson disease 6, autosomal recessive early-onset	risk factor(Last reviewed: Sep 1, 2008)	no assertion criteria provided	MT	12397	MT	12397	9705	24744
m.14319T>C	MT-ND6	Parkinson disease 6, autosomal recessive early-onset	risk factor(Last reviewed: Sep 1, 2008)	no assertion criteria provided	MT	14319	MT	14319	9695	24734
m.1095T>C	MT-RNR1	not specified|Auditory neuropathy|Deafness, nonsyndromic sensorineural, mitochondrial|streptomycin response - Toxicity/ADR|tobramycin response - Toxicity/ADR|kanamycin response - Toxicity/ADR|neomycin response - Toxicity/ADR|amikacin response - Toxicity/ADR|gentamicin response - Toxicity/ADR|aminoglycoside antibacterials response - Toxicity/ADR|Aminoglycoside-induced deafness	drug response(Last reviewed: Dec 26, 2008)	reviewed by expert panel	MT	1095	MT	1095	9631	24670
m.8344A>G	MT-TK	Mitochondrial diseases|Myoclonus with epilepsy with ragged red fibers|Parkinson disease, mitochondrial|not provided|Leigh syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 29, 2015)	criteria provided, conflicting interpretations	MT	8344	MT	8344	9579	24618
NC_012920.1:m.3243A>G	MT-TL1	Stroke|Sensorineural hearing loss|Short stature|Glucose intolerance|not provided|Myoclonus with epilepsy with ragged red fibers|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|Mitochondrial diseases|Myoclonus with epilepsy with ragged red fibers|Diabetes-deafness syndrome maternally transmitted|Muscle stiffness, painful|Age-related macular degeneration 2|Cyclical vomiting syndrome|MERRF/MELAS overlap syndrome|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|3-Methylglutaconic aciduria type 1|Leigh syndrome|Hepatic failure, early-onset, and neurologic disorder due to cytochrome C oxidase deficiency	Pathogenic(Last reviewed: Jan 29, 2015)	criteria provided, multiple submitters, no conflicts	MT	3243	MT	3243	9589	24628
m.15965A>G	MT-TP	Parkinson disease, mitochondrial	risk factor(Last reviewed: Apr 1, 1999)	no assertion criteria provided	MT	15965	MT	15965	9571	24610
m.4336T>C	MT-TQ	Sensorineural deafness and migraine|not provided	Uncertain significance(Last reviewed: Jun 1, 2001)	criteria provided, single submitter	MT	4336	MT	4336	9615	24654
m.15950G>A	MT-TT	Parkinson disease, mitochondrial	risk factor(Last reviewed: Apr 1, 1999)	no assertion criteria provided	MT	15950	MT	15950	9559	24598
NM_000256.3(MYBPC3):c.1219G>C (p.Gly407Arg)	MYBPC3	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	11	47365047	11	47343496	487636	480708
NM_000256.3(MYBPC3):c.2603G>A (p.Gly868Asp)	MYBPC3	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	11	47357562	11	47336011	487610	480707
NM_000256.3(MYBPC3):c.1321G>A (p.Glu441Lys)	MYBPC3	not provided|Primary familial hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 4|Wolff-Parkinson-White pattern|Hypertrophic cardiomyopathy|Cardiovascular phenotype|not specified	Uncertain significance(Last reviewed: Jun 1, 2014)	criteria provided, multiple submitters, no conflicts	11	47364602	11	47343051	36601	45263
NM_001040114.1(MYH11):c.5918A>G (p.Asn1973Ser)	MYH11|NDE1	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	16	15797870	16	15704013	487586	480716
NM_002471.3(MYH6):c.4430G>T (p.Arg1477Leu)	MYH6	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	14	23857062	14	23387853	487615	480712
NM_002471.3(MYH6):c.3010G>T (p.Ala1004Ser)	MYH6	Cardiovascular phenotype|Familial hypertrophic cardiomyopathy 14|Dilated cardiomyopathy 1EE|Primary dilated cardiomyopathy|Familial hypertrophic cardiomyopathy 14|Sudden cardiac death|not specified|not provided|Cardiomyopathy|Primary familial hypertrophic cardiomyopathy|Wolff-Parkinson-White pattern	Conflicting interpretations of pathogenicity(Last reviewed: Jun 24, 2013)	criteria provided, conflicting interpretations	14	23862646	14	23393437	14151	29190
NM_000257.3(MYH7):c.5779A>T (p.Ile1927Phe)	MYH7	Primary familial hypertrophic cardiomyopathy|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	criteria provided, single submitter	14	23882979	14	23413770	487639	480713
NM_000257.4(MYH7):c.4377G>T (p.Lys1459Asn)	MYH7|MHRT	Cardiovascular phenotype|not specified|not provided|Cardiomyopathy|Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|Wolff-Parkinson-White pattern|Hypertrophic cardiomyopathy	Likely benign(Last reviewed: May 25, 2015)	reviewed by expert panel	14	23886504	14	23417295	43012	52182
NM_000257.3(MYH7):c.2389G>A (p.Ala797Thr)	MYH7	Severe combined immunodeficiency disease|Combined immunodeficiency|Lymphopenia|Immunodeficiency|Abnormality of T cell physiology|Abnormality of cellular immune system|Myopathy, myosin storage, autosomal recessive|Scapuloperoneal myopathy, MYH7-related|Dilated cardiomyopathy 1S|Myopathy, distal, 1|Familial hypertrophic cardiomyopathy 1|Congenital myopathy with fiber type disproportion|Myosin storage myopathy|Cardiovascular phenotype|not provided|Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|Wolff-Parkinson-White pattern|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: May 18, 2017)	criteria provided, multiple submitters, no conflicts	14	23894525	14	23425316	42901	52071
NM_000257.3(MYH7):c.728G>A (p.Arg243His)	MYH7	not provided|Familial hypertrophic cardiomyopathy 1|Left ventricular noncompaction 5|Hypertrophic cardiomyopathy|Wolff-Parkinson-White pattern	Conflicting interpretations of pathogenicity(Last reviewed: Jun 3, 2008)	criteria provided, conflicting interpretations	14	23900798	14	23431589	14126	29165
NM_016013.3(NDUFAF1):c.619A>C (p.Thr207Pro)	NDUFAF1	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11	Pathogenic(Last reviewed: Jul 11, 2007)	no assertion criteria provided	15	41687197	15	41394999	30622	39579
NM_021074.4(NDUFV2):c.86T>C (p.Val29Ala)	NDUFV2	Parkinson disease, mitochondrial|Mitochondrial complex I deficiency|not specified|not provided	Benign(Last reviewed: Apr 1, 1998)	criteria provided, multiple submitters, no conflicts	18	9117867	18	9117869	9054	24093
NM_006393.2(NEBL):c.2473C>T (p.His825Tyr)	NEBL	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	10	21101743	10	20812814	487585	480703
NM_018055.4(NODAL):c.778G>A (p.Gly260Arg)	NODAL	Visceral heterotaxy 5, autosomal|Wolff-Parkinson-White pattern|Inborn genetic diseases	Conflicting interpretations of pathogenicity(Last reviewed: Mar 1, 2009)	criteria provided, conflicting interpretations	10	72195155	10	70435399	8269	23308
NM_000271.4(NPC1):c.2974G>C (p.Gly992Arg)	NPC1	not provided|Niemann-Pick disease, type C|Niemann-Pick disease type C1	Pathogenic/Likely pathogenic(Last reviewed: Jul 22, 2008)	criteria provided, multiple submitters, no conflicts	18	21118573	18	23538609	2969	18008
NM_006432.4(NPC2):c.441+1G>A	NPC2	not specified|not provided|Niemann-Pick disease type C2	Uncertain significance(Last reviewed: Jan 29, 2016)	criteria provided, multiple submitters, no conflicts	14	74947404	14	74480701	100734	106599
NM_006186.3(NR4A2):c.-387A>T	NR4A2	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	157189252	2	156332740	331671	284978
NM_006186.3(NR4A2):c.-384T>C	NR4A2	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	157189249	2	156332737	331670	284576
NM_006186.3(NR4A2):c.-325C>G	NR4A2	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	157189190	2	156332678	331669	282322
NM_006186.3(NR4A2):c.-241C>G	NR4A2	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	157189106	2	156332594	331668	284969
NM_006186.3(NR4A2):c.-227C>G	NR4A2	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	157189092	2	156332580	331667	284959
NM_006186.3(NR4A2):c.-223C>T	NR4A2	Parkinson Disease, Dominant/Recessive	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	157189088	2	156332576	331666	283008
NM_006186.3(NR4A2):c.-166C>G	NR4A2	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	157189031	2	156332519	331665	282318
NM_006186.3(NR4A2):c.-144G>A	NR4A2	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	157189009	2	156332497	331664	283007
NM_006186.3(NR4A2):c.585C>T (p.Asp195=)	NR4A2	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	157186114	2	156329602	331663	282317
NM_006186.3(NR4A2):c.657T>C (p.Ala219=)	NR4A2	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	157186042	2	156329530	331662	284563
NM_006186.3(NR4A2):c.732C>A (p.Leu244=)	NR4A2	Parkinson Disease, Dominant/Recessive	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	157185967	2	156329455	331661	284553
NM_006186.3(NR4A2):c.1158+13C>T	NR4A2	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	157184350	2	156327838	331660	284958
NM_006186.3(NR4A2):c.1635G>T (p.Gly545=)	NR4A2	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	157182418	2	156325906	331659	282316
NM_006186.3(NR4A2):c.1659C>G (p.Ser553=)	NR4A2	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	157182394	2	156325882	331658	284957
NM_006186.3(NR4A2):c.1746G>A (p.Val582=)	NR4A2	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	157182307	2	156325795	331657	282315
NM_006186.3(NR4A2):c.*192C>G	NR4A2	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	157182064	2	156325552	331656	284551
NM_006186.3(NR4A2):c.*331T>G	NR4A2	Parkinson Disease, Dominant/Recessive	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	157181925	2	156325413	331655	283004
NM_006186.3(NR4A2):c.*352C>A	NR4A2	Parkinson Disease, Dominant/Recessive	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	157181904	2	156325392	331654	282313
NM_006186.3(NR4A2):c.*418_*419delCA	NR4A2	Parkinson Disease, Dominant/Recessive	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	157181837 - 157181838	2	156325325 - 156325326	331653	284954
NM_006186.3(NR4A2):c.*659_*661delTAA	NR4A2	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	157181595 - 157181597	2	156325083 - 156325085	331652	282312
NM_006186.3(NR4A2):c.*822A>C	NR4A2	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	157181434	2	156324922	331651	282301
NM_006186.3(NR4A2):c.*933G>A	NR4A2	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	157181323	2	156324811	331650	284548
NM_006186.3(NR4A2):c.*1198C>T	NR4A2	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	157181058	2	156324546	331649	284952
NM_006186.3(NR4A2):c.*1311A>G	NR4A2	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	157180945	2	156324433	331648	282298
NR4A2, -245T-G	NR4A2	Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jun 8, 2004)	no assertion criteria provided					7680	22719
NR4A2, 1-BP DEL, -291T	NR4A2	Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jun 8, 2004)	no assertion criteria provided					7679	22718
NM_018206.5(VPS35):c.-34G>A	ORC6|VPS35	Parkinson Disease, Dominant|Meier-Gorlin syndrome	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	16	46723079	16	46689167	319298	343011
NM_014321.3(ORC6):c.-47G>A	ORC6|VPS35	Meier-Gorlin syndrome|not specified|Parkinson Disease, Dominant	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	16	46723571	16	46689659	260387	255744
NM_014321.3(ORC6):c.-20T>C	ORC6|VPS35	Meier-Gorlin syndrome|not specified|Parkinson Disease, Dominant	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	16	46723598	16	46689686	260386	255745
NM_004562.2(PRKN):c.7+1G>T	PACRG|PRKN	Parkinson disease 2	Pathogenic(Last reviewed: Mar 1, 2006)	no assertion criteria provided	6	163148693	6	162727661	7053	22092
NC_000001.11:g.(?_7969325)_(7969424_?)del	PARK7	Parkinson disease 7	Likely pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, single submitter	1	8029385 - 8029484	1	7969325 - 7969424	584372	556503
NM_007262.4(PARK7):c.511G>T (p.Ala171Ser)	PARK7	Parkinson disease 7	Uncertain significance(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	1	8045055	1	7984995	582678	558597
NM_007262.4(PARK7):c.448G>A (p.Gly150Ser)	PARK7	Parkinson disease 7	Uncertain significance(Last reviewed: Mar 6, 2018)	criteria provided, single submitter	1	8044992	1	7984932	577231	557378
NM_007262.4(PARK7):c.105dup (p.Ala36Cysfs)	PARK7	Parkinson disease 7	Pathogenic(Last reviewed: Jun 7, 2018)	criteria provided, single submitter	1	8025398	1	7965338	573287	557376
NM_007262.4(PARK7):c.91-4G>A	PARK7	Parkinson disease 7	Likely benign(Last reviewed: Sep 26, 2017)	criteria provided, single submitter	1	8025380	1	7965320	534230	516087
NM_007262.4(PARK7):c.293G>A (p.Arg98Gln)	PARK7	Parkinson disease 7	Benign(Last reviewed: Dec 4, 2017)	criteria provided, single submitter	1	8030994	1	7970934	465831	448380
NM_007262.4(PARK7):c.[-24+75_-24+92dup;487G>A]	PARK7		Pathogenic(Last reviewed: Nov 1, 2005)	no assertion criteria provided	1|1	8021928 - 8021945	1|1	7961868 - 7961885	446717	75266|22107
NM_007262.4(PARK7):c.*125G>A	PARK7	Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	8045239	1	7985179	298124	283319
NM_007262.4(PARK7):c.500C>G (p.Ala167Gly)	PARK7	Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	8045044	1	7984984	298123	283318
NM_007262.4(PARK7):c.323-14A>G	PARK7	Parkinson Disease, Recessive	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	8037698	1	7977638	298122	281870
NM_007262.4(PARK7):c.234C>T (p.Gly78=)	PARK7	Parkinson Disease, Recessive|not provided|Parkinson disease 7	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	8029446	1	7969386	298121	283121
NM_007262.4(PARK7):c.223G>A (p.Gly75Ser)	PARK7	Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	8029435	1	7969375	298120	283317
NM_007262.4(PARK7):c.73G>A (p.Val25Ile)	PARK7	Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	8022918	1	7962858	298119	283116
NM_007262.4(PARK7):c.59T>C (p.Val20Ala)	PARK7	Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	8022904	1	7962844	298118	281253
NM_007262.4(PARK7):c.-22C>T	PARK7	Parkinson Disease, Recessive	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	8022824	1	7962764	298117	283115
NM_007262.4(PARK7):c.-30G>C	PARK7	Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	8021847	1	7961787	298116	281251
NM_007262.4(PARK7):c.-70C>T	PARK7	Parkinson Disease, Recessive	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	8021807	1	7961747	298115	283316
NM_007262.4(PARK7):c.-80T>A	PARK7	Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	8021797	1	7961737	298114	281869
NM_007262.4(PARK7):c.-99T>C	PARK7	Parkinson Disease, Recessive	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	8021778	1	7961718	298113	283315
NM_007262.4(PARK7):c.-127G>C	PARK7	Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	8021750	1	7961690	298112	283113
NM_007262.4(PARK7):c.-137G>A	PARK7	Parkinson Disease, Recessive	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	8021740	1	7961680	298111	283314
NM_007262.4(PARK7):c.399G>C (p.Met133Ile)	PARK7	Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 22, 2014)	no assertion criteria provided	1	8037788	1	7977728	96726	102612
NM_007262.4(PARK7):c.115G>T (p.Ala39Ser)	PARK7	Parkinson disease, autosomal recessive early-onset, digenic, PINK1/DJ1	Pathogenic(Last reviewed: Jun 1, 2006)	no assertion criteria provided	1	8025408	1	7965348	7069	22108
NM_007262.4(PARK7):c.192G>C (p.Glu64Asp)	PARK7	Parkinson disease 7	Pathogenic(Last reviewed: Oct 1, 2004)	no assertion criteria provided	1	8025485	1	7965425	7067	22106
NM_007262.4(PARK7):c.446A>C (p.Asp149Ala)	PARK7	Parkinson disease 7	Pathogenic(Last reviewed: Aug 2, 2013)	no assertion criteria provided	1	8044990	1	7984930	7066	22105
NM_007262.4(PARK7):c.78G>A (p.Met26Ile)	PARK7	Parkinson disease 7	Pathogenic(Last reviewed: Jul 1, 2012)	no assertion criteria provided	1	8022923	1	7962863	7065	22104
NM_007262.4(PARK7):c.497T>C (p.Leu166Pro)	PARK7	Parkinson disease 7	Pathogenic(Last reviewed: Jul 1, 2012)	no assertion criteria provided	1	8045041	1	7984981	7064	22103
NC_000001.10:g.(8018845_8022846)_(8037799_8044954)del	PARK7	Parkinson disease 7	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	1	8018845 - 8044954			7063	22102
NM_018622.6(PARL):c.230G>A (p.Ser77Asn)	PARL	not provided	Uncertain significance(Last reviewed: Nov 1, 2011)	no assertion criteria provided	3	183585744	3	183867956	218097	214751
NM_032409.3(PINK1):c.1212C>G (p.Tyr404Ter)	PINK1|PINK1-AS	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Sep 17, 2017)	criteria provided, single submitter	1	20975086	1	20648593	631592	619988
NM_032409.3(PINK1):c.774C>A (p.Tyr258Ter)	PINK1	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	1	20966483	1	20639990	631591	619987
NM_032409.3(PINK1):c.665G>A (p.Trp222Ter)	PINK1	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Sep 18, 2017)	criteria provided, single submitter	1	20964612	1	20638119	631590	619986
NM_032409.2:c.322delC	PINK1	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 4, 2018)	criteria provided, single submitter	1	20960362 - 20960363	1	20633870	631589	619985
NM_032409.2(PINK1):c.599delC (p.Ala200Aspfs)	PINK1	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: May 2, 2018)	criteria provided, single submitter	1	20964546	1	20638053	581272	556768
NM_032409.2(PINK1):c.1173T>C (p.Asp391=)	PINK1|PINK1-AS	not provided|Parkinson disease 6, autosomal recessive early-onset	Benign(Last reviewed: Dec 29, 2017)	criteria provided, multiple submitters, no conflicts	1	20975047	1	20648554	534248	515409
NM_032409.2(PINK1):c.1488G>A (p.Lys496=)	PINK1|PINK1-AS	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Dec 19, 2017)	criteria provided, single submitter	1	20975724	1	20649231	534247	515514
NM_032409.2(PINK1):c.1015G>A (p.Ala339Thr)	PINK1|PINK1-AS	not provided|Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jun 15, 2018)	criteria provided, multiple submitters, no conflicts	1	20972108	1	20645615	500148	491572
NM_032409.2(PINK1):c.565G>A (p.Gly189Arg)	PINK1	not provided|Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Oct 31, 2017)	criteria provided, multiple submitters, no conflicts	1	20964512	1	20638019	493026	485989
NM_032409.2(PINK1):c.935G>A (p.Arg312Gln)	PINK1|PINK1-AS	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Apr 19, 2017)	criteria provided, single submitter	1	20971141	1	20644648	465847	447474
NM_032409.2(PINK1):c.804A>G (p.Leu268=)	PINK1|PINK1-AS	Parkinson disease 6, autosomal recessive early-onset	Benign(Last reviewed: Aug 4, 2017)	criteria provided, single submitter	1	20971010	1	20644517	465846	447721
NM_032409.2(PINK1):c.587C>T (p.Pro196Leu)	PINK1	not provided|Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Feb 22, 2017)	criteria provided, multiple submitters, no conflicts	1	20964534	1	20638041	445908	439180
NM_032409.2(PINK1):c.1474C>T (p.Arg492Ter)	PINK1|PINK1-AS	not provided	Pathogenic(Last reviewed: Jan 2, 2019)	criteria provided, single submitter	1	20975710	1	20649217	431963	425331
NM_005216.4(DDOST):c.*457A>C	PINK1|PINK1-AS|DDOST	Parkinson Disease, Recessive|Congenital disorder of glycosylation	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	20978415	1	20651922	295048	279978
NM_032409.2(PINK1):c.*807T>C	PINK1|PINK1-AS	Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	20977991	1	20651498	295032	278559
NM_032409.2(PINK1):c.*655T>C	PINK1|PINK1-AS	Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	20977839	1	20651346	295028	278551
NM_032409.2(PINK1):c.*613A>G	PINK1|PINK1-AS	Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	20977797	1	20651304	295027	278550
NM_032409.2(PINK1):c.*571delC	PINK1|PINK1-AS	Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	20977755	1	20651262	295025	278549
NM_032409.2(PINK1):c.*534A>G	PINK1|PINK1-AS	Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	20977718	1	20651225	295023	278678
NM_032409.2(PINK1):c.*532G>A	PINK1|PINK1-AS	Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	20977716	1	20651223	295022	278676
NM_032409.2(PINK1):c.*538_*541dupAAGT	PINK1|PINK1-AS	Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	20977722 - 20977725	1	20651229 - 20651232	295021	278548
NM_032409.2(PINK1):c.*356_*357delCG	PINK1|PINK1-AS	Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	20977540 - 20977541	1	20651047 - 20651048	295017	279814
NM_032409.2(PINK1):c.*349G>C	PINK1|PINK1-AS	Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	20977533	1	20651040	295016	278657
NM_032409.2(PINK1):c.*121G>A	PINK1|PINK1-AS	Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	20977305	1	20650812	295012	279962
NM_032409.2(PINK1):c.*18G>A	PINK1|PINK1-AS	Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	20977202	1	20650709	295010	278542
NM_032409.2(PINK1):c.1719C>G (p.Leu573=)	PINK1|PINK1-AS	Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	20977157	1	20650664	295009	279812
NM_032409.2(PINK1):c.1698G>A (p.Thr566=)	PINK1|PINK1-AS	Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	20977136	1	20650643	295008	278541
NM_032409.2(PINK1):c.1578G>C (p.Lys526Asn)	PINK1|PINK1-AS	Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	20977016	1	20650523	295007	279953
NM_032409.2(PINK1):c.1251+5G>A	PINK1|PINK1-AS	Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	20975130	1	20648637	295005	279803
NM_032409.2(PINK1):c.1018G>A (p.Ala340Thr)	PINK1|PINK1-AS	Parkinson Disease, Recessive	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	20972111	1	20645618	295004	278643
NM_032409.2(PINK1):c.960-11C>T	PINK1|PINK1-AS	Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	20972042	1	20645549	295003	279798
NM_032409.2(PINK1):c.936G>A (p.Arg312=)	PINK1|PINK1-AS	Parkinson Disease, Recessive|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	1	20971142	1	20644649	295002	278534
NM_032409.2(PINK1):c.826C>T (p.Arg276Trp)	PINK1|PINK1-AS	Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	20971032	1	20644539	295001	278532
NM_032409.2(PINK1):c.695C>T (p.Ala232Val)	PINK1	Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	20966404	1	20639911	295000	279797
NM_032409.2(PINK1):c.344A>T (p.Gln115Leu)	PINK1	Parkinson Disease, Recessive|not provided|Parkinson disease 6, autosomal recessive early-onset	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	20960385	1	20633892	294999	279796
NM_032409.2(PINK1):c.165G>A (p.Glu55=)	PINK1|MIR6084	Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	20960206	1	20633713	294998	278531
NM_032409.2(PINK1):c.88G>C (p.Gly30Arg)	PINK1	Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	20960129	1	20633636	294997	278529
NM_032409.2(PINK1):c.858G>A (p.Pro286=)	PINK1|PINK1-AS	Parkinson Disease, Recessive|not provided|Parkinson disease 6, autosomal recessive early-onset	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	1	20971064	1	20644571	289332	273569
NM_032409.2(PINK1):c.1251+10G>A	PINK1|PINK1-AS	Parkinson Disease, Recessive|not provided	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	20975135	1	20648642	288962	273199
NM_032409.2(PINK1):c.960-5G>A	PINK1|PINK1-AS	Parkinson Disease, Recessive|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	20972048	1	20645555	262028	249678
NM_032409.2(PINK1):c.388-7A>G	PINK1	Parkinson Disease, Recessive|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	20964328	1	20637835	262027	249677
NM_032409.2(PINK1):c.189C>T (p.Leu63=)	PINK1|MIR6084	Parkinson Disease, Recessive|Parkinson disease 6, autosomal recessive early-onset|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	20960230	1	20633737	262026	249676
NM_032409.2(PINK1):c.620delG (p.Arg207Glnfs)	PINK1	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Jun 9, 2014)	criteria provided, single submitter	1	20964567	1	20638074	189240	187107
NM_032409.2(PINK1):c.799C>T (p.Gln267Ter)	PINK1|PINK1-AS	Parkinson disease 6, autosomal recessive early-onset	not provided	no assertion provided	1	20971005	1	20644512	183259	181392
NM_032409.2(PINK1):c.923T>A (p.Leu308Gln)	PINK1|PINK1-AS	Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 22, 2014)	no assertion criteria provided	1	20971129	1	20644636	96729	102615
NM_032409.2(PINK1):c.644C>T (p.Pro215Leu)	PINK1	Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 22, 2014)	no assertion criteria provided	1	20964591	1	20638098	96728	102614
NM_032409.2(PINK1):c.1196C>T (p.Pro399Leu)	PINK1|PINK1-AS	Parkinson disease, autosomal recessive early-onset, digenic, PINK1/DJ1|Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jun 1, 2006)	criteria provided, single submitter	1	20975070	1	20648577	2417	17456
NM_032409.2(PINK1):c.1291T>C (p.Tyr431His)	PINK1|PINK1-AS	Parkinson disease 6	risk factor(Last reviewed: Oct 1, 2006)	no assertion criteria provided	1	20975527	1	20649034	2416	17455
NM_032409.2(PINK1):c.1366C>T (p.Gln456Ter)	PINK1|PINK1-AS	not provided|Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Sep 16, 2008)	criteria provided, single submitter	1	20975602	1	20649109	2415	17454
NM_032409.2(PINK1):c.650C>A (p.Ala217Asp)	PINK1	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Sep 1, 2006)	no assertion criteria provided	1	20964597	1	20638104	2414	17453
NM_032409.2(PINK1):c.938C>T (p.Thr313Met)	PINK1|PINK1-AS	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Oct 1, 2006)	no assertion criteria provided	1	20971144	1	20644651	2413	17452
NM_005216.4(DDOST):c.*807_*5409del	PINK1|PINK1-AS	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Jun 14, 2005)	no assertion criteria provided	1	20973463 - 20978065	1	20646970 - 20651572	2412	17451
NM_032409.2(PINK1):c.836G>A (p.Arg279His)	PINK1|PINK1-AS	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Oct 1, 2008)	no assertion criteria provided	1	20971042	1	20644549	2411	17450
NM_032409.2(PINK1):c.1600_1602dup (p.Gln534_Ser535insGln)	PINK1|PINK1-AS	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Sep 1, 2005)	no assertion criteria provided	1	20977038 - 20977040	1	20650545 - 20650547	2410	17449
NM_032409.3(PINK1):c.1570_1573dup (p.Asp525Valfs)	PINK1|PINK1-AS	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	1	20977008 - 20977011	1	20650515 - 20650518	2409	17448
NM_032409.2(PINK1):c.1040T>C (p.Leu347Pro)	PINK1|PINK1-AS	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Apr 19, 2005)	no assertion criteria provided	1	20972133	1	20645640	2408	17447
NM_032409.2(PINK1):c.736C>T (p.Arg246Ter)	PINK1	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	1	20966445	1	20639952	2407	17446
NM_032409.2(PINK1):c.1311G>A (p.Trp437Ter)	PINK1|PINK1-AS	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Sep 1, 2008)	no assertion criteria provided	1	20975547	1	20649054	2406	17445
NM_032409.2(PINK1):c.813C>A (p.His271Gln)	PINK1|PINK1-AS	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	1	20971019	1	20644526	2405	17444
NM_032409.2(PINK1):c.926G>A (p.Gly309Asp)	PINK1|PINK1-AS	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Feb 15, 2008)	no assertion criteria provided	1	20971132	1	20644639	2404	17443
NM_032409.2(PINK1):c.*510G>A	PINK1-AS|PINK1	Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	20977694	1	20651201	295020	278543
NM_000325.5(PITX2):c.194C>T (p.Pro65Leu)	PITX2	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	4	111543423	4	110622267	487594	480684
NM_003560.3(PLA2G6):c.991G>A (p.Asp331Asn)	PLA2G6	not provided|Infantile neuroaxonal dystrophy	Conflicting interpretations of pathogenicity(Last reviewed: Dec 18, 2017)	criteria provided, conflicting interpretations	22	38528924	22	38132917	522939	513670
NM_003560.3(PLA2G6):c.16C>T (p.Arg6Cys)	PLA2G6	Infantile neuroaxonal dystrophy|Parkinson disease 14|Neurodegeneration with brain iron accumulation 2b|not provided	Uncertain significance(Last reviewed: Oct 31, 2017)	criteria provided, multiple submitters, no conflicts	22	38565418	22	38169411	493345	486308
NM_003560.3(PLA2G6):c.1427+1G>A	PLA2G6	Parkinson disease 14|Neurodegeneration with brain iron accumulation 2b|Infantile neuroaxonal dystrophy|Infantile neuroaxonal dystrophy	Likely pathogenic(Last reviewed: Jun 18, 2017)	criteria provided, multiple submitters, no conflicts	22	38522377	22	38126370	437465	431023
NM_003560.3(PLA2G6):c.416G>A (p.Arg139His)	PLA2G6	Parkinson disease 14|Infantile neuroaxonal dystrophy|Neurodegeneration with brain iron accumulation 2b|not provided	Uncertain significance(Last reviewed: Oct 31, 2017)	criteria provided, multiple submitters, no conflicts	22	38541454	22	38145447	426191	415714
NM_003560.3(PLA2G6):c.91G>A (p.Asp31Asn)	PLA2G6	Infantile neuroaxonal dystrophy|Neurodegeneration with brain iron accumulation 2b|Parkinson disease 14|Infantile neuroaxonal dystrophy|not provided	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	22	38565343	22	38169336	341650	352560
NM_003560.3(PLA2G6):c.101C>T (p.Ser34Leu)	PLA2G6	Infantile neuroaxonal dystrophy|Neurodegeneration with brain iron accumulation 2b|Parkinson disease 14|not specified|Infantile neuroaxonal dystrophy|not provided	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	22	38565333	22	38169326	341649	347766
NM_003560.3(PLA2G6):c.1077G>A (p.Ser359=)	PLA2G6	not provided	Pathogenic(Last reviewed: Jul 12, 2018)	criteria provided, single submitter	22	38528838	22	38132831	279875	264928
NM_003560.3(PLA2G6):c.898G>A (p.Ala300Thr)	PLA2G6	not provided|Infantile neuroaxonal dystrophy|Parkinson disease 14|Neurodegeneration with brain iron accumulation 2b|Infantile neuroaxonal dystrophy	Uncertain significance(Last reviewed: Aug 19, 2015)	criteria provided, multiple submitters, no conflicts	22	38529017	22	38133010	235257	236944
NM_003560.3(PLA2G6):c.1615G>A (p.Gly539Ser)	PLA2G6	Neurodegeneration with brain iron accumulation 2b|Parkinson disease 14|Infantile neuroaxonal dystrophy|Iron accumulation in brain	Uncertain significance(Last reviewed: May 9, 2014)	criteria provided, multiple submitters, no conflicts	22	38516893	22	38120886	159740	169787
NM_003560.3(PLA2G6):c.991G>T (p.Asp331Tyr)	PLA2G6	not provided|Parkinson disease 14	Pathogenic(Last reviewed: Jul 5, 2011)	criteria provided, single submitter	22	38528924	22	38132917	30371	39328
NM_003560.3(PLA2G6):c.216C>A (p.Phe72Leu)	PLA2G6	Parkinson disease 14	Pathogenic(Last reviewed: Oct 12, 2010)	no assertion criteria provided	22	38541654	22	38145647	30368	39325
NM_003560.3(PLA2G6):c.1354C>T (p.Gln452Ter)	PLA2G6	Parkinson disease 14	Pathogenic(Last reviewed: Oct 12, 2010)	no assertion criteria provided	22	38522451	22	38126444	30367	39324
NM_003560.2(PLA2G6):c.1904G>A (p.Arg635Gln)	PLA2G6	PLA2G6-associated neurodegeneration|Parkinson disease 14	Uncertain significance(Last reviewed: Oct 12, 2010)	criteria provided, single submitter	22	38511664	22	38115657	30366	39323
NM_003560.3(PLA2G6):c.2239C>T (p.Arg747Trp)	PLA2G6	Parkinson disease 14|Neurodegeneration with brain iron accumulation 2b|Infantile neuroaxonal dystrophy|Parkinson disease 14	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2009)	criteria provided, multiple submitters, no conflicts	22	38508548	22	38112541	6204	21243
NM_003560.3(PLA2G6):c.2222G>A (p.Arg741Gln)	PLA2G6	Parkinson disease 14	Pathogenic(Last reviewed: Feb 1, 2009)	no assertion criteria provided	22	38508565	22	38112558	6203	21242
NM_003560.3(PLA2G6):c.238G>A (p.Ala80Thr)	PLA2G6	Parkinson disease 14|Neurodegeneration with brain iron accumulation 2b|Infantile neuroaxonal dystrophy|Infantile neuroaxonal dystrophy|Neurodegeneration with brain iron accumulation 2b	Uncertain significance(Last reviewed: Oct 28, 2008)	criteria provided, multiple submitters, no conflicts	22	38541632	22	38145625	6202	21241
NM_003560.3(PLA2G6):c.2370T>G (p.Tyr790Ter)	PLA2G6	Parkinson disease 14|Neurodegeneration with brain iron accumulation 2b|Infantile neuroaxonal dystrophy|Infantile neuroaxonal dystrophy|Iron accumulation in brain|PLA2G6-associated neurodegeneration|Inborn genetic diseases|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 17, 2014)	criteria provided, multiple submitters, no conflicts	22	38508219	22	38112212	6195	21234
NM_005397.3(PODXL):c.881G>A (p.Arg294Gln)	PODXL	Parkinson disease, late-onset	Uncertain significance(Last reviewed: Dec 12, 2015)	criteria provided, single submitter	7	131194170	7	131509411	218945	215778
NM_005397.3(PODXL):c.1118G>A (p.Ser373Asn)	PODXL	Parkinson disease, late-onset	Uncertain significance(Last reviewed: Dec 12, 2015)	criteria provided, single submitter	7	131191373	7	131506614	218944	215777
NM_005397.3(PODXL):c.1285C>A (p.Pro429Thr)	PODXL	Parkinson disease, late-onset	Uncertain significance(Last reviewed: Dec 12, 2015)	criteria provided, single submitter	7	131190725	7	131505966	218943	215776
NM_005397.3(PODXL):c.89_90insGTCGCCCC (p.Gln32Profs)	PODXL	not provided|Parkinson disease 2	Likely pathogenic(Last reviewed: Dec 12, 2015)	criteria provided, single submitter	7	131241029 - 131241030	7	131556270 - 131556271	218942	215779
NM_002693.2(POLG):c.3406G>A (p.Glu1136Lys)	POLG	not provided	Likely pathogenic(Last reviewed: Aug 14, 2017)	criteria provided, single submitter	15	89861848	15	89318617	206558	202917
NM_002693.2(POLG):c.1174C>G (p.Leu392Val)	POLG	not provided|Progressive sclerosing poliodystrophy|Seizures|Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 1|Mitochondrial DNA depletion syndrome 1 (MNGIE type)|Cerebellar ataxia infantile with progressive external ophthalmoplegia|Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis|Progressive sclerosing poliodystrophy|Mitochondrial DNA depletion syndrome 4B, MNGIE type|not specified	Conflicting interpretations of pathogenicity(Last reviewed: May 23, 2017)	criteria provided, conflicting interpretations	15	89871763	15	89328532	198151	195312
NM_022114.3(PRDM16):c.1642C>A (p.Pro548Thr)	PRDM16	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	1	3328403	1	3411839	487633	480676
NM_022114.3(PRDM16):c.2666C>T (p.Pro889Leu)	PRDM16	Left ventricular noncompaction 8|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	criteria provided, single submitter	1	3331186	1	3414622	487607	480677
NM_022114.3(PRDM16):c.2855C>T (p.Thr952Met)	PRDM16	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	1	3334555	1	3417991	487592	480678
NM_022114.3(PRDM16):c.706G>A (p.Asp236Asn)	PRDM16	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	1	3319384	1	3402820	487582	480675
NM_016203.3(PRKAG2):c.31A>G (p.Lys11Glu)	PRKAG2	Wolff-Parkinson-White pattern|Glycogen storage disease of heart, lethal congenital|Familial hypertrophic cardiomyopathy 6|Primary familial hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	151573675	7	151876590	520489	511090
NM_016203.3(PRKAG2):c.359G>A (p.Arg120His)	PRKAG2	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	7	151478345	7	151781259	487637	480696
NM_016203.3(PRKAG2):c.547G>A (p.Glu183Lys)	PRKAG2	Wolff-Parkinson-White pattern	Pathogenic(Last reviewed: Jan 14, 2016)	criteria provided, single submitter	7	151372643	7	151675557	430968	424509
NM_016203.3(PRKAG2):c.-580C>T	PRKAG2|PRKAG2-AS1	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	151574285	7	151877200	359367	305452
NM_016203.3(PRKAG2):c.-575C>T	PRKAG2|PRKAG2-AS1	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	151574280	7	151877195	359366	310359
NM_016203.3(PRKAG2):c.-560C>T	PRKAG2|PRKAG2-AS1	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	151574265	7	151877180	359365	305450
NM_016203.3(PRKAG2):c.-520C>T	PRKAG2|PRKAG2-AS1	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	151574225	7	151877140	359364	310235
NM_016203.3(PRKAG2):c.-517G>T	PRKAG2|PRKAG2-AS1	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	151574222	7	151877137	359363	305449
NM_016203.3(PRKAG2):c.-397G>C	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	151574102	7	151877017	359362	310234
NM_016203.3(PRKAG2):c.-351G>A	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	151574056	7	151876971	359361	310230
NM_016203.3(PRKAG2):c.-322T>C	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	151574027	7	151876942	359360	302225
NM_016203.3(PRKAG2):c.-287C>G	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	151573992	7	151876907	359359	310357
NM_016203.3(PRKAG2):c.-274C>A	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	151573979	7	151876894	359358	305448
NM_016203.3(PRKAG2):c.-262C>T	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	151573967	7	151876882	359357	310347
NM_016203.3(PRKAG2):c.-252C>T	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	151573957	7	151876872	359356	302224
NM_016203.3(PRKAG2):c.-249G>C	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	151573954	7	151876869	359355	310346
NM_016203.3(PRKAG2):c.-90G>T	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	151573795	7	151876710	359354	305447
NM_016203.3(PRKAG2):c.-40C>T	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	151573745	7	151876660	359353	305446
NM_016203.3(PRKAG2):c.-16A>G	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	151573721	7	151876636	359352	310329
NM_016203.3(PRKAG2):c.138G>A (p.Pro46=)	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|not specified|Cardiomyopathy|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	7	151483604	7	151786518	359351	305445
NM_016203.3(PRKAG2):c.186+7C>T	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	151483549	7	151786463	359350	302218
NM_016203.3(PRKAG2):c.224G>C (p.Gly75Ala)	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	151478480	7	151781394	359349	310328
NM_016203.3(PRKAG2):c.248C>T (p.Pro83Leu)	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Cardiomyopathy|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	7	151478456	7	151781370	359348	305444
NM_016203.3(PRKAG2):c.395A>G (p.Lys132Arg)	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	151478309	7	151781223	359347	302217
NM_016203.3(PRKAG2):c.429G>A (p.Ser143=)	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	151478275	7	151781189	359346	305443
NM_016203.3(PRKAG2):c.433G>A (p.Gly145Arg)	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	151478271	7	151781185	359345	310229
NM_016203.3(PRKAG2):c.787C>A (p.Arg263=)	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	151292508	7	151595422	359344	305441
NM_016203.3(PRKAG2):c.*55C>T	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	151254232	7	151557146	359343	305440
NM_016203.3(PRKAG2):c.*112A>G	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	151254175	7	151557089	359342	302216
NM_016203.3(PRKAG2):c.*127C>G	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	151254160	7	151557074	359341	302215
NM_016203.3(PRKAG2):c.*135T>C	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	151254152	7	151557066	359340	305434
NM_016203.3(PRKAG2):c.*350C>A	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	151253937	7	151556851	359339	302214
NM_016203.3(PRKAG2):c.*365G>A	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	151253922	7	151556836	359338	310228
NM_016203.3(PRKAG2):c.*384C>T	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	151253903	7	151556817	359337	310327
NM_016203.3(PRKAG2):c.*452C>T	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	151253835	7	151556749	359336	310227
NM_016203.3(PRKAG2):c.*522G>T	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	151253765	7	151556679	359335	305426
NM_016203.3(PRKAG2):c.*572G>A	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	151253715	7	151556629	359334	310221
NM_016203.3(PRKAG2):c.*612G>A	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	151253675	7	151556589	359333	302212
NM_016203.3(PRKAG2):c.*614A>T	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	151253673	7	151556587	359332	305406
NM_016203.3(PRKAG2):c.*835T>C	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	151253452	7	151556366	359331	310325
NM_016203.3(PRKAG2):c.*887G>A	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	151253400	7	151556314	359330	305405
NM_016203.3(PRKAG2):c.*896delT	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	151253391	7	151556305	359329	310209
NM_016203.3(PRKAG2):c.*964G>A	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	151253323	7	151556237	359328	305396
NM_016203.3(PRKAG2):c.*1012T>G	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	151253275	7	151556189	359327	310323
NM_016203.3(PRKAG2):c.*1021delT	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	151253266	7	151556180	359326	310322
NM_016203.3(PRKAG2):c.*1021_*1022delTGinsGT	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	151253265 - 151253266	7	151556179 - 151556180	359325	302210
NM_016203.3(PRKAG2):c.*1029dupG	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	151253258	7	151556172	359324	302207
NM_016203.3(PRKAG2):c.*1040delT	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	151253247	7	151556161	359323	305395
NM_016203.3(PRKAG2):c.*1040dupT	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	151253247	7	151556161	359322	302204
NM_016203.3(PRKAG2):c.*1041dupC	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	151253246	7	151556160	359321	302201
NM_016203.3(PRKAG2):c.*1061G>A	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	151253226	7	151556140	359320	302196
NM_016203.3(PRKAG2):c.-26C>T	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|not specified|not provided|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	151573731	7	151876646	260692	252655
NM_016203.3(PRKAG2):c.1310C>G (p.Ala437Gly)	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome|Primary familial hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Nov 4, 2015)	criteria provided, multiple submitters, no conflicts	7	151262895	7	151565809	222770	224349
NM_016203.3(PRKAG2):c.1646A>C (p.Asp549Ala)	PRKAG2	not provided	Likely pathogenic(Last reviewed: Apr 13, 2015)	criteria provided, single submitter	7	151257642	7	151560556	181481	179112
NM_016203.3(PRKAG2):c.202G>A (p.Gly68Ser)	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|not specified|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	7	151478502	7	151781416	181465	179136
NM_016203.3(PRKAG2):c.1006G>A (p.Val336Ile)	PRKAG2	Cardiovascular phenotype|not specified|not provided	Uncertain significance(Last reviewed: May 30, 2014)	criteria provided, multiple submitters, no conflicts	7	151269795	7	151572709	179205	174049
NM_016203.3(PRKAG2):c.912G>A (p.Ala304=)	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|not specified|Wolff-Parkinson-White syndrome|Cardiovascular phenotype|Glycogen storage disease of heart, lethal congenital	Conflicting interpretations of pathogenicity(Last reviewed: Apr 4, 2017)	criteria provided, conflicting interpretations	7	151273491	7	151576405	45738	54903
NM_016203.3(PRKAG2):c.620C>G (p.Ser207Cys)	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Wolff-Parkinson-White syndrome|not specified|Glycogen storage disease of heart, lethal congenital	Uncertain significance(Last reviewed: Jul 6, 2012)	criteria provided, multiple submitters, no conflicts	7	151372570	7	151675484	45729	54894
NM_016203.3(PRKAG2):c.59G>T (p.Ser20Ile)	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Cardiovascular phenotype|Wolff-Parkinson-White syndrome|not specified|Cardiomyopathy|Glycogen storage disease of heart, lethal congenital	Benign/Likely benign(Last reviewed: May 10, 2011)	criteria provided, multiple submitters, no conflicts	7	151573647	7	151876562	45727	54892
NM_016203.3(PRKAG2):c.425C>T (p.Thr142Ile)	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|not specified|not provided|Arrhythmogenic right ventricular cardiomyopathy, type 9|Wolff-Parkinson-White syndrome|Hypertrophic cardiomyopathy|Glycogen storage disease of heart, lethal congenital|Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern|Cardiomyopathy|Glycogen storage disease of heart, lethal congenital	Uncertain significance(Last reviewed: May 23, 2017)	criteria provided, multiple submitters, no conflicts	7	151478279	7	151781193	45717	54882
NM_016203.3(PRKAG2):c.240C>A (p.Gly80=)	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|not specified|Cardiomyopathy|Wolff-Parkinson-White syndrome|Glycogen storage disease of heart, lethal congenital	Conflicting interpretations of pathogenicity(Last reviewed: Jun 11, 2012)	criteria provided, conflicting interpretations	7	151478464	7	151781378	45710	54875
NM_016203.3(PRKAG2):c.207G>A (p.Pro69=)	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Cardiomyopathy|Wolff-Parkinson-White syndrome|Cardiovascular phenotype|not specified|Glycogen storage disease of heart, lethal congenital	Benign/Likely benign(Last reviewed: Mar 11, 2015)	criteria provided, multiple submitters, no conflicts	7	151478497	7	151781411	45709	54874
NM_016203.3(PRKAG2):c.1623T>C (p.Ile541=)	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|not specified|Wolff-Parkinson-White syndrome|Cardiovascular phenotype|not provided|Cardiomyopathy|Glycogen storage disease of heart, lethal congenital	Benign/Likely benign(Last reviewed: Aug 7, 2017)	criteria provided, multiple submitters, no conflicts	7	151257665	7	151560579	45702	54867
NM_016203.3(PRKAG2):c.1390G>A (p.Asp464Asn)	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|not specified|not provided|Cardiomyopathy|Wolff-Parkinson-White syndrome|Primary familial hypertrophic cardiomyopathy|Glycogen storage disease of heart, lethal congenital	Uncertain significance(Last reviewed: Jul 23, 2015)	criteria provided, multiple submitters, no conflicts	7	151262815	7	151565729	45697	54862
NM_016203.3(PRKAG2):c.123C>T (p.Ser41=)	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Cardiovascular phenotype|not specified|Wolff-Parkinson-White syndrome|Cardiomyopathy|Glycogen storage disease of heart, lethal congenital	Conflicting interpretations of pathogenicity(Last reviewed: Sep 14, 2017)	criteria provided, conflicting interpretations	7	151483619	7	151786533	45692	54857
NM_016203.3(PRKAG2):c.114+12C>T	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|not provided|Wolff-Parkinson-White syndrome|not specified|Glycogen storage disease of heart, lethal congenital	Benign/Likely benign(Last reviewed: Jun 27, 2011)	criteria provided, multiple submitters, no conflicts	7	151573580	7	151876495	45689	54854
NM_016203.3(PRKAG2):c.111T>A (p.Ile37=)	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Wolff-Parkinson-White syndrome|Cardiovascular phenotype|not specified|Cardiomyopathy|Glycogen storage disease of heart, lethal congenital	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	7	151573595	7	151876510	45688	54853
NM_016203.3(PRKAG2):c.*3G>A	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Cardiovascular phenotype|Cardiomyopathy|Wolff-Parkinson-White syndrome|not specified|not provided|Glycogen storage disease of heart, lethal congenital	Benign/Likely benign(Last reviewed: Oct 23, 2015)	criteria provided, multiple submitters, no conflicts	7	151254284	7	151557198	45684	54849
NM_016203.3(PRKAG2):c.298G>A (p.Gly100Ser)	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Cardiomyopathy|Wolff-Parkinson-White pattern|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome|Cardiovascular phenotype|PRKAG2 cardiac syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jul 24, 2012)	criteria provided, conflicting interpretations	7	151478406	7	151781320	36697	45358
NM_016203.3(PRKAG2):c.1593G>A (p.Arg531=)	PRKAG2	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|not specified|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome|Cardiovascular phenotype|Cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Mar 15, 2012)	criteria provided, conflicting interpretations	7	151257695	7	151560609	36696	45357
NM_016203.3(PRKAG2):c.1516G>C (p.Glu506Gln)	PRKAG2	Primary familial hypertrophic cardiomyopathy|not provided|Familial hypertrophic cardiomyopathy 6	Likely pathogenic(Last reviewed: Nov 1, 2009)	criteria provided, multiple submitters, no conflicts	7	151261232	7	151564146	6855	21894
NM_016203.3(PRKAG2):c.1589A>G (p.His530Arg)	PRKAG2	not provided|Familial hypertrophic cardiomyopathy 6	Pathogenic(Last reviewed: May 1, 2008)	criteria provided, single submitter	7	151257699	7	151560613	6854	21893
NM_016203.3(PRKAG2):c.1591C>G (p.Arg531Gly)	PRKAG2	Wolff-Parkinson-White syndrome, childhood-onset	Pathogenic(Last reviewed: Dec 18, 2001)	no assertion criteria provided	7	151257697	7	151560611	6851	21890
NM_016203.3(PRKAG2):c.1463A>T (p.Asn488Ile)	PRKAG2	Familial hypertrophic cardiomyopathy 6	Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	7	151261285	7	151564199	6850	21889
NM_016203.3(PRKAG2):c.1199C>A (p.Thr400Asn)	PRKAG2	Primary familial hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 6	Likely pathogenic(Last reviewed: Feb 1, 2002)	criteria provided, single submitter	7	151265836	7	151568750	6849	21888
NM_016203.3(PRKAG2):c.1050_1051insTTA (p.Arg350_Glu351insLeu)	PRKAG2	Familial hypertrophic cardiomyopathy 6	Pathogenic(Last reviewed: May 15, 2001)	no assertion criteria provided	7	151269750 - 151269751	7	151572664 - 151572665	6848	21887
NM_016203.3(PRKAG2):c.1148A>G (p.His383Arg)	PRKAG2	not specified|Familial hypertrophic cardiomyopathy 6	Uncertain significance(Last reviewed: May 15, 2001)	criteria provided, single submitter	7	151265887	7	151568801	6847	21886
NM_016203.3(PRKAG2):c.905G>A (p.Arg302Gln)	PRKAG2	Primary familial hypertrophic cardiomyopathy|Wolff-Parkinson-White pattern|Cardiovascular phenotype|not provided|Cardiomyopathy|Glycogen storage disease of heart, lethal congenital|Familial hypertrophic cardiomyopathy 6|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Aug 18, 2014)	criteria provided, multiple submitters, no conflicts	7	151273498	7	151576412	6846	21885
NM_001164758.1(PRKAR1B):c.149T>G (p.Leu50Arg)	PRKAR1B	not provided	Uncertain significance(Last reviewed: Aug 28, 2017)	no assertion criteria provided	7	750994	7	711357	375411	362178
NC_000006.12:g.(?_161973282)_(162054194_?)dup	PRKN	Parkinson disease 2	Likely pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, single submitter	6	162394314 - 162475226	6	161973282 - 162054194	583917	560506
NC_000006.12:g.(?_161569335)_(161569436_?)del	PRKN	Parkinson disease 2	Pathogenic(Last reviewed: Feb 21, 2018)	criteria provided, single submitter	6	161990367 - 161990468	6	161569335 - 161569436	583674	560399
NC_000006.12:g.(?_162262505)_(162262785_?)dup	PRKN	Parkinson disease 2	Likely pathogenic(Last reviewed: May 7, 2018)	criteria provided, single submitter	6	162683537 - 162683817	6	162262505 - 162262785	583519	560508
NC_000006.12:g.(?_161548834)_(161549023_?)dup	PRKN	Parkinson disease 2	Uncertain significance(Last reviewed: Mar 6, 2018)	criteria provided, single submitter	6	161969866 - 161970055	6	161548834 - 161549023	583484	563258
NC_000006.12:g.(?_162262505)_(162443493_?)dup	PRKN	Parkinson disease 2	Uncertain significance(Last reviewed: May 24, 2018)	criteria provided, single submitter	6	162683537 - 162864525	6	162262505 - 162443493	583436	563260
NM_004562.2(PRKN):c.560T>G (p.Leu187Ter)	PRKN	Parkinson disease 2	Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	6	162475181	6	162054149	582111	560503
NM_004562.2(PRKN):c.775A>G (p.Ile259Val)	PRKN	Parkinson disease 2	Uncertain significance(Last reviewed: Mar 13, 2018)	criteria provided, single submitter	6	162206900	6	161785868	581407	563474
NM_004562.2(PRKN):c.4A>G (p.Ile2Val)	PRKN|PACRG	Parkinson disease 2	Uncertain significance(Last reviewed: Jan 19, 2018)	criteria provided, single submitter	6	163148697	6	162727665	579609	563481
NM_004562.2(PRKN):c.686T>C (p.Ile229Thr)	PRKN	Parkinson disease 2	Uncertain significance(Last reviewed: Apr 12, 2018)	criteria provided, single submitter	6	162394382	6	161973350	579186	563480
NM_004562.2(PRKN):c.838G>A (p.Asp280Asn)	PRKN	Parkinson disease 2	Uncertain significance(Last reviewed: May 14, 2018)	criteria provided, multiple submitters, no conflicts	6	162206837	6	161785805	579080	565509
NM_004562.2(PRKN):c.98G>A (p.Arg33Gln)	PRKN	Parkinson disease 2	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, single submitter	6	162864415	6	162443383	578186	560658
NM_004562.2(PRKN):c.930G>C (p.Glu310Asp)	PRKN	Parkinson disease 2	Uncertain significance(Last reviewed: Mar 9, 2018)	criteria provided, single submitter	6	161990390	6	161569358	577057	565508
NM_004562.2(PRKN):c.766C>T (p.Arg256Cys)	PRKN	Parkinson disease 2	Uncertain significance(Last reviewed: Jan 11, 2018)	criteria provided, single submitter	6	162206909	6	161785877	574874	560656
NM_004562.2(PRKN):c.988G>A (p.Val330Met)	PRKN	Parkinson disease 2	Uncertain significance(Last reviewed: Jun 20, 2018)	criteria provided, single submitter	6	161969981	6	161548949	574344	560501
NM_004562.2(PRKN):c.7+5G>T	PRKN|PACRG	Parkinson disease 2	Uncertain significance(Last reviewed: May 24, 2018)	criteria provided, single submitter	6	163148689	6	162727657	573661	560660
NM_004562.2(PRKN):c.734+1G>A	PRKN	Parkinson disease 2	Likely pathogenic(Last reviewed: Jun 19, 2018)	criteria provided, single submitter	6	162394333	6	161973301	571536	565522
NM_004562.2(PRKN):c.1117C>A (p.His373Asn)	PRKN	Parkinson disease 2	Uncertain significance(Last reviewed: Apr 4, 2018)	criteria provided, single submitter	6	161807876	6	161386844	567796	560654
NC_000006.12:g.162200911_162520394del319484	PRKN	Parkinson disease 2	Likely pathogenic(Last reviewed: Mar 1, 2018)	criteria provided, single submitter	6	162621943 - 162941426	6	162200911 - 162520394	560128	550844
NC_000006.12:g.(?_161785752)_(161973437_?)del	PRKN	Parkinson disease 2	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	6	162206784 - 162394469	6	161785752 - 161973437	536459	521887
NM_004562.2(PRKN):c.155delA (p.Asn52Metfs)	PRKN	Parkinson disease 2	Pathogenic(Last reviewed: May 21, 2018)	criteria provided, multiple submitters, no conflicts	6	162864358	6	162443326	536457	521494
NM_004562.2(PRKN):c.8-14A>G	PRKN	Parkinson disease 2	Uncertain significance(Last reviewed: Dec 22, 2017)	criteria provided, single submitter	6	162864519	6	162443487	468589	456276
NM_004562.2(PRKN):c.730G>A (p.Val244Ile)	PRKN	Parkinson disease 2	Uncertain significance(Last reviewed: Jun 13, 2017)	criteria provided, single submitter	6	162394338	6	161973306	468588	455450
NM_004562.2(PRKN):c.458C>G (p.Pro153Arg)	PRKN	Parkinson disease 2	Benign(Last reviewed: Nov 22, 2017)	criteria provided, single submitter	6	162622239	6	162201207	468587	455455
NM_004562.2(PRKN):c.136G>A (p.Ala46Thr)	PRKN	Parkinson disease 2	Benign(Last reviewed: Jul 29, 2017)	criteria provided, single submitter	6	162864377	6	162443345	468586	456269
NM_004562.2(PRKN):c.1330G>C (p.Glu444Gln)	PRKN	Parkinson disease 2	Uncertain significance(Last reviewed: Jan 23, 2017)	criteria provided, single submitter	6	161771199	6	161350167	468585	455430
NM_004562.2(PRKN):c.101A>G (p.Gln34Arg)	PRKN	Parkinson disease 2	Benign(Last reviewed: Apr 12, 2017)	criteria provided, single submitter	6	162864412	6	162443380	468584	455534
NM_004562.2(PRKN):c.1001G>A (p.Arg334His)	PRKN	Parkinson disease 2	Uncertain significance(Last reviewed: Jun 22, 2017)	criteria provided, single submitter	6	161969968	6	161548936	468583	456260
NC_000006.12:g.(?_162443290)_(162443493_?)dup	PRKN	Parkinson disease 2	Pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, single submitter	6	162864322 - 162864525	6	162443290 - 162443493	468582	455272
NC_000006.12:g.(?_162262505)_(162443493_?)del	PRKN	Parkinson disease 2	Pathogenic(Last reviewed: Dec 22, 2017)	criteria provided, single submitter			6	162262505 - 162443493	468581	455116
NC_000006.12:g.(?_162262505)_(162262785_?)del	PRKN	Parkinson disease 2	Pathogenic(Last reviewed: Apr 26, 2018)	criteria provided, single submitter			6	162262505 - 162262785	468580	455271
NC_000006.12:g.(?_162201111)_(162262785_?)del	PRKN	Parkinson disease 2	Pathogenic(Last reviewed: Jun 26, 2018)	criteria provided, single submitter	6	162622143 - 162683817	6	162201111 - 162262785	468579	455998
NC_000006.12:g.(?_162201111)_(162201272_?)del	PRKN	Parkinson disease 2	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, single submitter			6	162201111 - 162201272	468578	455265
NM_004562.2(PRKN):c.919C>T (p.Leu307=)	PRKN	not provided|Parkinson disease 2	Conflicting interpretations of pathogenicity(Last reviewed: Aug 22, 2017)	criteria provided, conflicting interpretations	6	161990401	6	161569369	444707	438347
NM_004562.2(PRKN):c.1204C>T (p.Arg402Cys)	PRKN	Parkinson disease 2|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 22, 2017)	criteria provided, conflicting interpretations	6	161781201	6	161360169	425402	413736
NC_000006.12:g.(?_162054091)_(162054174_?)del	PRKN	Parkinson disease 2	Pathogenic(Last reviewed: Sep 23, 2016)	criteria provided, single submitter	6	162475123 - 162475206	6	162054091 - 162054174	417464	395171
NC_000006.12:g.(?_161347558)_(162054174_?)dup	PRKN|LOC105378098	Parkinson disease 2	Uncertain significance(Last reviewed: Aug 5, 2016)	criteria provided, single submitter	6	161768590 - 162475206	6	161347558 - 162054174	417462	394996
NC_000006.12:g.(?_162201131)_(162201252_?)dup	PRKN	Parkinson disease 2	Uncertain significance(Last reviewed: Dec 8, 2016)	criteria provided, single submitter	6	162622163 - 162622284	6	162201131 - 162201252	417461	394998
NC_000006.12:g.(?_162201131)_(162443473_?)del	PRKN	Parkinson disease 2	Pathogenic(Last reviewed: Nov 12, 2016)	criteria provided, single submitter	6	162622163 - 162864505	6	162201131 - 162443473	417459	395641
NM_004562.2(PRKN):c.957T>C (p.Gly319=)	PRKN	Parkinson disease 2	Benign(Last reviewed: Apr 14, 2017)	criteria provided, single submitter	6	161970012	6	161548980	415532	395226
NM_004562.2(PRKN):c.574A>C (p.Met192Leu)	PRKN	not specified|Parkinson disease 2|not provided	Benign(Last reviewed: Dec 29, 2017)	criteria provided, multiple submitters, no conflicts	6	162475167	6	162054135	415531	395426
NM_004562.2(PRKN):c.816C>T (p.Leu272=)	PRKN	Parkinson disease 2	Benign(Last reviewed: Jan 27, 2017)	criteria provided, single submitter	6	162206859	6	161785827	415530	395072
NM_004562.2(PRKN):c.172-9C>G	PRKN	Parkinson disease 2	Uncertain significance(Last reviewed: Sep 26, 2016)	criteria provided, single submitter	6	162683806	6	162262774	409271	395080
NM_004562.2(PRKN):c.689C>T (p.Ala230Val)	PRKN	Parkinson disease 2	Uncertain significance(Last reviewed: Jul 29, 2016)	criteria provided, single submitter	6	162394379	6	161973347	409270	395227
NM_004562.2(PRKN):c.443T>A (p.Val148Glu)	PRKN	Parkinson disease 2	Uncertain significance(Last reviewed: Apr 29, 2016)	criteria provided, single submitter	6	162622254	6	162201222	409269	395079
NM_004562.2(PRKN):c.125G>A (p.Arg42His)	PRKN	Parkinson disease 2	Uncertain significance(Last reviewed: Dec 3, 2016)	criteria provided, single submitter	6	162864388	6	162443356	409268	395228
NM_004562.2(PRKN):c.761A>G (p.Asn254Ser)	PRKN	Parkinson disease 2	Uncertain significance(Last reviewed: Jun 13, 2018)	criteria provided, single submitter	6	162206914	6	161785882	409267	395420
NM_004562.2(PRKN):c.850G>C (p.Gly284Arg)	PRKN	Parkinson disease 2	Pathogenic(Last reviewed: Nov 12, 2016)	criteria provided, single submitter	6	162206825	6	161785793	409266	395419
NM_004562.2(PRKN):c.-107G>A	PRKN|PACRG	Parkinson Disease, Juvenile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	6	163148807	6	162727775	356025	306813
NM_004562.2(PRKN):c.-46C>T	PRKN|PACRG	Parkinson Disease, Juvenile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	6	163148746	6	162727714	356024	306812
NM_004562.2(PRKN):c.-42T>C	PRKN|PACRG	Parkinson Disease, Juvenile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	6	163148742	6	162727710	356023	302129
NM_004562.2(PRKN):c.-30T>C	PRKN|PACRG	Parkinson Disease, Juvenile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	6	163148730	6	162727698	356022	306811
NM_004562.2(PRKN):c.7+4C>T	PRKN|PACRG	Parkinson Disease, Juvenile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	6	163148690	6	162727658	356021	306546
NM_004562.2(PRKN):c.111G>A (p.Pro37=)	PRKN	Parkinson Disease, Juvenile|Parkinson disease 2	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	162864402	6	162443370	356020	306809
NM_004562.2(PRKN):c.522C>T (p.Leu174=)	PRKN	Parkinson Disease, Juvenile|Parkinson disease 2	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	6	162622175	6	162201143	356019	302128
NM_004562.2(PRKN):c.706A>G (p.Ile236Val)	PRKN	Parkinson Disease, Juvenile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	6	162394362	6	161973330	356018	302116
NM_004562.2(PRKN):c.783A>G (p.Leu261=)	PRKN	Parkinson Disease, Juvenile|not provided|Parkinson disease 2	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	162206892	6	161785860	356017	299590
NM_004562.2(PRKN):c.1289G>A (p.Gly430Asp)	PRKN	Parkinson disease 2	Likely pathogenic(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	6	161771240	6	161350208	356016	306532
NM_004562.2(PRKN):c.1213G>A (p.Ala405Thr)	PRKN	Parkinson Disease, Juvenile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	6	161781192	6	161360160	356015	299589
NM_004562.2(PRKN):c.1364G>A (p.Arg455His)	PRKN	Parkinson Disease, Juvenile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	6	161771165	6	161350133	356014	302111
NM_004562.2(PRKN):c.*15C>A	PRKN	Parkinson Disease, Juvenile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	6	161771116	6	161350084	356013	299583
NM_004562.2(PRKN):c.*98G>A	PRKN	Parkinson Disease, Juvenile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	6	161771033	6	161350001	356012	306808
NM_004562.2(PRKN):c.*114_*115dupAC	PRKN	Parkinson Disease, Juvenile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	6	161771016 - 161771017	6	161349984 - 161349985	356011	302108
NM_004562.2(PRKN):c.*301G>C	PRKN	Parkinson Disease, Juvenile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	6	161770830	6	161349798	356010	306531
NM_004562.2(PRKN):c.*314C>A	PRKN	Parkinson Disease, Juvenile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	6	161770817	6	161349785	356009	299582
NM_004562.2(PRKN):c.*372C>G	PRKN	Parkinson Disease, Juvenile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	6	161770759	6	161349727	356008	302107
NM_004562.2(PRKN):c.*472T>C	PRKN	Parkinson Disease, Juvenile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	6	161770659	6	161349627	356007	302104
NM_004562.2(PRKN):c.*652C>T	PRKN	Parkinson Disease, Juvenile	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	6	161770479	6	161349447	356006	299579
NM_004562.2(PRKN):c.*820A>T	PRKN	Parkinson Disease, Juvenile	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	6	161770311	6	161349279	356005	302102
NM_004562.2(PRKN):c.*887_*890delGATA	PRKN	Parkinson Disease, Juvenile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	6	161770241 - 161770244	6	161349209 - 161349212	356004	306800
NM_004562.2(PRKN):c.*1016C>T	PRKN	Parkinson Disease, Juvenile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	6	161770115	6	161349083	356003	302101
NM_004562.2(PRKN):c.*1028_*1029delTC	PRKN	Parkinson Disease, Juvenile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	6	161770102 - 161770103	6	161349070 - 161349071	356002	306529
NM_004562.2(PRKN):c.*1156C>G	PRKN	Parkinson Disease, Juvenile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	6	161769975	6	161348943	356001	306528
NM_004562.2(PRKN):c.*1252C>T	PRKN	Parkinson Disease, Juvenile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	6	161769879	6	161348847	356000	299576
NM_004562.2(PRKN):c.*1281C>T	PRKN	Parkinson Disease, Juvenile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	6	161769850	6	161348818	355999	306524
NM_004562.2(PRKN):c.*1296A>G	PRKN	Parkinson Disease, Juvenile	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	6	161769835	6	161348803	355998	302100
NM_004562.2(PRKN):c.*1386A>G	PRKN	Parkinson Disease, Juvenile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	6	161769745	6	161348713	355997	306792
NM_004562.2(PRKN):c.*1462C>A	PRKN	Parkinson Disease, Juvenile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	6	161769669	6	161348637	355996	302095
NM_004562.2(PRKN):c.*1470G>A	PRKN	Parkinson Disease, Juvenile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	6	161769661	6	161348629	355995	306785
NM_004562.2(PRKN):c.*1601G>A	PRKN	Parkinson Disease, Juvenile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	6	161769530	6	161348498	355994	306523
NM_004562.2(PRKN):c.*1685A>G	PRKN	Parkinson Disease, Juvenile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	6	161769446	6	161348414	355993	302094
NM_004562.2(PRKN):c.*1694C>T	PRKN	Parkinson Disease, Juvenile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	6	161769437	6	161348405	355992	306784
NM_004562.2(PRKN):c.*1695G>A	PRKN	Parkinson Disease, Juvenile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	6	161769436	6	161348404	355991	302087
NM_004562.2(PRKN):c.*2021G>A	PRKN	Parkinson Disease, Juvenile	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	6	161769110	6	161348078	355990	299575
NM_004562.2(PRKN):c.*2022T>C	PRKN	Parkinson Disease, Juvenile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	6	161769109	6	161348077	355989	299567
NM_004562.2(PRKN):c.*2194G>A	PRKN	Parkinson Disease, Juvenile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	6	161768937	6	161347905	355988	306783
NM_004562.2(PRKN):c.*2217G>A	PRKN	Parkinson Disease, Juvenile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	6	161768914	6	161347882	355987	299566
NM_004562.2(PRKN):c.*2354C>T	PRKN	Parkinson Disease, Juvenile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	6	161768777	6	161347745	355986	299558
NM_004562.2(PRKN):c.*2363C>A	PRKN	Parkinson Disease, Juvenile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	6	161768768	6	161347736	355985	302086
NM_004562.2(PRKN):c.*2443A>G	PRKN	Parkinson Disease, Juvenile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	6	161768688	6	161347656	355984	299552
NM_004562.2(PRKN):c.*2474A>C	PRKN	Parkinson Disease, Juvenile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	6	161768657	6	161347625	355983	306775
NM_004562.2(PRKN):c.*2475A>C	PRKN	Parkinson Disease, Juvenile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	6	161768656	6	161347624	355982	306507
NM_004562.2(PRKN):c.*2480C>A	PRKN	Parkinson Disease, Juvenile	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	6	161768651	6	161347619	355981	306772
NM_004562.2(PRKN):c.*2492A>G	PRKN	Parkinson Disease, Juvenile	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	6	161768639	6	161347607	355980	306771
NM_004562.2(PRKN):c.*2526_*2527delCA	PRKN	Parkinson Disease, Juvenile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	6	161768604 - 161768605	6	161347572 - 161347573	355979	299551
NM_004562.2(PRKN):c.48G>A (p.Glu16=)	PRKN	Parkinson Disease, Juvenile|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	6	162864465	6	162443433	289182	273419
NM_004562.2(PRKN):c.1310C>T (p.Pro437Leu)	PRKN	not provided|Parkinson disease 2	Conflicting interpretations of pathogenicity(Last reviewed: Oct 21, 2017)	criteria provided, conflicting interpretations	6	161771219	6	161350187	283504	267741
NM_004562.2(PRKN):c.1071C>G (p.Gly357=)	PRKN	Parkinson disease 2	Likely benign(Last reviewed: Feb 8, 2016)	criteria provided, single submitter	6	161969898	6	161548866	239951	239896
NM_004562.2(PRKN):c.1292G>T (p.Cys431Phe)	PRKN	Parkinson disease 2	Pathogenic(Last reviewed: Aug 1, 2000)	no assertion criteria provided	6	161771237	6	161350205	50354	59479
NM_004562.2(PRKN):c.500G>A (p.Ser167Asn)	PRKN	Parkinson Disease, Juvenile|Parkinson disease 2|not specified	Benign/Likely benign(Last reviewed: Apr 17, 2001)	criteria provided, multiple submitters, no conflicts	6	162622197	6	162201165	41223	49647
NM_004562.2(PRKN):c.1180G>A (p.Asp394Asn)	PRKN	not specified|Parkinson disease 2	Benign(Last reviewed: Jul 27, 2017)	criteria provided, multiple submitters, no conflicts	6	161781225	6	161360193	41222	49646
NM_004562.2(PRKN):c.1138G>C (p.Val380Leu)	PRKN	Parkinson Disease, Juvenile|Parkinson disease 2|not specified	Benign/Likely benign(Last reviewed: May 21, 2015)	criteria provided, multiple submitters, no conflicts	6	161807855	6	161386823	41221	49645
NM_004562.2(PRKN):c.1096C>T (p.Arg366Trp)	PRKN	Parkinson disease 2	Likely benign(Last reviewed: Dec 26, 2017)	criteria provided, single submitter	6	161807897	6	161386865	41220	49644
PARK2, EX5-6DEL	PRKN	Parkinson disease 2	Pathogenic(Last reviewed: Feb 1, 2006)	no assertion criteria provided					7055	22094
NM_004562.2(PRKN):c.719C>T (p.Thr240Met)	PRKN	not provided|Neoplasm of ovary|Parkinson disease 2	Conflicting interpretations of pathogenicity(Last reviewed: Feb 1, 2006)	criteria provided, conflicting interpretations	6	162394349	6	161973317	7054	22093
PARK2, 1-BP DEL, 1072T	PRKN	Parkinson disease 2	Pathogenic(Last reviewed: Sep 1, 2005)	no assertion criteria provided					7052	22091
NM_004562.2(PRKN):c.633A>T (p.Lys211Asn)	PRKN	Parkinson disease 2	Pathogenic(Last reviewed: Sep 1, 2005)	no assertion criteria provided	6	162394435	6	161973403	7051	22090
NM_004562.2(PRKN):c.823C>T (p.Arg275Trp)	PRKN	Parkinson disease 2|Leprosy 2|Neoplasm of ovary|Lung cancer|Parkinson disease 2|Young-onset Parkinson disease|not provided	Pathogenic(Last reviewed: Sep 1, 2005)	criteria provided, multiple submitters, no conflicts	6	162206852	6	161785820	7050	22089
PARK2, 1-BP DEL, 255A	PRKN	Parkinson disease 2	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided					7048	22087
NM_004562.2(PRKN):c.167T>A (p.Val56Glu)	PRKN	Parkinson disease 2	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	6	162864346	6	162443314	7047	22086
NM_004562.2(PRKN):c.635G>A (p.Cys212Tyr)	PRKN	Parkinson disease 2	Pathogenic(Last reviewed: Jun 1, 2002)	criteria provided, single submitter	6	162394433	6	161973401	7046	22085
NM_004562.2(PRKN):c.735-?_871+?del	PRKN	Parkinson disease 2	Pathogenic(Last reviewed: Sep 1, 2005)	no assertion criteria provided	6	162206804 - 162206940	6	161785772 - 161785908	7045	22084
PARK2, 1-BP DEL, 202A	PRKN	Parkinson disease 2	Pathogenic(Last reviewed: Apr 22, 2003)	no assertion criteria provided					7044	22083
NM_004562.2(PRKN):c.483A>T (p.Lys161Asn)	PRKN	Parkinson disease 2	Pathogenic(Last reviewed: Sep 1, 2005)	no assertion criteria provided	6	162622214	6	162201182	7043	22082
NM_004562.2(PRKN):c.1358G>A (p.Trp453Ter)	PRKN	not provided|Parkinson disease 2	Likely pathogenic(Last reviewed: Sep 1, 2005)	criteria provided, single submitter	6	161771171	6	161350139	7042	22081
NM_004562.2(PRKN):c.872-?_1083+?del	PRKN	Parkinson disease 2	Pathogenic(Last reviewed: Oct 24, 1998)	no assertion criteria provided	6	161969886 - 161990448	6	161548854 - 161569416	7041	22080
NM_004562.2(PRKN):c.8-?_171+?del	PRKN	Parkinson disease 2	Pathogenic(Last reviewed: Nov 14, 2016)	criteria provided, single submitter	6	162864342 - 162864505	6	162443310 - 162443473	7040	22079
NM_004562.2(PRKN):c.245C>A (p.Ala82Glu)	PRKN	Parkinson disease 2|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 1, 2001)	criteria provided, conflicting interpretations	6	162683724	6	162262692	7038	22077
NM_004562.2(PRKN):c.931C>T (p.Gln311Ter)	PRKN	Parkinson disease 2	Pathogenic(Last reviewed: Sep 1, 2005)	no assertion criteria provided	6	161990389	6	161569357	7037	22076
NM_004562.2(PRKN):c.719C>G (p.Thr240Arg)	PRKN	Parkinson disease 2	Pathogenic(Last reviewed: Sep 1, 2005)	no assertion criteria provided	6	162394349	6	161973317	7036	22075
NM_004562.2(PRKN):c.413-?_534+?del	PRKN	Parkinson disease 2	Pathogenic(Last reviewed: Dec 1, 2005)	no assertion criteria provided	6	162622163 - 162622284	6	162201131 - 162201252	7035	22074
NM_004562.2(PRKN):c.172-?_871+?del	PRKN	Parkinson disease 2	Pathogenic(Last reviewed: Apr 9, 1998)	no assertion criteria provided	6	162206804 - 162683797	6	161785772 - 162262765	7034	22073
NM_000311.4(PRNP):c.160_183GGTGGTGGCTGGGGGCAGCCTCAT(4) (p.Gln59_Pro60insGlnGlyGlyGlyGlyTrpGlyGlnGlnGlyGlyGlyGlyTrpGlyGlnGlnGlyGlyGlyGlyTrpGlyGlnGlnGlyGlyGlyGlyTrpGlyGlnGlnGlyGlyGlyGlyTrpGlyGln)	PRNP	Genetic prion diseases|Huntington disease-like 1|Gerstmann-Straussler-Scheinker syndrome|Jakob-Creutzfeldt disease	Pathogenic(Last reviewed: Dec 18, 2008)	no assertion criteria provided	20	4680026 - 4680049	20	4699380 - 4699403	13394	28433
PSEN1, 3-BP DEL	PSEN1	Alzheimer disease, familial, 3, with spastic paraparesis and unusual plaques	Pathogenic(Last reviewed: Mar 1, 2005)	no assertion criteria provided					18154	33193
NM_000021.3(PSEN1):c.1307C>A (p.Pro436Gln)	PSEN1	not provided|Alzheimer disease, type 3	Pathogenic(Last reviewed: Jun 15, 2004)	no assertion criteria provided	14	73685900	14	73219192	18150	33189
PTH, IVS2DS, G-C, +1, EX2DEL	PTH	Hypoparathyroidism familial isolated	Pathogenic(Last reviewed: May 1, 1992)	no assertion criteria provided					13757	28796
NM_171998.3(RAB39B):c.574G>A (p.Gly192Arg)	RAB39B	Parkinsonism, early onset with mental retardation|X-linked dominant Parkinson's disease	Pathogenic(Last reviewed: Sep 14, 2015)	criteria provided, single submitter	X	154490156	X	155260871	218362	215090
NM_001134363.2(RBM20):c.934C>A (p.Leu312Met)	RBM20	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	10	112541301	10	110781543	487629	480702
NM_022450.3(RHBDF1):c.47A>C (p.Lys16Thr)	RHBDF1	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	16	114967	16	64969	487618	480720
NM_022450.3(RHBDF1):c.1613C>T (p.Ala538Val)	RHBDF1	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	16	110482	16	60484	487611	480717
NM_022450.3(RHBDF1):c.200G>A (p.Arg67Gln)	RHBDF1	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	16	114745	16	64747	487605	480719
NM_022450.3(RHBDF1):c.14G>A (p.Arg5His)	RHBDF1	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	16	115000	16	65002	487604	480721
NM_022450.3(RHBDF1):c.1384G>A (p.Gly462Arg)	RHBDF1	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	16	111394	16	61396	487583	480718
NM_024557.5(RIC3):c.169C>A (p.Pro57Thr)	RIC3	not provided	Uncertain significance(Last reviewed: Sep 26, 2016)	no assertion criteria provided	11	8161696	11	8140149	254687	249263
NM_001143854.1(RPH3A):c.1349C>G (p.Thr450Ser)	RPH3A	not specified	Uncertain significance(Last reviewed: Jan 14, 2016)	criteria provided, single submitter	12	113321120	12	112883315	224156	225884
NM_001035.2(RYR2):c.3767C>T (p.Pro1256Leu)	RYR2	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	1	237753261	1	237589961	487620	480674
NM_001035.2(RYR2):c.2984T>C (p.Met995Thr)	RYR2	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	1	237711808	1	237548508	487602	480673
NM_001035.2(RYR2):c.4747C>T (p.Pro1583Ser)	RYR2	not specified|not provided|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	criteria provided, multiple submitters, no conflicts	1	237774125	1	237610825	419965	405107
NM_001035.2(RYR2):c.3181G>A (p.Gly1061Ser)	RYR2	Catecholaminergic polymorphic ventricular tachycardia|Arrhythmogenic right ventricular cardiomyopathy|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	237713958	1	237550658	296718	281616
NM_001035.2(RYR2):c.11919T>G (p.Asp3973Glu)	RYR2	not specified|Wolff-Parkinson-White pattern|Catecholaminergic polymorphic ventricular tachycardia	Uncertain significance(Last reviewed: Apr 14, 2016)	criteria provided, multiple submitters, no conflicts	1	237944903	1	237781603	201316	196689
NM_001035.2(RYR2):c.982G>A (p.Ala328Thr)	RYR2	Catecholaminergic polymorphic ventricular tachycardia|not provided|Arrhythmogenic right ventricular cardiomyopathy|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Feb 19, 2018)	criteria provided, multiple submitters, no conflicts	1	237586525	1	237423225	93480	99385
NM_001035.2(RYR2):c.8162T>C (p.Ile2721Thr)	RYR2	Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia|not specified|Wolff-Parkinson-White pattern|Arrhythmogenic right ventricular cardiomyopathy|Cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Dec 1, 2016)	criteria provided, conflicting interpretations	1	237821276	1	237657976	43828	52997
NM_198056.2(SCN5A):c.1705C>G (p.Arg569Gly)	SCN5A	not provided|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	criteria provided, single submitter	3	38645388	3	38603897	201576	196972
NM_000335.4(SCN5A):c.5357G>A (p.Ser1786Asn)	SCN5A	Cardiovascular phenotype|Arrhythmogenic right ventricular dysplasia/cardiomyopathy|not specified|not provided|Brugada syndrome|Long QT syndrome|Arrhythmia	Conflicting interpretations of pathogenicity(Last reviewed: Jun 24, 2013)	criteria provided, conflicting interpretations	3	38592503	3	38551012	67988	78880
NM_198056.2(SCN5A):c.1567C>T (p.Arg523Cys)	SCN5A	Congenital long QT syndrome|Brugada syndrome|not provided|Wolff-Parkinson-White pattern|Paroxysmal familial ventricular fibrillation 1|Progressive familial heart block type 1A|Atrial fibrillation, familial, 10|Dilated cardiomyopathy 1E|Long QT syndrome 3|Brugada syndrome 1	Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2012)	criteria provided, conflicting interpretations	3	38645526	3	38604035	67667	78562
NM_015046.5(SETX):c.472T>G (p.Leu158Val)	SETX	Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant|Spinocerebellar ataxia autosomal recessive 1|Amyotrophic lateral sclerosis type 4|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	9	135218103	9	132342716	365376	316922
NM_000441.1(SLC26A4):c.85G>C (p.Glu29Gln)	SLC26A4|SLC26A4-AS1	SLC26A4-Related Disorders|Wolff-Parkinson-White pattern|Pendred syndrome|Enlarged vestibular aqueduct|Enlarged vestibular aqueduct|Pendred syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 23, 2014)	criteria provided, multiple submitters, no conflicts	7	107302171	7	107661726	4839	19878
NM_017986.3(SLC52A1):c.1240G>A (p.Ala414Thr)	SLC52A1	Vitamin B2 deficiency	Uncertain significance(Last reviewed: Apr 9, 2018)	criteria provided, single submitter	17	4936359	17	5033064	583054	571709
NM_001044.4(SLC6A3):c.70G>A (p.Val24Met)	SLC6A3	Infantile Parkinsonism-dystonia|Tobacco addiction, susceptibility to|Infantile Parkinsonism-dystonia	Uncertain significance(Last reviewed: Jun 14, 2018)	criteria provided, multiple submitters, no conflicts	5	1443243	5	1443128	538067	521089
NM_003073.4(SMARCB1):c.34C>T (p.Gln12Ter)	SMARCB1	Schwannomatosis 1	Pathogenic(Last reviewed: Apr 1, 2007)	no assertion criteria provided	22	24129390	22	23787203	8026	23065
NM_000543.4(SMPD1):c.1829_1831delGCC (p.Arg610del)	SMPD1	not specified|Niemann-Pick disease, type B|Niemann-Pick disease, type A|not provided|Sphingomyelin/cholesterol lipidosis|Niemann-Pick disease, type A|Niemann-Pick disease, type B	Pathogenic(Last reviewed: Jul 1, 2009)	criteria provided, multiple submitters, no conflicts	11	6415770 - 6415772	11	6394540 - 6394542	198093	195254
NM_000543.4(SMPD1):c.996delC (p.Phe333Serfs)	SMPD1	not provided|Sphingomyelin/cholesterol lipidosis|Niemann-Pick disease, type A	Pathogenic(Last reviewed: May 1, 1991)	criteria provided, multiple submitters, no conflicts	11	6413291	11	6392061	2990	18029
NM_000345.3(SNCA):c.-26+1G>A	SNCA|SNCA-AS1	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Sep 18, 2017)	criteria provided, single submitter	4	90758112	4	89836961	631952	620776
NC_000004.12:g.(?_89726164)_(89835687_?)dup	SNCA	Lewy body dementia|Parkinson disease 1	Pathogenic(Last reviewed: May 12, 2018)	criteria provided, single submitter	4	90647315 - 90756838	4	89726164 - 89835687	531846	519673
NM_000345.3(SNCA):c.-274G>A	SNCA|SNCA-AS1	Parkinson Disease, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90758361	4	89837210	369445	353674
NM_000345.3(SNCA):c.-251A>C	SNCA|SNCA-AS1	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90758338	4	89837187	350112	299966
NM_000345.3(SNCA):c.-219G>C	SNCA|SNCA-AS1	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90758306	4	89837155	350111	299952
NM_000345.3(SNCA):c.-129G>A	SNCA|SNCA-AS1	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90758216	4	89837065	350110	296211
NM_000345.3(SNCA):c.-42T>C	SNCA|SNCA-AS1	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90758129	4	89836978	350109	294667
NM_000345.3(SNCA):c.-40G>A	SNCA|SNCA-AS1	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90758127	4	89836976	350108	294666
NM_000345.3(SNCA):c.-26+15C>T	SNCA|SNCA-AS1	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90758098	4	89836947	350107	299943
NM_000345.3(SNCA):c.243A>G (p.Thr81=)	SNCA	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90743460	4	89822309	350106	299978
NM_000345.3(SNCA):c.298T>C (p.Leu100=)	SNCA	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90743405	4	89822254	350105	299977
NM_000345.3(SNCA):c.408C>T (p.Tyr136=)	SNCA	Lewy body dementia|Parkinson disease 1|Parkinson Disease, Dominant	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	4	90647794	4	89726643	350104	294660
NM_000345.3(SNCA):c.*139T>G	SNCA	Parkinson Disease, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90647640	4	89726489	350103	294658
NM_000345.3(SNCA):c.*173G>A	SNCA	Parkinson Disease, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90647606	4	89726455	350102	299932
NM_000345.3(SNCA):c.*211G>A	SNCA	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90647568	4	89726417	350101	299924
NM_000345.3(SNCA):c.*277G>T	SNCA	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90647502	4	89726351	350100	296195
NM_000345.3(SNCA):c.*465A>T	SNCA	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90647314	4	89726163	350099	299976
NM_000345.3(SNCA):c.*501C>T	SNCA	Parkinson Disease, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90647278	4	89726127	350098	299975
NM_000345.3(SNCA):c.*580_*584delATTTT	SNCA	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90647195 - 90647199	4	89726044 - 89726048	350097	294655
NM_000345.3(SNCA):c.*593C>A	SNCA	Parkinson Disease, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90647186	4	89726035	350096	294651
NM_000345.3(SNCA):c.*630T>G	SNCA	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90647149	4	89725998	350095	299973
NM_000345.3(SNCA):c.*860T>A	SNCA	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90646919	4	89725768	350094	299923
NM_000345.3(SNCA):c.*893C>T	SNCA	Parkinson Disease, Dominant	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90646886	4	89725735	350093	299919
NM_000345.3(SNCA):c.*1002T>G	SNCA	Parkinson Disease, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90646777	4	89725626	350092	299964
NM_000345.3(SNCA):c.*1033T>C	SNCA	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90646746	4	89725595	350091	299913
NM_000345.3(SNCA):c.*1047T>G	SNCA	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90646732	4	89725581	350090	294649
NM_000345.3(SNCA):c.*1077delT	SNCA	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90646702	4	89725551	350089	299963
NM_000345.3(SNCA):c.*1078A>T	SNCA	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90646701	4	89725550	350088	299912
NM_000345.3(SNCA):c.*1245delT	SNCA	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90646534	4	89725383	350087	294645
NM_000345.3(SNCA):c.*1274_*1277delCTCT	SNCA	Parkinson Disease, Dominant	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90646502 - 90646505	4	89725351 - 89725354	350086	299959
NM_000345.3(SNCA):c.*1287G>A	SNCA	Parkinson Disease, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90646492	4	89725341	350085	299958
NM_000345.3(SNCA):c.*1289T>C	SNCA	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90646490	4	89725339	350084	294641
NM_000345.3(SNCA):c.*1291_*1292insTTTCT	SNCA	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90646487 - 90646488	4	89725336 - 89725337	350083	299903
NM_000345.3(SNCA):c.*1292_*1296dupCTTTT	SNCA	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90646483 - 90646487	4	89725332 - 89725336	350082	294640
NM_000345.3(SNCA):c.*1291_*1292insTTTTT	SNCA	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90646487 - 90646488	4	89725336 - 89725337	350081	296179
NM_000345.3(SNCA):c.*1291_*1292insTTT	SNCA	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90646487 - 90646488	4	89725336 - 89725337	350080	299956
NM_000345.3(SNCA):c.*1308_*1309dupTT	SNCA	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90646470 - 90646471	4	89725319 - 89725320	350079	299953
NM_000345.3(SNCA):c.*1305_*1309dupTTTTT	SNCA	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90646470 - 90646474	4	89725319 - 89725323	350078	294637
NM_000345.3(SNCA):c.*1306_*1309dupTTTT	SNCA	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90646470 - 90646473	4	89725319 - 89725322	350077	294636
NM_000345.3(SNCA):c.*1310A>T	SNCA	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90646469	4	89725318	350076	299944
NM_000345.3(SNCA):c.*1306_*1310dupTTTTA	SNCA	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90646469 - 90646473	4	89725318 - 89725322	350075	299890
NM_000345.3(SNCA):c.*1308_*1310dupTTA	SNCA	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90646469 - 90646471	4	89725318 - 89725320	350074	294634
NM_000345.3(SNCA):c.*1310_*1311insTTTTT	SNCA	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90646468 - 90646469	4	89725317 - 89725318	350073	294633
NM_000345.3(SNCA):c.*1310_*1311insTTT	SNCA	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90646468 - 90646469	4	89725317 - 89725318	350072	299881
NM_000345.3(SNCA):c.*1311delC	SNCA	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90646468	4	89725317	350071	296153
NM_000345.3(SNCA):c.*1307_*1311dupTTTAC	SNCA	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90646468 - 90646472	4	89725317 - 89725321	350070	299888
NM_000345.3(SNCA):c.*1325A>G	SNCA	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90646454	4	89725303	350069	294630
NM_000345.3(SNCA):c.*1677C>T	SNCA	Parkinson Disease, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90646102	4	89724951	350068	296145
NM_000345.3(SNCA):c.*1702G>A	SNCA	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90646077	4	89724926	350067	299935
NM_000345.3(SNCA):c.*1896C>T	SNCA	Parkinson Disease, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90645883	4	89724732	350066	299878
NM_000345.3(SNCA):c.*2037T>C	SNCA	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90645742	4	89724591	350065	299930
NM_000345.3(SNCA):c.*2105G>A	SNCA	Parkinson Disease, Dominant	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90645674	4	89724523	350064	299868
NM_000345.3(SNCA):c.*2108A>T	SNCA	Parkinson Disease, Dominant	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90645671	4	89724520	350063	294628
NM_000345.3(SNCA):c.*2227C>A	SNCA	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90645552	4	89724401	350062	296144
NM_000345.3(SNCA):c.*2269C>T	SNCA	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90645510	4	89724359	350061	299859
NM_000345.3(SNCA):c.*2277A>C	SNCA	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90645502	4	89724351	350060	299856
NM_000345.3(SNCA):c.*2291C>T	SNCA	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90645488	4	89724337	350059	296136
NM_000345.3(SNCA):c.*2330C>T	SNCA	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90645449	4	89724298	350058	299848
NM_000345.3(SNCA):c.*2501C>A	SNCA	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	90645278	4	89724127	350057	299916
NM_000345.3(SNCA):c.150T>G (p.His50Gln)	SNCA	Parkinson disease 1|Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Aug 8, 2014)	criteria provided, single submitter	4	90749307	4	89828156	162095	171811
NM_000345.3(SNCA):c.152G>A (p.Gly51Asp)	SNCA	Parkinson disease 1	Pathogenic(Last reviewed: Apr 1, 2013)	no assertion criteria provided	4	90749305	4	89828154	97000	102896
SNCA, DUPLICATION	SNCA	Parkinson disease 1|Lewy body dementia	Pathogenic(Last reviewed: Oct 14, 2008)	no assertion criteria provided					14011	29050
SNCA, TRIPLICATION	SNCA	Parkinson disease 4	Pathogenic(Last reviewed: Mar 20, 2007)	no assertion criteria provided					14009	29048
NM_000345.3(SNCA):c.88G>C (p.Ala30Pro)	SNCA	Parkinson disease 1	Pathogenic(Last reviewed: Nov 22, 2013)	no assertion criteria provided	4	90756731	4	89835580	14008	29047
NM_000345.3(SNCA):c.157G>A (p.Ala53Thr)	SNCA	Lewy body dementia|Parkinson disease 1|Parkinson disease 1	Pathogenic(Last reviewed: Jun 1, 2010)	criteria provided, single submitter	4	90749300	4	89828149	14007	29046
NM_005460.3(SNCAIP):c.*314T>C	SNCAIP|MGC32805	Parkinson Disease, Dominant/Recessive	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	5	121799505	5	122463810	350510	300574
NM_005460.3(SNCAIP):c.*202A>T	SNCAIP|MGC32805	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	5	121799393	5	122463698	350509	296780
NM_005460.3(SNCAIP):c.*170A>G	SNCAIP|MGC32805	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	5	121799361	5	122463666	350508	300496
NM_005460.3(SNCAIP):c.*102A>G	SNCAIP|MGC32805	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	5	121799293	5	122463598	350507	300495
NM_005460.3(SNCAIP):c.*70C>G	SNCAIP|MGC32805	Parkinson Disease, Dominant/Recessive	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	5	121799261	5	122463566	350506	296767
NM_005460.3(SNCAIP):c.*46T>G	SNCAIP|MGC32805	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	5	121799237	5	122463542	350505	295005
NM_005460.3(SNCAIP):c.2736C>G (p.Ser912Arg)	SNCAIP|MGC32805	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	5	121787278	5	122451583	350504	295003
NM_005460.3(SNCAIP):c.2710A>G (p.Lys904Glu)	SNCAIP|MGC32805	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	5	121787252	5	122451557	350503	300573
NM_005460.3(SNCAIP):c.2417G>A (p.Arg806His)	SNCAIP|MGC32805	Parkinson Disease, Dominant/Recessive	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	5	121786959	5	122451264	350502	300484
NM_005460.3(SNCAIP):c.2148C>T (p.Ser716=)	SNCAIP|MGC32805	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	5	121786690	5	122450995	350501	295001
NM_005460.3(SNCAIP):c.2140G>A (p.Ala714Thr)	SNCAIP|MGC32805	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	5	121786682	5	122450987	350500	300483
NM_005460.3(SNCAIP):c.2131A>G (p.Met711Val)	SNCAIP|MGC32805	Parkinson Disease, Dominant/Recessive	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	5	121786673	5	122450978	350499	296766
NM_005460.3(SNCAIP):c.2125G>C (p.Glu709Gln)	SNCAIP|MGC32805	Parkinson Disease, Dominant/Recessive|not specified	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	121786667	5	122450972	350498	300482
NM_005460.3(SNCAIP):c.2022A>G (p.Ser674=)	SNCAIP|MGC32805	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	5	121786564	5	122450869	350497	300543
NM_005460.3(SNCAIP):c.1969C>T (p.Leu657=)	SNCAIP|MGC32805	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	5	121786511	5	122450816	350496	300542
NM_005460.3(SNCAIP):c.1510C>T (p.Leu504=)	SNCAIP|MGC32805	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	5	121780345	5	122444650	350495	294999
NM_005460.3(SNCAIP):c.1218C>T (p.Ser406=)	SNCAIP	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	5	121767699	5	122432004	350494	300472
NM_005460.3(SNCAIP):c.1134C>T (p.Leu378=)	SNCAIP	Parkinson Disease, Dominant/Recessive	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	5	121761178	5	122425483	350493	294994
NM_005460.3(SNCAIP):c.786A>C (p.Thr262=)	SNCAIP	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	5	121759218	5	122423523	350492	300471
NM_005460.3(SNCAIP):c.708C>T (p.Thr236=)	SNCAIP	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	5	121759140	5	122423445	350491	296761
NM_005460.3(SNCAIP):c.688A>G (p.Lys230Glu)	SNCAIP	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	5	121759120	5	122423425	350490	300469
NM_005460.3(SNCAIP):c.672C>T (p.Val224=)	SNCAIP	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	5	121759104	5	122423409	350489	300540
NM_005460.3(SNCAIP):c.665C>T (p.Ser222Leu)	SNCAIP	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	5	121759097	5	122423402	350488	294993
NM_005460.3(SNCAIP):c.636C>T (p.Pro212=)	SNCAIP	Parkinson Disease, Dominant/Recessive	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	5	121759068	5	122423373	350487	300451
NM_005460.3(SNCAIP):c.608A>G (p.Asn203Ser)	SNCAIP	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	5	121759040	5	122423345	350486	296739
NM_005460.3(SNCAIP):c.444C>T (p.Leu148=)	SNCAIP	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	5	121758876	5	122423181	350485	300525
NM_005460.3(SNCAIP):c.429G>A (p.Leu143=)	SNCAIP	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	5	121758861	5	122423166	350484	296738
NM_005460.3(SNCAIP):c.204T>C (p.Asp68=)	SNCAIP	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	5	121758636	5	122422941	350483	300518
NM_005460.3(SNCAIP):c.81G>A (p.Thr27=)	SNCAIP	Parkinson Disease, Dominant/Recessive	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	5	121739511	5	122403816	350482	300450
NM_005460.3(SNCAIP):c.-13G>T	SNCAIP	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	5	121726817	5	122391122	350481	300509
NM_005460.3(SNCAIP):c.-47+3G>A	SNCAIP	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	5	121647982	5	122312287	350480	300501
NM_005460.3(SNCAIP):c.-49C>G	SNCAIP	Parkinson Disease, Dominant/Recessive	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	5	121647977	5	122312282	350479	296735
NM_005460.3(SNCAIP):c.-66C>T	SNCAIP	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	5	121647960	5	122312265	350478	294991
NM_005460.3(SNCAIP):c.1861C>T (p.Arg621Cys)	SNCAIP|MGC32805	Parkinson disease, late-onset|Parkinson Disease, Dominant/Recessive	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	5	121786403	5	122450708	6078	21117
NM_003098.2(SNTA1):c.1088A>C (p.Glu363Ala)	SNTA1	Cardiovascular phenotype|Wolff-Parkinson-White pattern|not provided	Uncertain significance(Last reviewed: May 7, 2015)	criteria provided, multiple submitters, no conflicts	20	31998090	20	33410284	190918	188722
NM_003895.3(SYNJ1):c.3718C>T (p.Arg1240Cys)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 1	Uncertain significance(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	21	34012077	21	32639767	634476	622474
NC_000021.9:g.(?_32601843)_(32702067_?)dup	SYNJ1|CFAP298|C21orf59-TCP10L	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: May 15, 2018)	criteria provided, single submitter	21	33974153 - 34074377	21	32601843 - 32702067	584218	573717
NM_003895.3(SYNJ1):c.2991+6G>A	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Feb 10, 2018)	criteria provided, single submitter	21	34025592	21	32653282	583130	573055
NM_003895.3(SYNJ1):c.587G>C (p.Arg196Thr)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Feb 26, 2018)	criteria provided, single submitter	21	34072157	21	32699847	582994	573063
NM_003895.3(SYNJ1):c.1223G>A (p.Ser408Asn)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Mar 21, 2018)	criteria provided, single submitter	21	34058070	21	32685760	582650	573754
NM_003895.3(SYNJ1):c.2770G>A (p.Val924Ile)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jun 26, 2018)	criteria provided, single submitter	21	34029139	21	32656829	581736	573746
NM_003895.3(SYNJ1):c.3214T>C (p.Ser1072Pro)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Feb 19, 2018)	criteria provided, single submitter	21	34018853	21	32646543	580644	573738
NM_003895.3(SYNJ1):c.2495A>G (p.Tyr832Cys)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Apr 4, 2018)	criteria provided, single submitter	21	34030109	21	32657799	579673	573058
NM_003895.3(SYNJ1):c.3398_3403delTGCCGC (p.Leu1133_Pro1134del)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jun 2, 2018)	criteria provided, single submitter	21	34018061 - 34018066	21	32645751 - 32645756	579422	573038
NM_003895.3(SYNJ1):c.2861T>C (p.Ile954Thr)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jun 26, 2018)	criteria provided, single submitter	21	34029048	21	32656738	578766	573740
NM_003895.3(SYNJ1):c.3914C>G (p.Pro1305Arg)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Mar 26, 2018)	criteria provided, single submitter	21	34011336	21	32639026	577253	573731
NM_003895.3(SYNJ1):c.920G>A (p.Arg307His)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Mar 28, 2018)	criteria provided, single submitter	21	34060664	21	32688354	576906	571498
NM_003895.3(SYNJ1):c.3999T>G (p.His1333Gln)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jun 26, 2018)	criteria provided, single submitter	21	34011251	21	32638941	576646	573729
NM_003895.3(SYNJ1):c.3256C>G (p.Arg1086Gly)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Mar 2, 2018)	criteria provided, single submitter	21	34018811	21	32646501	576516	573050
NM_003895.3(SYNJ1):c.3704C>A (p.Pro1235Gln)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Apr 27, 2018)	criteria provided, single submitter	21	34014207	21	32641897	576177	575148
NM_003895.3(SYNJ1):c.1720G>A (p.Val574Ile)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jun 5, 2018)	criteria provided, single submitter	21	34045773	21	32673463	575982	573750
NM_003895.3(SYNJ1):c.1047G>A (p.Met349Ile)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Feb 10, 2018)	criteria provided, single submitter	21	34059306	21	32686996	575493	573756
NM_003895.3(SYNJ1):c.3704C>T (p.Pro1235Leu)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jun 28, 2018)	criteria provided, single submitter	21	34014207	21	32641897	575346	571479
NM_003895.3(SYNJ1):c.24G>A (p.Trp8Ter)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Pathogenic(Last reviewed: Jun 7, 2018)	criteria provided, single submitter	21	34100328	21	32728017	575322	571505
NM_003895.3(SYNJ1):c.1625G>A (p.Arg542His)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jun 5, 2018)	criteria provided, single submitter	21	34050957	21	32678647	574661	571492
NM_003895.3(SYNJ1):c.2371G>T (p.Asp791Tyr)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jun 22, 2018)	criteria provided, single submitter	21	34037273	21	32664963	573462	573060
NM_003895.3(SYNJ1):c.4642A>G (p.Ser1548Gly)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Apr 10, 2018)	criteria provided, single submitter	21	34003502	21	32631192	573244	573029
NM_003895.3(SYNJ1):c.2898A>G (p.Glu966=)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: May 2, 2018)	criteria provided, single submitter	21	34029011	21	32656701	572728	573739
NM_003895.3(SYNJ1):c.3727G>A (p.Val1243Ile)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jan 10, 2018)	criteria provided, single submitter	21	34012068	21	32639758	572373	573036
NM_003895.3(SYNJ1):c.142A>G (p.Ile48Val)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: May 23, 2018)	criteria provided, single submitter	21	34099182	21	32726871	572043	571503
NM_003895.3(SYNJ1):c.4345delA (p.Thr1449Leufs)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: May 17, 2018)	criteria provided, single submitter	21	34003799	21	32631489	571107	571475
NM_003895.3(SYNJ1):c.3884C>T (p.Pro1295Leu)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: May 15, 2018)	criteria provided, single submitter	21	34011366	21	32639056	571046	571476
NM_003895.3(SYNJ1):c.2908_2912delATAAG (p.Arg971Cysfs)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Pathogenic(Last reviewed: Jun 13, 2018)	criteria provided, single submitter	21	34028997 - 34029001	21	32656687 - 32656691	570902	571490
NM_003895.3(SYNJ1):c.1318-2A>G	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely pathogenic(Last reviewed: Jan 18, 2018)	criteria provided, single submitter	21	34053960	21	32681650	570738	573062
NM_003895.3(SYNJ1):c.158A>G (p.Asp53Gly)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jun 15, 2018)	criteria provided, single submitter	21	34099166	21	32726855	570473	575151
NM_003895.3(SYNJ1):c.137T>A (p.Phe46Tyr)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: May 15, 2018)	criteria provided, single submitter	21	34099187	21	32726876	570462	573759
NM_003895.3(SYNJ1):c.747A>T (p.Glu249Asp)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jun 28, 2018)	criteria provided, single submitter	21	34067442	21	32695132	570013	571499
NM_003895.3(SYNJ1):c.3437G>A (p.Arg1146Gln)	SYNJ1	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jun 19, 2018)	criteria provided, single submitter	21	34018027	21	32645717	569857	573736
NM_003895.3(SYNJ1):c.4241C>T (p.Thr1414Ile)	SYNJ1	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jun 25, 2018)	criteria provided, single submitter	21	34003903	21	32631593	569496	575147
NM_003895.3(SYNJ1):c.2288A>G (p.Tyr763Cys)	SYNJ1	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: May 29, 2018)	criteria provided, single submitter	21	34037356	21	32665046	569415	575150
NM_003895.3(SYNJ1):c.3671G>A (p.Gly1224Asp)	SYNJ1	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	21	34014240	21	32641930	568134	571485
NM_003895.3(SYNJ1):c.2595_2597delTCT (p.Leu866del)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jan 29, 2018)	criteria provided, single submitter	21	34029412 - 34029414	21	32657102 - 32657104	567697	573748
NM_003895.3(SYNJ1):c.3863C>T (p.Pro1288Leu)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: May 22, 2018)	criteria provided, single submitter	21	34011387	21	32639077	567214	573034
NM_003895.3(SYNJ1):c.3174T>G (p.Ser1058Arg)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: May 15, 2018)	criteria provided, single submitter	21	34018893	21	32646583	566546	571486
NM_003895.3(SYNJ1):c.328G>C (p.Gly110Arg)	SYNJ1	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: May 29, 2018)	criteria provided, single submitter	21	34074271	21	32701961	565896	573757
NM_003895.3(SYNJ1):c.3332C>A (p.Pro1111Gln)	SYNJ1	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: May 7, 2018)	criteria provided, single submitter	21	34018735	21	32646425	565611	573042
NM_203446.2(SYNJ1):c.512G>A (p.Trp171Ter)	SYNJ1	Parkinson disease 20, early-onset	Pathogenic(Last reviewed: Aug 30, 2016)	criteria provided, single submitter	21	34072232	21	32699922	549503	539985
NM_003895.3(SYNJ1):c.3864G>T (p.Pro1288=)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Aug 24, 2017)	criteria provided, single submitter	21	34011386	21	32639076	544589	533759
NM_003895.3(SYNJ1):c.4767C>T (p.Thr1589=)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Dec 8, 2017)	criteria provided, single submitter	21	34003377	21	32631067	544588	533778
NM_003895.3(SYNJ1):c.4029G>A (p.Pro1343=)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Sep 13, 2017)	criteria provided, single submitter	21	34011221	21	32638911	544587	533788
NM_003895.3(SYNJ1):c.4344G>A (p.Arg1448=)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Benign(Last reviewed: Dec 28, 2017)	criteria provided, single submitter	21	34003800	21	32631490	544586	534349
NM_003895.3(SYNJ1):c.3402G>A (p.Pro1134=)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Oct 16, 2017)	criteria provided, single submitter	21	34018062	21	32645752	544585	533768
NM_003895.3(SYNJ1):c.2263-8G>A	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Sep 17, 2017)	criteria provided, single submitter	21	34037389	21	32665079	544584	533789
NM_003895.3(SYNJ1):c.210C>G (p.Leu70=)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	21	34099114	21	32726803	544583	533825
NM_203446.2(SYNJ1):c.823-7dup	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Benign(Last reviewed: Dec 28, 2017)	criteria provided, single submitter	21	34066628	21	32694318	544582	533791
NM_003895.3(SYNJ1):c.282A>G (p.Lys94=)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jan 17, 2018)	criteria provided, single submitter	21	34074317	21	32702007	544581	533792
NM_003895.3(SYNJ1):c.3114T>C (p.Leu1038=)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	21	34022534	21	32650224	544580	533775
NM_003895.3(SYNJ1):c.1652C>T (p.Ala551Val)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Nov 27, 2017)	criteria provided, single submitter	21	34045841	21	32673531	544579	533814
NM_003895.3(SYNJ1):c.4341C>T (p.Asp1447=)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Nov 6, 2017)	criteria provided, single submitter	21	34003803	21	32631493	544578	534351
NM_003895.3(SYNJ1):c.3060G>T (p.Met1020Ile)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Benign(Last reviewed: Dec 14, 2017)	criteria provided, single submitter	21	34022588	21	32650278	544577	533777
NM_003895.3(SYNJ1):c.4215_4216insAATAC (p.Leu1406Asnfs)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Benign(Last reviewed: Oct 19, 2017)	criteria provided, single submitter	21	34003928 - 34003929	21	32631618 - 32631619	544576	533787
NM_003895.3(SYNJ1):c.2961C>T (p.Ala987=)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Dec 13, 2017)	criteria provided, single submitter	21	34025628	21	32653318	544575	534360
NM_003895.3(SYNJ1):c.2031G>A (p.Leu677=)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Benign(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	21	34038781	21	32666471	544574	534367
NM_003895.3(SYNJ1):c.2343T>A (p.Val781=)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Benign(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	21	34037301	21	32664991	544573	533794
NM_003895.3(SYNJ1):c.4550C>G (p.Pro1517Arg)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 27, 2017)	criteria provided, single submitter	21	34003594	21	32631284	544572	534347
NM_003895.3(SYNJ1):c.51_62delTGGCGGCGGCTG (p.Gly19_Gly22del)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 31, 2017)	criteria provided, single submitter	21	34100290 - 34100301	21	32727979 - 32727990	544571	533795
NM_003895.3(SYNJ1):c.3527C>T (p.Pro1176Leu)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Mar 13, 2018)	criteria provided, single submitter	21	34017298	21	32644988	544570	533786
NM_003895.3(SYNJ1):c.3697G>C (p.Ala1233Pro)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: May 21, 2018)	criteria provided, single submitter	21	34014214	21	32641904	544569	534356
NM_003895.3(SYNJ1):c.1949G>T (p.Trp650Leu)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 27, 2017)	criteria provided, single submitter	21	34038863	21	32666553	544568	533800
NM_003895.3(SYNJ1):c.3954T>A (p.Asn1318Lys)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Dec 12, 2017)	criteria provided, single submitter	21	34011296	21	32638986	544567	533751
NM_003895.3(SYNJ1):c.2579-10C>G	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 14, 2017)	criteria provided, single submitter	21	34029440	21	32657130	544566	533784
NM_003895.3(SYNJ1):c.3296C>G (p.Pro1099Arg)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 28, 2017)	criteria provided, single submitter	21	34018771	21	32646461	544565	533809
NM_003895.3(SYNJ1):c.1583T>C (p.Leu528Ser)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 25, 2017)	criteria provided, single submitter	21	34050999	21	32678689	544564	533802
NM_203446.2(SYNJ1):c.3946dup (p.Gln1316Profs)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 29, 2017)	criteria provided, single submitter	21	34011304	21	32638994	544563	534354
NM_003895.3(SYNJ1):c.4025A>G (p.Gln1342Arg)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Dec 2, 2017)	criteria provided, single submitter	21	34011225	21	32638915	544562	533779
NM_003895.3(SYNJ1):c.3928A>G (p.Met1310Val)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 22, 2017)	criteria provided, single submitter	21	34011322	21	32639012	544561	533758
NM_003895.3(SYNJ1):c.2237T>C (p.Ile746Thr)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Apr 23, 2018)	criteria provided, single submitter	21	34038278	21	32665968	544560	533799
NM_003895.3(SYNJ1):c.2903T>C (p.Ile968Thr)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 31, 2017)	criteria provided, single submitter	21	34029006	21	32656696	544559	533782
NM_003895.3(SYNJ1):c.3421C>T (p.Pro1141Ser)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 24, 2017)	criteria provided, single submitter	21	34018043	21	32645733	544558	533801
NM_003895.3(SYNJ1):c.1423A>G (p.Ile475Val)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jan 5, 2018)	criteria provided, single submitter	21	34053853	21	32681543	544557	533804
NM_003895.3(SYNJ1):c.1726G>A (p.Val576Ile)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 18, 2017)	criteria provided, single submitter	21	34045767	21	32673457	544556	534368
NM_003895.3(SYNJ1):c.2909T>C (p.Ile970Thr)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Nov 15, 2017)	criteria provided, single submitter	21	34029000	21	32656690	544555	533781
NM_003895.3(SYNJ1):c.2714T>C (p.Ile905Thr)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Mar 27, 2018)	criteria provided, single submitter	21	34029195	21	32656885	544554	533811
NM_003895.3(SYNJ1):c.926G>A (p.Arg309His)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 28, 2017)	criteria provided, single submitter	21	34060658	21	32688348	544553	533815
NM_003895.3(SYNJ1):c.4217T>C (p.Leu1406Ser)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Apr 6, 2018)	criteria provided, single submitter	21	34003927	21	32631617	544552	533780
NM_003895.3(SYNJ1):c.428T>C (p.Ile143Thr)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 25, 2017)	criteria provided, single submitter	21	34072316	21	32700006	544551	533818
NM_003895.3(SYNJ1):c.2748G>C (p.Glu916Asp)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 14, 2017)	criteria provided, single submitter	21	34029161	21	32656851	544550	534364
NM_003895.3(SYNJ1):c.3326G>A (p.Arg1109Gln)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Dec 4, 2017)	criteria provided, single submitter	21	34018741	21	32646431	544549	533805
NM_003895.3(SYNJ1):c.316C>T (p.Arg106Trp)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jan 4, 2018)	criteria provided, single submitter	21	34074283	21	32701973	544548	533816
NM_003895.3(SYNJ1):c.3641G>C (p.Ser1214Thr)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Dec 9, 2017)	criteria provided, single submitter	21	34014270	21	32641960	544547	533798
NM_003895.3(SYNJ1):c.76A>G (p.Arg26Gly)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Mar 12, 2018)	criteria provided, single submitter	21	34100276	21	32727965	544546	534372
NM_003895.3(SYNJ1):c.960T>C (p.Ala320=)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: May 1, 2017)	criteria provided, single submitter	21	34060624	21	32688314	478369	469576
NM_003895.3(SYNJ1):c.959C>G (p.Ala320Gly)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 1, 2017)	criteria provided, single submitter	21	34060625	21	32688315	478368	471589
NM_003895.3(SYNJ1):c.925C>T (p.Arg309Cys)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jun 14, 2017)	criteria provided, single submitter	21	34060659	21	32688349	478367	471591
NM_003895.3(SYNJ1):c.822+7A>G	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset|not provided	Benign(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	21	34067360	21	32695050	478366	471594
NM_003895.3(SYNJ1):c.690A>G (p.Thr230=)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset|not provided	Benign(Last reviewed: Dec 21, 2017)	criteria provided, multiple submitters, no conflicts	21	34067499	21	32695189	478365	471129
NM_003895.3(SYNJ1):c.596+9A>G	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset|not provided	Benign(Last reviewed: Aug 8, 2017)	criteria provided, multiple submitters, no conflicts	21	34072139	21	32699829	478364	471133
NM_003895.3(SYNJ1):c.538T>C (p.Leu180=)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jun 14, 2017)	criteria provided, single submitter	21	34072206	21	32699896	478363	471599
NM_003895.3(SYNJ1):c.4790C>T (p.Thr1597Met)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Oct 30, 2017)	criteria provided, single submitter	21	34003354	21	32631044	478362	469550
NM_003895.3(SYNJ1):c.4757C>T (p.Pro1586Leu)	SYNJ1	not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Dec 29, 2017)	criteria provided, multiple submitters, no conflicts	21	34003387	21	32631077	478361	471083
NM_003895.3(SYNJ1):c.4640C>T (p.Pro1547Leu)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset|not provided	Benign(Last reviewed: Dec 26, 2017)	criteria provided, multiple submitters, no conflicts	21	34003504	21	32631194	478360	471567
NM_003895.3(SYNJ1):c.4603T>A (p.Ser1535Thr)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: May 23, 2017)	criteria provided, single submitter	21	34003541	21	32631231	478359	471088
NM_003895.3(SYNJ1):c.4581G>A (p.Glu1527=)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	21	34003563	21	32631253	478358	469552
NM_003895.3(SYNJ1):c.4551G>A (p.Pro1517=)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Feb 28, 2017)	criteria provided, single submitter	21	34003593	21	32631283	478357	471092
NM_003895.3(SYNJ1):c.4358G>A (p.Gly1453Glu)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset|not provided	Benign(Last reviewed: Aug 3, 2017)	criteria provided, multiple submitters, no conflicts	21	34003786	21	32631476	478356	471569
NM_003895.3(SYNJ1):c.4263G>T (p.Arg1421=)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Mar 20, 2017)	criteria provided, single submitter	21	34003881	21	32631571	478355	470593
NM_003895.3(SYNJ1):c.4252A>G (p.Ile1418Val)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Oct 30, 2017)	criteria provided, single submitter	21	34003892	21	32631582	478354	471571
NM_003895.3(SYNJ1):c.4202C>T (p.Thr1401Met)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 20, 2017)	criteria provided, single submitter	21	34003942	21	32631632	478353	470595
NM_003895.3(SYNJ1):c.4033G>A (p.Val1345Ile)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Oct 31, 2017)	criteria provided, single submitter	21	34004111	21	32631801	478352	471096
NM_003895.3(SYNJ1):c.3879C>T (p.Pro1293=)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Apr 17, 2017)	criteria provided, single submitter	21	34011371	21	32639061	478351	469557
NM_003895.3(SYNJ1):c.3839T>C (p.Leu1280Pro)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Apr 2, 2018)	criteria provided, single submitter	21	34011411	21	32639101	478350	470597
NM_003895.3(SYNJ1):c.3808T>C (p.Ser1270Pro)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Apr 22, 2017)	criteria provided, single submitter	21	34011987	21	32639677	478349	471573
NM_003895.3(SYNJ1):c.3806C>T (p.Thr1269Met)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Apr 23, 2017)	criteria provided, single submitter	21	34011989	21	32639679	478348	471102
NM_003895.3(SYNJ1):c.3755G>A (p.Arg1252Gln)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset|not provided	Uncertain significance(Last reviewed: Sep 18, 2017)	criteria provided, multiple submitters, no conflicts	21	34012040	21	32639730	478347	471106
NM_003895.3(SYNJ1):c.3753G>A (p.Ala1251=)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jun 27, 2017)	criteria provided, single submitter	21	34012042	21	32639732	478346	470598
NM_003895.3(SYNJ1):c.3707C>T (p.Thr1236Met)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 19, 2017)	criteria provided, conflicting interpretations	21	34012088	21	32639778	478345	469561
NM_003895.3(SYNJ1):c.3705G>A (p.Pro1235=)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jun 1, 2018)	criteria provided, single submitter	21	34014206	21	32641896	478344	470600
NM_003895.3(SYNJ1):c.3548G>A (p.Gly1183Asp)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Mar 13, 2017)	criteria provided, single submitter	21	34015767	21	32643457	478343	469562
NM_003895.3(SYNJ1):c.4032+5G>T	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset|not provided	Benign(Last reviewed: Jan 10, 2018)	criteria provided, multiple submitters, no conflicts	21	34011213	21	32638903	478342	471100
NM_003895.3(SYNJ1):c.3486A>G (p.Pro1162=)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset|not provided	Benign/Likely benign(Last reviewed: Jan 1, 2018)	criteria provided, multiple submitters, no conflicts	21	34017978	21	32645668	478341	471107
NM_003895.3(SYNJ1):c.3407A>G (p.Lys1136Arg)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jun 24, 2017)	criteria provided, single submitter	21	34018057	21	32645747	478340	471114
NM_003895.3(SYNJ1):c.3322A>G (p.Ser1108Gly)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Oct 12, 2017)	criteria provided, single submitter	21	34018745	21	32646435	478339	470606
NM_003895.3(SYNJ1):c.2999A>G (p.Asn1000Ser)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 3, 2017)	criteria provided, single submitter	21	34022649	21	32650339	478338	470608
NM_003895.3(SYNJ1):c.2992-5G>A	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jul 24, 2017)	criteria provided, single submitter	21	34022661	21	32650351	478337	471575
NM_003895.3(SYNJ1):c.2991+5G>A	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Nov 6, 2017)	criteria provided, single submitter	21	34025593	21	32653283	478336	471577
NM_003895.3(SYNJ1):c.2721A>G (p.Ile907Met)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: May 16, 2017)	criteria provided, single submitter	21	34029188	21	32656878	478335	471579
NM_003895.3(SYNJ1):c.2703C>T (p.Val901=)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Oct 20, 2017)	criteria provided, single submitter	21	34029206	21	32656896	478334	469563
NM_003895.3(SYNJ1):c.2463G>A (p.Pro821=)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Sep 12, 2017)	criteria provided, single submitter	21	34030141	21	32657831	478333	469565
NM_003895.3(SYNJ1):c.2050_2051delCAinsAG (p.Gln684Arg)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jun 8, 2017)	criteria provided, single submitter	21	34038761 - 34038762	21	32666451 - 32666452	478332	471120
NM_003895.3(SYNJ1):c.2023G>A (p.Val675Ile)	SYNJ1	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 1|Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53|Epileptic encephalopathy, early infantile, 53	Conflicting interpretations of pathogenicity(Last reviewed: Sep 29, 2017)	criteria provided, conflicting interpretations	21	34038789	21	32666479	478331	471582
NM_003895.3(SYNJ1):c.1947C>G (p.Leu649=)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Oct 30, 2017)	criteria provided, single submitter	21	34038865	21	32666555	478330	471125
NM_003895.3(SYNJ1):c.1672A>G (p.Ser558Gly)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Mar 26, 2018)	criteria provided, single submitter	21	34045821	21	32673511	478329	470609
NM_003895.3(SYNJ1):c.1663G>A (p.Val555Ile)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Benign(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	21	34045830	21	32673520	478328	470612
NM_003895.3(SYNJ1):c.1598G>A (p.Arg533Gln)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Feb 3, 2017)	criteria provided, single submitter	21	34050984	21	32678674	478327	471585
NM_003895.3(SYNJ1):c.123G>A (p.Ala41=)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset|not provided	Benign(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	21	34099201	21	32726890	478326	471135
NM_003895.3(SYNJ1):c.1236-8G>T	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Benign(Last reviewed: Jan 4, 2018)	criteria provided, single submitter	21	34056437	21	32684127	478325	469567
NM_003895.3(SYNJ1):c.1147G>A (p.Ala383Thr)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	21	34058146	21	32685836	478324	471126
NM_003895.3(SYNJ1):c.1119C>T (p.Asp373=)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Feb 17, 2017)	criteria provided, single submitter	21	34058174	21	32685864	478323	469569
NM_003895.3(SYNJ1):c.1026A>G (p.Gly342=)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: May 16, 2017)	criteria provided, single submitter	21	34059327	21	32687017	478316	470613
NM_003895.3(SYNJ1):c.160C>T (p.Pro54Ser)	SYNJ1	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset|not provided	Benign/Likely benign(Last reviewed: Jun 12, 2017)	criteria provided, multiple submitters, no conflicts	21	34099164	21	32726853	445927	439199
NM_203446.2(SYNJ1):c.1376G>C (p.Arg459Pro)	SYNJ1	Parkinson disease 20, early-onset	Pathogenic(Last reviewed: Mar 8, 2017)	no assertion criteria provided	21	34053900	21	32681590	393356	380176
NM_203446.2(SYNJ1):c.773G>A (p.Arg258Gln)	SYNJ1	Parkinson disease 20, early-onset	Pathogenic(Last reviewed: Sep 1, 2013)	criteria provided, single submitter	21	34067416	21	32695106	88844	94413
NM_007375.3(TARDBP):c.1144G>A (p.Ala382Thr)	TARDBP	FRONTOTEMPORAL DEMENTIA WITH TDP43 INCLUSIONS, TARDBP-RELATED|not provided|Amyotrophic lateral sclerosis type 10	Likely pathogenic(Last reviewed: May 1, 2014)	criteria provided, single submitter	1	11082610	1	11022553	21474	34326
NG_008165.1:g.12526_12528CAM[(>46)]	TBP	Spinocerebellar ataxia 17|Parkinson disease, late-onset	Pathogenic, risk factor(Last reviewed: Dec 1, 2004)	no assertion criteria provided					562072	553248
NM_001077653.2(TBX20):c.995delC (p.Pro332Glnfs)	TBX20	Hypoplastic left heart syndrome|Hypoplastic right heart syndrome|Wolff-Parkinson-White pattern	Pathogenic(Last reviewed: Dec 1, 2015)	no assertion criteria provided	7	35244090	7	35204478	438266	431889
NM_016569.3(TBX3):c.1051C>T (p.Gln351Ter)	TBX3	Ulnar-mammary syndrome	Pathogenic(Last reviewed: Dec 1, 2009)	no assertion criteria provided	12	115114166	12	114676361	31909	40565
NM_000192.3(TBX5):c.618T>G (p.Phe206Leu)	TBX5	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	12	114832591	12	114394786	487603	480709
NM_003673.3(TCAP):c.97C>T (p.Arg33Trp)	TCAP	not provided|Wolff-Parkinson-White pattern|Dilated cardiomyopathy 1N|Primary familial hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Apr 2, 2018)	criteria provided, multiple submitters, no conflicts	17	37821709	17	39665456	282451	266688
NM_003242.5(TGFBR2):c.1563G>A (p.Trp521Ter)	TGFBR2	Wolff-Parkinson-White pattern|Thoracic aortic aneurysm and aortic dissection	Uncertain significance(Last reviewed: Jul 14, 2017)	criteria provided, single submitter	3	30732950	3	30691458	487632	480682
NM_000360.3(TH):c.1400A>G (p.Asp467Gly)	TH	Segawa syndrome, autosomal recessive	Conflicting interpretations of pathogenicity(Last reviewed: May 12, 2017)	criteria provided, conflicting interpretations	11	2185557	11	2164327	304067	313638
NM_001009923.2(TMEM230):c.422G>T (p.Arg141Leu)	TMEM230	not provided	Uncertain significance(Last reviewed: Apr 1, 2014)	no assertion criteria provided	20	5081567	20	5100921	243014	244095
NM_000404.3(GLB1):c.51dup (p.Leu18Serfs)	TMPPE|GLB1	Gangliosidosis GM1 type 3|GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis	Pathogenic(Last reviewed: Sep 13, 2013)	criteria provided, single submitter	3	33138527	3	33097035	92911	98818
NM_005781.4(TNK2):c.1088T>C (p.Val363Ala)	TNK2	Parkinson disease	Uncertain significance(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	3	195605390	3	195878519	224860	226710
NM_005781.4(TNK2):c.2630G>A (p.Arg877His)	TNK2	not specified|Parkinson disease	Conflicting interpretations of pathogenicity(Last reviewed: Jan 1, 2016)	criteria provided, conflicting interpretations	3	195594494	3	195867623	224859	226709
NM_005781.4(TNK2):c.2930C>T (p.Ala977Val)	TNK2	Parkinson disease	Uncertain significance(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	3	195594092	3	195867221	224858	226708
NM_005781.4(TNK2):c.1912G>A (p.Val638Met)	TNK2	Autosomal recessive infantile epilepsy|Parkinson disease	Uncertain significance(Last reviewed: Sep 1, 2013)	criteria provided, single submitter	3	195595212	3	195868341	88849	94418
NG_007866.2:g.2764G>A	TNNI3|DNAAF3	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Dilated Cardiomyopathy, Recessive|Hypertrophic cardiomyopathy|Familial restrictive cardiomyopathy	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	19	55671337	19	55159969	369296	353525
NM_001256714.1(DNAAF3):c.1606G>A (p.Val536Met)	TNNI3|DNAAF3	Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Familial restrictive cardiomyopathy|Ciliary dyskinesia|Hypertrophic cardiomyopathy	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	19	55670651	19	55159283	369295	353524
NM_000363.4(TNNI3):c.-148A>G	TNNI3	Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Hypertrophic cardiomyopathy|Familial restrictive cardiomyopathy	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	19	55669105	19	55157737	369294	353523
NM_000363.4(TNNI3):c.-133G>T	TNNI3	Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	19	55669090	19	55157722	330203	350409
NM_000363.4(TNNI3):c.-103C>T	TNNI3	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Dilated Cardiomyopathy, Recessive|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	19	55669060	19	55157692	330202	334391
NM_000363.4(TNNI3):c.-85A>C	TNNI3	Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	19	55669042	19	55157674	330201	350406
NM_000363.4(TNNI3):c.157C>T (p.Leu53=)	TNNI3	Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	19	55667694	19	55156326	330200	344273
NM_000363.4(TNNI3):c.283-9C>T	TNNI3	Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	19	55666207	19	55154839	330199	349397
NM_000363.4(TNNI3):c.550-11C>T	TNNI3	Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	19	55663296	19	55151928	330198	344272
NM_001256714.1(DNAAF3):c.994-14C>T	TNNI3|DNAAF3	Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|not specified|Ciliary dyskinesia|Ciliary dyskinesia, primary, 2|Hypertrophic cardiomyopathy|Familial restrictive cardiomyopathy	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	19	55672569	19	55161201	257695	257247
NM_001256714.1(DNAAF3):c.870T>C (p.Ala290=)	TNNI3|DNAAF3	Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|not specified|Ciliary dyskinesia|Ciliary dyskinesia, primary, 2|Hypertrophic cardiomyopathy|Familial restrictive cardiomyopathy	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	19	55672784	19	55161416	257694	257248
NM_001256714.1(DNAAF3):c.733G>A (p.Gly245Ser)	TNNI3|DNAAF3	Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Ciliary dyskinesia|Hypertrophic cardiomyopathy|Familial restrictive cardiomyopathy|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	19	55673145	19	55161777	257691	257251
NM_001256714.1(DNAAF3):c.714A>G (p.Val238=)	TNNI3|DNAAF3	Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|not specified|Ciliary dyskinesia|Hypertrophic cardiomyopathy|Familial restrictive cardiomyopathy	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	19	55673164	19	55161796	257689	257252
NM_001256714.1(DNAAF3):c.531A>G (p.Arg177=)	TNNI3|DNAAF3	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Dilated Cardiomyopathy, Recessive|Ciliary dyskinesia|Hypertrophic cardiomyopathy|Familial restrictive cardiomyopathy|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	19	55673654	19	55162286	257688	257253
NM_001256714.1(DNAAF3):c.1440-8A>G	TNNI3|DNAAF3	Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Familial restrictive cardiomyopathy|Ciliary dyskinesia|Ciliary dyskinesia, primary, 2|Hypertrophic cardiomyopathy|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	19	55670825	19	55159457	257684	257238
NM_001256714.1(DNAAF3):c.1365-14C>T	TNNI3|DNAAF3	Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Familial restrictive cardiomyopathy|Ciliary dyskinesia|Hypertrophic cardiomyopathy|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	19	55670989	19	55159621	257682	257239
NM_001256714.1(DNAAF3):c.1257G>A (p.Pro419=)	TNNI3|DNAAF3	Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Familial restrictive cardiomyopathy|Ciliary dyskinesia|Ciliary dyskinesia, primary, 2|Hypertrophic cardiomyopathy|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	19	55671374	19	55160006	257680	257242
NM_001256714.1(DNAAF3):c.1205T>C (p.Leu402Pro)	TNNI3|DNAAF3	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Dilated Cardiomyopathy, Recessive|not specified|Ciliary dyskinesia|Hypertrophic cardiomyopathy|Familial restrictive cardiomyopathy	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	19	55672055	19	55160687	257679	257243
NM_001256714.1(DNAAF3):c.1079A>G (p.Glu360Gly)	TNNI3|DNAAF3	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Dilated Cardiomyopathy, Recessive|not specified|Ciliary dyskinesia|Ciliary dyskinesia, primary, 2|Hypertrophic cardiomyopathy|Familial restrictive cardiomyopathy	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	19	55672470	19	55161102	257676	257246
NM_000363.4(TNNI3):c.*35C>T	TNNI3	Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	19	55663167	19	55151799	188677	186575
NM_000363.4(TNNI3):c.372+7C>T	TNNI3	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Dilated Cardiomyopathy, Recessive|Familial restrictive cardiomyopathy|not specified|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	19	55666102	19	55154734	165519	176339
NM_000363.4(TNNI3):c.-35C>A	TNNI3|DNAAF3	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Dilated Cardiomyopathy, Recessive|Familial restrictive cardiomyopathy|not specified|Ciliary dyskinesia|Hypertrophic cardiomyopathy	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	19	55668992	19	55157624	137687	141390
NM_003283.5(TNNT1):c.33-8G>A	TNNI3|TNNT1	Nemaline Myopathy, Recessive|Familial restrictive cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Benign/Likely benign(Last reviewed: Jan 13, 2015)	criteria provided, multiple submitters, no conflicts	19	55658397	19	55147029	130603	136049
NM_000363.4(TNNI3):c.422G>A (p.Arg141Gln)	TNNI3	Primary familial hypertrophic cardiomyopathy|not provided|Cardiomyopathy|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Sep 15, 2017)	criteria provided, multiple submitters, no conflicts	19	55665525	19	55154157	43381	52551
NM_000363.4(TNNI3):c.25-8T>A	TNNI3|DNAAF3	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Dilated Cardiomyopathy, Recessive|Familial restrictive cardiomyopathy|not specified|Ciliary dyskinesia|Cardiomyopathy|Hypertrophic cardiomyopathy	Benign/Likely benign(Last reviewed: Oct 28, 2006)	criteria provided, multiple submitters, no conflicts	19	55668509	19	55157141	43371	52541
NM_000363.4(TNNI3):c.198G>A (p.Glu66=)	TNNI3	Cardiovascular phenotype|Familial restrictive cardiomyopathy|not specified|Cardiomyopathy|Hypertrophic cardiomyopathy|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Benign/Likely benign(Last reviewed: Dec 21, 2007)	criteria provided, multiple submitters, no conflicts	19	55667653	19	55156285	43364	52534
NM_000363.4(TNNI3):c.150+13G>A	TNNI3|DNAAF3	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Dilated Cardiomyopathy, Recessive|Familial restrictive cardiomyopathy|Ciliary dyskinesia|Hypertrophic cardiomyopathy|not specified	Benign/Likely benign(Last reviewed: Jun 27, 2011)	criteria provided, multiple submitters, no conflicts	19	55667958	19	55156590	43362	52532
NM_000363.4(TNNI3):c.12-7delC	TNNI3	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Dilated Cardiomyopathy, Recessive|Familial restrictive cardiomyopathy|not specified|Cardiomyopathy|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Jul 26, 2012)	criteria provided, conflicting interpretations	19	55668683	19	55157315	43361	52531
NM_003283.5(TNNT1):c.35A>G (p.Glu12Gly)	TNNI3|TNNT1	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Familial restrictive cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Dilated Cardiomyopathy, Recessive	Benign/Likely benign(Last reviewed: Mar 18, 2012)	criteria provided, multiple submitters, no conflicts	19	55658387	19	55147019	31865	40525
NM_003283.5(TNNT1):c.-20A>G	TNNI3|TNNT1	Nemaline Myopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Familial restrictive cardiomyopathy|not specified|not provided|Dilated Cardiomyopathy, Recessive|Hypertrophic cardiomyopathy	Benign/Likely benign(Last reviewed: Mar 18, 2012)	criteria provided, multiple submitters, no conflicts	19	55660537	19	55149169	31855	40515
NM_000363.4(TNNI3):c.607G>A (p.Gly203Ser)	TNNI3	Familial hypertrophic cardiomyopathy 7	Pathogenic(Last reviewed: Aug 1, 1997)	no assertion criteria provided	19	55663228	19	55151860	12432	27471
NM_000363.4(TNNI3):c.244C>T (p.Pro82Ser)	TNNI3	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Dilated Cardiomyopathy, Recessive|Cardiovascular phenotype|not specified|Familial hypertrophic cardiomyopathy 7|Hypertrophic cardiomyopathy|Familial restrictive cardiomyopathy|not provided|Cardiomyopathy	Benign/Likely benign, risk factor(Last reviewed: Jan 11, 2016)	criteria provided, multiple submitters, no conflicts	19	55667607	19	55156239	12421	27460
NM_000364.3(TNNT2):c.3G>A (p.Met1Ile)	TNNT2	Wolff-Parkinson-White pattern	Likely pathogenic(Last reviewed: Jul 14, 2017)	no assertion criteria provided	1	201342380	1	201373252	487631	480671
NM_003285.2(TNR):c.463T>A (p.Cys155Ser)	TNR	Parkinson disease	Uncertain significance(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	1	175375388	1	175406252	224865	226707
NM_003285.2(TNR):c.496A>G (p.Thr166Ala)	TNR	Parkinson disease	Uncertain significance(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	1	175375355	1	175406219	224864	226706
NM_003285.2(TNR):c.538A>C (p.Asn180His)	TNR	Parkinson disease	Uncertain significance(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	1	175372714	1	175403578	224863	226705
NM_003285.2(TNR):c.1732C>T (p.Arg578Ter)	TNR	Parkinson disease	Uncertain significance(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	1	175355213	1	175386077	224862	226704
NM_003285.2(TNR):c.1774A>G (p.Thr592Ala)	TNR	Parkinson disease	Uncertain significance(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	1	175355171	1	175386035	224861	226703
NM_017636.3(TRPM4):c.2732C>T (p.Thr911Met)	TRPM4	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	19	49703643	19	49200386	487616	480724
NM_001144832.2(TTC39A):c.1334C>T (p.Thr445Met)	TTC39A	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	1	51756242	1	51290570	487628	480680
NM_001144832.2(TTC39A):c.1502C>G (p.Ala501Gly)	TTC39A	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	1	51755680	1	51290008	487623	480679
NM_133432.3(TTN):c.40084C>T (p.Leu13362=)	TTN|TTN-AS1	Wolff-Parkinson-White pattern	Likely pathogenic(Last reviewed: Jul 14, 2017)	no assertion criteria provided	2	179445202	2	178580475	487595	480681
NM_133432.3(TTN):c.65863C>T (p.Arg21955Ter)	TTN|TTN-AS1	Primary dilated cardiomyopathy|Wolff-Parkinson-White pattern	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179413670	2	178548943	223300	225032
NM_021830.4(TWNK):c.1001G>A (p.Arg334Gln)	TWNK	Mitochondrial diseases|Progressive external ophthalmoplegia with mitochondrial DNA deletions, digenic	Pathogenic(Last reviewed: Aug 1, 2003)	no assertion criteria provided	10	102748968	10	100989211	4623	19662
NM_004181.4(UCHL1):c.*309T>C	UCHL1	Parkinson Disease, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	41270399	4	41268382	348778	294817
NM_004181.4(UCHL1):c.*294G>A	UCHL1	Parkinson Disease, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	41270384	4	41268367	348777	298513
NM_004181.4(UCHL1):c.*125C>T	UCHL1	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	41270215	4	41268198	348776	293418
NM_004181.4(UCHL1):c.609A>G (p.Glu203=)	UCHL1	Parkinson Disease, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	41270027	4	41268010	348775	298451
NM_004181.4(UCHL1):c.558C>T (p.Gly186=)	UCHL1	Parkinson Disease, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	41266151	4	41264134	348774	298512
NM_004181.4(UCHL1):c.527-3C>T	UCHL1	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	41266117	4	41264100	348773	298447
NM_004181.4(UCHL1):c.513C>T (p.His171=)	UCHL1	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	41265295	4	41263278	348772	298446
NM_004181.4(UCHL1):c.326-4delT	UCHL1	Parkinson Disease, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	41263728	4	41261711	348771	293417
NM_004181.4(UCHL1):c.175-5C>T	UCHL1	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	41262659	4	41260642	348770	298445
NM_004181.4(UCHL1):c.45+6T>C	UCHL1	Parkinson Disease, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	41259149	4	41257132	348769	293414
NM_004181.4(UCHL1):c.33+5G>C	UCHL1	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	41259031	4	41257014	348768	294808
NM_004181.4(UCHL1):c.-16C>T	UCHL1	Parkinson Disease, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	41258978	4	41256961	348767	294806
NM_004181.4(UCHL1):c.-24A>G	UCHL1	Parkinson Disease, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	41258970	4	41256953	348766	298506
NM_004181.4(UCHL1):c.-47C>T	UCHL1	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	41258947	4	41256930	348765	298505
NM_004181.4(UCHL1):c.-71C>G	UCHL1	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	41258923	4	41256906	348764	298441
NM_004181.4(UCHL1):c.20A>C (p.Glu7Ala)	UCHL1	Spastic paraplegia 79, autosomal recessive	Pathogenic(Last reviewed: Feb 26, 2013)	no assertion criteria provided	4	41259013	4	41256996	88635	94224
NM_004181.4(UCHL1):c.53C>A (p.Ser18Tyr)	UCHL1	Parkinson Disease, Dominant|Parkinson disease 5	Benign(Last reviewed: Jun 1, 2011)	criteria provided, multiple submitters, no conflicts	4	41259633	4	41257616	12298	27337
NM_004181.4(UCHL1):c.279C>G (p.Ile93Met)	UCHL1	Parkinson disease 5	risk factor(Last reviewed: Apr 1, 2006)	no assertion criteria provided	4	41262768	4	41260751	12297	27336
NM_014000.2(VCL):c.3379G>A (p.Val1127Ile)	VCL	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	10	75877901	10	74118143	487634	480706
NM_014000.2(VCL):c.550C>T (p.His184Tyr)	VCL	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	10	75832538	10	74072780	487630	480704
NM_014000.2(VCL):c.1928C>T (p.Thr643Met)	VCL	not provided|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	criteria provided, single submitter	10	75860761	10	74101003	487627	480705
NM_020821.2(VPS13C):c.9020G>A (p.Arg3007Gln)	VPS13C	Parkinson disease 23, autosomal recessive early-onset	Uncertain significance(Last reviewed: Feb 19, 2018)	no assertion criteria provided	15	62199548	15	61907349	599078	590310
NM_020821.2(VPS13C):c.387C>T (p.Gly129=)	VPS13C	Parkinson disease 23, autosomal recessive early-onset	Uncertain significance(Last reviewed: Apr 12, 2017)	criteria provided, single submitter	15	62320618	15	62028419	547944	538444
NM_020821.2(VPS13C):c.802_805dup (p.Arg269Thrfs)	VPS13C	Parkinson disease 23, autosomal recessive early-onset	Pathogenic(Last reviewed: Mar 18, 2016)	no assertion criteria provided	15	62305258 - 62305261	15	62013059 - 62013062	224604	226382
NM_020821.2(VPS13C):c.4777delC (p.Gln1593Lysfs)	VPS13C	Parkinson disease 23, autosomal recessive early-onset|Parkinson disease	Pathogenic(Last reviewed: Mar 18, 2016)	criteria provided, single submitter	15	62239491	15	61947292	222071	223767
NM_020821.2(VPS13C):c.4165G>C (p.Gly1389Arg)	VPS13C	Parkinson disease 23, autosomal recessive early-onset|Parkinson disease	Pathogenic(Last reviewed: Mar 18, 2016)	criteria provided, single submitter	15	62250807	15	61958608	222070	223768
NM_020821.2(VPS13C):c.9568G>T (p.Glu3190Ter)	VPS13C	Parkinson disease 23, autosomal recessive early-onset|Parkinson disease	Pathogenic(Last reviewed: Mar 18, 2016)	criteria provided, single submitter	15	62174851	15	61882652	222069	223765
NM_020821.2(VPS13C):c.806_807insCAGA (p.Arg269Serfs)	VPS13C	Parkinson disease	Pathogenic(Last reviewed: Nov 16, 2015)	criteria provided, single submitter	15	62305256 - 62305257	15	62013057 - 62013058	222068	223769
NM_020821.2(VPS13C):c.8445+2T>G	VPS13C	Parkinson disease 23, autosomal recessive early-onset|Parkinson disease	Pathogenic(Last reviewed: Mar 18, 2016)	criteria provided, single submitter	15	62207830	15	61915631	222067	223766
NM_018206.5(VPS35):c.1550T>G (p.Phe517Cys)	VPS35	Parkinson disease 17	Uncertain significance(Last reviewed: Feb 27, 2018)	criteria provided, single submitter	16	46702939	16	46669027	579180	570298
NM_018206.5(VPS35):c.1313G>A (p.Cys438Tyr)	VPS35	Parkinson disease 17	Uncertain significance(Last reviewed: May 7, 2018)	criteria provided, single submitter	16	46706232	16	46672320	571710	570197
NM_018206.5(VPS35):c.945A>T (p.Gly315=)	VPS35	Parkinson disease 17	Likely benign(Last reviewed: Oct 19, 2017)	criteria provided, single submitter	16	46708542	16	46674630	539748	530114
NM_018206.5(VPS35):c.2359G>A (p.Glu787Lys)	VPS35	Parkinson disease 17	Uncertain significance(Last reviewed: Apr 19, 2017)	no assertion criteria provided	16	46694416	16	46660504	487679	480750
NM_018206.5(VPS35):c.2320C>A (p.Leu774Met)	VPS35	Parkinson disease 17	Uncertain significance(Last reviewed: Apr 19, 2017)	no assertion criteria provided	16	46694455	16	46660543	487678	480751
NM_018206.5(VPS35):c.2210C>T (p.Ala737Val)	VPS35	Parkinson disease 17	Uncertain significance(Last reviewed: Apr 19, 2017)	no assertion criteria provided	16	46695631	16	46661719	487677	480752
NM_018206.5(VPS35):c.1819A>G (p.Met607Val)	VPS35	Parkinson disease 17	Uncertain significance(Last reviewed: Apr 19, 2017)	no assertion criteria provided	16	46696903	16	46662991	487676	480753
NM_018206.5(VPS35):c.1796A>G (p.His599Arg)	VPS35	Parkinson disease 17	Uncertain significance(Last reviewed: Apr 19, 2017)	no assertion criteria provided	16	46696926	16	46663014	487675	480754
NM_018206.5(VPS35):c.1679T>C (p.Ile560Thr)	VPS35	Parkinson disease 17	Uncertain significance(Last reviewed: Apr 19, 2017)	no assertion criteria provided	16	46697043	16	46663131	487674	480755
NM_018206.5(VPS35):c.1570C>T (p.Arg524Trp)	VPS35	Parkinson disease 17	Uncertain significance(Last reviewed: Apr 19, 2017)	no assertion criteria provided	16	46702919	16	46669007	487673	480756
NM_018206.5(VPS35):c.1520A>T (p.Tyr507Phe)	VPS35	Parkinson disease 17	Uncertain significance(Last reviewed: Apr 19, 2017)	no assertion criteria provided	16	46705621	16	46671709	487672	480757
NM_018206.5(VPS35):c.946C>T (p.Pro316Ser)	VPS35	Parkinson disease 17	Uncertain significance(Last reviewed: Apr 19, 2017)	no assertion criteria provided	16	46708541	16	46674629	487671	480758
NM_018206.5(VPS35):c.723T>G (p.Ile241Met)	VPS35	Parkinson disease 17	Uncertain significance(Last reviewed: Apr 19, 2017)	no assertion criteria provided	16	46711308	16	46677396	487670	480759
NM_018206.5(VPS35):c.171G>A (p.Met57Ile)	VPS35	Parkinson disease 17	Uncertain significance(Last reviewed: Apr 19, 2017)	no assertion criteria provided	16	46716019	16	46682107	487669	480760
NM_018206.5(VPS35):c.151G>A (p.Gly51Ser)	VPS35	Parkinson disease 17	Uncertain significance(Last reviewed: Apr 19, 2017)	no assertion criteria provided	16	46716039	16	46682127	487668	480761
NM_018206.5(VPS35):c.1938T>C (p.His646=)	VPS35	Parkinson disease 17	Benign(Last reviewed: Dec 29, 2017)	criteria provided, single submitter	16	46696284	16	46662372	472501	466454
NM_018206.5(VPS35):c.1881C>T (p.Ala627=)	VPS35	Parkinson disease 17	Likely benign(Last reviewed: Jul 10, 2017)	criteria provided, single submitter	16	46696341	16	46662429	472500	466705
NM_018206.5(VPS35):c.1391T>C (p.Val464Ala)	VPS35	Parkinson disease 17	Uncertain significance(Last reviewed: Jan 27, 2017)	criteria provided, single submitter	16	46705750	16	46671838	472499	466476
NM_018206.5(VPS35):c.-35C>T	VPS35	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	16	46723080	16	46689168	319299	325368
NM_018206.5(VPS35):c.-19C>T	VPS35	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	16	46723064	16	46689152	319297	325366
NM_018206.5(VPS35):c.89T>A (p.Met30Lys)	VPS35	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	16	46717433	16	46683521	319296	335061
NM_018206.5(VPS35):c.678C>T (p.Arg226=)	VPS35	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	16	46712897	16	46678985	319295	341511
NM_018206.5(VPS35):c.851G>A (p.Arg284Gln)	VPS35	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	16	46710558	16	46676646	319294	343010
NM_018206.5(VPS35):c.1035G>A (p.Glu345=)	VPS35	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	16	46708351	16	46674439	319293	335043
NM_018206.5(VPS35):c.1145A>G (p.Lys382Arg)	VPS35	Parkinson Disease, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	16	46708241	16	46674329	319292	325362
NM_018206.5(VPS35):c.1488T>C (p.His496=)	VPS35	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	16	46705653	16	46671741	319291	335042
NM_018206.5(VPS35):c.1912A>T (p.Met638Leu)	VPS35	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	16	46696310	16	46662398	319290	341506
NM_018206.5(VPS35):c.2241C>T (p.Ile747=)	VPS35	Parkinson Disease, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	16	46694534	16	46660622	319289	325360
NM_018206.5(VPS35):c.*258del	VPS35	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	16	46694126	16	46660214	319288	341504
NM_018206.5(VPS35):c.*259_*260dup	VPS35	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	16	46694124 - 46694125	16	46660212 - 46660213	319287	335039
NM_018206.5(VPS35):c.*275_*276insCAA	VPS35	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	16	46694108 - 46694109	16	46660196 - 46660197	319286	343006
NM_018206.5(VPS35):c.*276A>C	VPS35	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	16	46694108	16	46660196	319285	341503
NM_018206.5(VPS35):c.*276_*277insCAA	VPS35	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	16	46694107 - 46694108	16	46660195 - 46660196	319284	341499
NM_018206.5(VPS35):c.*277_*278insCA	VPS35	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	16	46694106 - 46694107	16	46660194 - 46660195	319283	325358
NM_018206.5(VPS35):c.*278_*279insCAA	VPS35	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	16	46694105 - 46694106	16	46660193 - 46660194	319282	343005
NM_018206.5(VPS35):c.*279_*280insCAAA	VPS35	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	16	46694104 - 46694105	16	46660192 - 46660193	319281	343001
NM_018206.5(VPS35):c.*282_*283insAAAA	VPS35	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	16	46694101 - 46694102	16	46660189 - 46660190	319280	325355
NM_018206.5(VPS35):c.*282_*283insAAA	VPS35	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	16	46694101 - 46694102	16	46660189 - 46660190	319279	342998
NM_018206.5(VPS35):c.*283del	VPS35	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	16	46694101	16	46660189	319278	325357
NM_018206.5(VPS35):c.*283_*284del	VPS35	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	16	46694100 - 46694101	16	46660188 - 46660189	319277	342996
NM_018206.5(VPS35):c.*285_*287dup	VPS35	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	16	46694097 - 46694099	16	46660185 - 46660187	319276	342992
NM_018206.5(VPS35):c.*287dup	VPS35	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	16	46694097	16	46660185	319275	342995
NM_018206.5(VPS35):c.*287_*288insAAAC	VPS35	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	16	46694096 - 46694097	16	46660184 - 46660185	319274	335036
NM_018206.5(VPS35):c.*287_*288insAAC	VPS35	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	16	46694096 - 46694097	16	46660184 - 46660185	319273	342991
NM_018206.5(VPS35):c.*346G>A	VPS35	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	16	46694038	16	46660126	319272	342990
NM_018206.5(VPS35):c.*354G>C	VPS35	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	16	46694030	16	46660118	319271	342989
NM_018206.5(VPS35):c.*380G>A	VPS35	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	16	46694004	16	46660092	319270	341497
NM_018206.5(VPS35):c.*401G>A	VPS35	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	16	46693983	16	46660071	319269	342987
NM_018206.5(VPS35):c.*617A>G	VPS35	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	16	46693767	16	46659855	319268	341495
NM_018206.5(VPS35):c.*761_*762dup	VPS35	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	16	46693622 - 46693623	16	46659710 - 46659711	319267	335034
NM_018206.5(VPS35):c.*762dup	VPS35	Parkinson Disease, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	16	46693622	16	46659710	319266	341491
NM_018206.5(VPS35):c.1576C>T (p.Arg526Cys)	VPS35	Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 22, 2014)	no assertion criteria provided	16	46702913	16	46669001	96727	102613
NM_018206.5(VPS35):c.1858G>A (p.Asp620Asn)	VPS35	Parkinson disease 17	Pathogenic(Last reviewed: Oct 1, 2012)	no assertion criteria provided	16	46696364	16	46662452	30196	39152
NM_007013.3(WWP1):c.1879A>T (p.Met627Leu)	WWP1	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	8	87454888	8	86442659	487621	480701
